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Abstract 
 
Bovine Tuberculosis (TB), caused by Mycobacterium bovis (M.bovis), has seen a 
significant rise in incidence in recent years, posing a considerable burden to the UK 
economy. Protective immunity is associated in part, with rapid IFNγ production and 
early Th1 polarisation. Natural Killer (NK) cells are known to be a significant source of 
IFNγ and may therefore play a pivotal role in the innate immune response to 
mycobacterial infection. This study hypothesised that bovine NK cells participate in the 
immune response to bovine TB by migrating towards and reciprocally interacting with 
M.bovis infected dendritic cells (DCs). 
Bovine NK cells comprise a heterogeneous population characterised by the expression 
of NKp46 and CD2. Quantitative PCR analyses revealed that blood derived NKp46+ 
CD2- NK cells transcribed higher levels of important inflammatory and lymphoid 
homing chemokine receptors and preferentially migrated towards M.bovis infected 
DCs within in vitro chemotaxis assays when compared with NKp46+ CD2+ NK cells. 
Furthermore, within co-culture assays, M.bovis infected DCs selectively induced the 
release of IFNγ from NKp46+ CD2- NK cells with no detectable levels of IFNγ produced 
by NKp46+ CD2+ cells. This was partially reliant upon IL-12 secreted by M.bovis 
infected DCs as well as direct cell-cell contact. In addition, NKp46+ CD2- NK cells were 
able to reciprocally activate infected DCs resulting in up-regulation of cell surface MHC 
class II. Furthermore, IFNγ expressing NKp46+ CD2- NK cells were detected in the 
peripheral circulation of cattle as early as two days following experimental infection 
with M.bovis. 
This study has provided evidence of reciprocal interactions between CD2- NK cells and 
mycobacterially infected DCs that could augment both antigen presentation and Th1 
biased immune responses. Therefore, this minor blood derived CD2- NK cell subset 
may be selectively responsible for promoting a protective immune response during the 
early phases of M.bovis infection and represents a potential target for future 
vaccination strategies. 
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1 Introduction  
1.1 Tuberculosis   
Tuberculosis (TB), a chronic respiratory illness caused by mycobacterial pathogens 
afflicts both humans and animals and may be fatal if left untreated. Despite being the 
focus of substantial global investment and scientific research for a number of years, TB 
is still the leading cause of mortality from a bacterial infection (WHO, 2010). 
Furthermore, infection of wildlife and domesticated animals inflicts significant 
economic damage, particularly apparent within the UK and may still pose a public 
health risk if appropriate preventative strategies are not employed (Cosivi et al., 1998, 
Thoen et al., 2006). In light of the global burden inflicted by TB, there is a fundamental 
need for research to elucidate immunological responses to mycobacterial infection 
which may underpin the future development of prophylactic, diagnostic and treatment 
strategies.  
1.1.1 The Mycobacterium tuberculosis (M.tb) complex  
In 1882 following experimental examination of tuberculous lesions from a range of 
hosts, Robert Koch first identified a slow replicating, acid fast bacillus as the causative 
agent of TB. At first believed to be only one species, later comparisons of isolates from 
humans and cattle suggested minor phenotypic differences may exist between the 
bacilli (de la Rua-Domenech, 2006). It was not until the advent of genomic sequencing 
that the multitudes of species were fully defined differing only in important deletions 
of genes found within the region of difference 1 (RD1) (Mostowy et al., 2005, Brosch et 
al., 2002). The M.tb complex therefore, identifies a group of mycobacterial species and 
sub-species which possess the capacity to induce TB. These include, M.tuberculosis, 
M.bovis, M.bovis BCG, M.africanum, M.microti, M. canettii, M. caprae, M. pinnipedii 
(Wirth et al., 2008, Mostowy et al., 2005). TB within humans is most commonly as a 
result of infection with M.tuberculosis, whilst comparatively, M.bovis a zoonotic 
pathogen, is able to infect a large range of mammalian hosts (Thoen et al., 2006). For 
this reason it was historically believed that M.bovis was a predecessor of 
M.tuberculosis with infected animals transmitting disease to humans (Smith et al., 
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2006). However, evolutionary sequence analysis elucidated the existence of two 
independent lineages originating over 40,000 years ago (Wirth et al., 2008). Both 
strains were believed to have infected humans but one of which may have been 
transmitted from humans to their livestock to give rise to the M.bovis strain which is 
rife within the wildlife and domesticated animal populations today (Mostowy et al., 
2005).    
1.1.2 Human tuberculosis infection 
The World Health Organisation (WHO) defined TB as global pandemic within the 
human population and in 2009 alone reported over 9 million cases of active infection 
with 1.7 million lives lost as a consequence (WHO, 2010). Strategies such as the DOT 
initiative (Directly Observed Therapy) introduced in the mid 1990’s and the subsequent 
Stop TB Partnership have contributed to the effective control of TB in the developed 
world. The majority of disease burden that is still seen today is found in regions of 
Africa and South East Asia, particularly prevalent as a concurrent infection within 
immune suppressed individuals (WHO, 2010).  
In most cases, TB infection is caused by the virulent strain M.tuberculosis, transmitted 
through inhalation of aerosolised bacilli released from infected individuals. During 
primary infection, mycobacterial pathogens manifest within the respiratory tract and 
apical lobes of the lungs and as a rare occurrence may result in active TB infection 
(Flynn and Chan, 2001). However in most individuals, the immune system possesses 
the capacity to control bacterial replication and contain the infection within a 
granulomatous Gohn Focus resulting in a latent infection without clinical symptoms. 
It is predicted that one third of the world’s population may be latently infected with TB 
and in the majority, mycobacteria remain dormant for the duration of their lifetime. 
However, in certain instances where the immune response appears unable to control 
bacterial replication, re-activation may occur resulting in active TB infection. Despite 
the focus of substantial research, the trigger which enables re-activation is not known 
but susceptibility in this manner is strongly associated with periods of immune 
suppression. This is particularly apparent in the developing world where concomitant 
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infections of TB commonly afflict HIV sufferers and account for almost 25% of the total 
TB related deaths (WHO, 2010).  
Upon active infection, the manifestation and severity of TB varies substantially 
between individuals and is influenced by the predisposing disease status as well as the 
length of time left untreated. If pathogenic bacilli are restricted within the respiratory 
tract and lungs, infection is defined as pulmonary TB with affected individuals 
commonly presenting with a persistent cough, haemoptysis, flu-like symptoms, 
malaise, fever and weight loss. In more severe cases extra-pulmonary infection is 
defined by local spread of mycobacteria resulting in pleural effusions or spread to local 
lymph nodes. In rare cases, commonly following re-activation and a long period of un-
diagnosed infection, patients suffer with severe wide-spread dissemination of 
mycobacteria defined as miliary TB infection. 
Whilst the majority of the cases of TB within humans are considered to be as a result 
of M.tuberculosis, the clinical presentation of zoonotic infection from M.bovis is 
indistinguishable from that of M.tuberculosis. Within the UK, M.bovis was historically 
believed to be the major source of extra-pulmonary TB infection of infants due to 
consumption of unsterilised cow’s milk (Thoen et al., 2006, de la Rua-Domenech, 
2006). The routine introduction of pasteurisation and strategies to reduce exposure 
from handling of infected animals reduced the incidence rates substantially and as a 
result is rare in today’s society, accounting for only 1% of cases (de la Rua-Domenech, 
2006). However, identification of the TB causing mycobacterial species requires 
specialised diagnostic facilities often not employed particularly in developing regions, 
therefore whilst considered a rare occurrence, the true prevalence of TB due to 
M.bovis within these regions is not known but may be as many as 10% of all cases 
(Cosivi et al., 1998). 
1.1.2.1 Diagnostic and treatment strategies  
Diagnostic measures to detect active TB infection vary substantially and whilst the 
protocols employed should depend on individual requirements, often in developing 
countries financial constraints restrict the use of specialised diagnostic protocols. Upon 
presentation of symptoms associated with TB, the presence of mycobacteria is 
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detected by acid fast (Zeihl-Neelson (ZN)) staining of sputum samples followed by 
chest radiography (Parsons et al., 2011). Detection of mycobacteria by ZN staining is 
the current ‘gold standard’ test used world-wide yet there are numerous constraints to 
this approach if secondary diagnostics are not employed. In particular, accurate 
diagnosis is heavily reliant on the ability to obtain an adequate sputum sample, may 
not be sensitive in HIV infected individuals and cannot differentiate between 
mycobacterial species or establish susceptibility to antimicrobial treatments (Parsons 
et al., 2011). Second line diagnostics are available within specialised laboratories and 
include determination of drug susceptibility of isolates by culture on solid or liquid 
media. Whilst, a long process due to the slow replication rate of mycobacteria, 
identification of drugs able to restrict mycobacterial growth can enable drug treatment 
strategies to be tailored to an individual’s requirements. More recently, highly specific 
DNA sequence based techniques have become available and are able to differentiate 
between strains of mycobacteria by PCR amplification (Reddington et al., 2011).  
Tuberculin skin testing regimes such as the Heaf or Mantoux test administer 
mycobacterial antigens to the skin with the subsequent development of delayed type 
hypersensitivity (DTH) responses reliant on the presence of antigen specific T cells. It is 
however important to consider that DTH responses only confirm the presence of 
mycobacteria specific adaptive immune responses which may be present within 
vaccinated, infected, treated or latently infected individuals. Furthermore, false 
negative diagnoses may be made within actively infected individuals that are immune 
compromised (Michel et al., 2010). More selective diagnostic regimes such as IFNγ 
release assays (IGRA), currently licensed as QuantiFERON-TB Gold (Cellestis) and T-
SPOT®.TB (Oxford Immunotec) are able to detect M.tuberculosis specific release of 
IFNγ upon re-stimulation with mycobacterial antigens. As such the ELISPOT based 
assay to diagnose active TB infection improves the specificity and sensitivity (83-97%) 
over use of the tuberculin skin test. However, no test is able to distinguish between 
active and latent TB infection (Lalvani, 2007, Menzies et al., 2007). 
TB is a treatable infection and the course of treatment is largely determined by the 
severity of infection. As a standard regime sufferers of pulmonary TB will receive 
combinations of antibiotic therapy including initially isoniazid, rifampicin, pyrazinamide 
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and ethambutol for a period of up to six months (NHS, 2011). However, poor patient 
compliance, amongst other factors, has led to the emergence of multi-drug resistant 
(MDR) strains of TB which are resistant to the first line antibiotics isoniazid and 
rifampicin. Yet more serious is the emergence of extremely drug-resistant (XDR) strains 
of TB which are able to replicate despite treatment with second line antibiotics 
(Gandhi et al., 2010). For this reason the current treatment regimes are considered 
antiquated and substantial scientific research is being conducted to aid drug discovery. 
Whilst diagnosis of TB by the protocols described identifies infected individuals, it does 
not circumvent the spread of infection that may have already occurred prior to 
detection and subsequent treatment. Diagnostic strategies for the future aim to 
differentiate between the heterogeneous phenotypes resulting following 
mycobacterial exposure. One of the most significant modern day challenges to the 
future of TB diagnoses lies in the identification of latently infected individuals 
susceptible to re-activation. Current strategies to address this are employing cytokine 
profiling (Sester et al., 2011) or whole genome approaches, seeking to identify 
signatures evident within the blood which may correlate with latency, vaccination or 
infection (Parida and Kaufmann, 2010).  
1.1.3 Bovine tuberculosis  
Several species of mycobacteria within the M.tb complex are able to infect wildlife and 
domesticated animal populations however; M.bovis afflicts the widest range of hosts 
and is most commonly the causative agent for bovine tuberculosis (bTB). Whilst cattle 
are the primary hosts for infection, M.bovis has also been found to be endemic within 
the wild badger population in the UK (Krebs et al., 1998). Furthermore, bovine TB is an 
issue of global significance and is rife within many wildlife populations including Brush-
Tailed Possums in New Zealand, White-Tail Deer in Michigan and Wild Boar in Spain 
(Buddle et al., 2011). 
1.1.3.1 Pathogenesis of bovine TB 
M.bovis is highly virulent in cattle with as little as 1 CFU administered intra-tracheally 
able to induce a pathological response (Dean et al., 2005). Infection predominantly 
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occurs by inhalation of bacilli carried within aerosols to the respiratory tract. This is 
evidenced by the post-mortem examination of naturally infected cattle with caseous 
and necrotic granulomas in the lymph nodes and tissues within the head, respiratory 
tract and thorax. Lesions are most commonly found within the respiratory tract alone 
(approximately 60% of cattle) whereas the remainder may present with additional 
lesions within tissues of the head (Corner, 1994, Neill et al., 2001, Neill et al., 1994, 
Whipple et al., 1996). In particular the retropharyngeal, bronchial and mediastinal 
lymph nodes as well as the lungs are primarily afflicted by infection (Liebana et al., 
2008, Neill et al., 2001). Disseminated TB is an extremely rare occurrence largely as a 
result of active control programs able to identify infected cattle prior to substantial 
spread of infection.  
1.1.3.2 Incidence and control strategies in the UK 
In 1934 within the UK, over 40% of dairy cattle were believed to be carriers of bovine 
TB infection and due to the consumption of contaminated milk, were a significant 
source of zoonotic TB amongst infants (de la Rua-Domenech, 2006). Subsequent steps 
were taken by the British government in attempts to eradicate TB within cattle with 
compulsory testing of herds introduced in the 1950’s and still conducted today. 
Regions with high incidence of bovine TB are tested annually with lower incremental 
testing in regions with lower incidence. In this manner, up until the 1970’s these ‘test 
and slaughter’ control strategies contributed to a significant decline with the lowest 
ever recorded incidences of bovine TB. However, over the past 40 years there has 
been a substantial increase in the number of herd breakdowns particularly evident in 
the South West regions of the UK (de la Rua-Domenech, 2006), with spread of 
infection into areas previously free of bovine TB such as Wales and West Midland 
regions. In 2009 alone DEFRA (Department for Environment, Food and Rural Affairs) 
reported over 30,000 cattle reactors with a cost in excess of £100 million to the UK 
economy (DEFRA, 2009).  
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Illustration of the spread of bovine TB into new areas of the UK from 1985-2006, 
Source VLA; January 2009 
 
The reasons for the dramatic rise in the prevalence of bovine TB are not known 
however, as an infectious pathogen both cattle-cattle and wildlife-cattle transmission 
may account for the persistence of infection and the subsequent repeated herd 
breakdowns that are observed. In particular, within the UK an environmental reservoir 
of infection exists within the wild badger population and has been implicated as a 
significant source of transmission to cattle (Krebs et al., 1998, Smith et al., 2006). To 
determine whether the culling of badgers would benefit the incidence rates of bovine 
TB, a randomised badger culling trial (RBCT) was implemented in 1998 within the most 
severely afflicted regions of the UK. Initial analysis suggested that the removal of 
reservoirs of infection may be beneficial with a reduction in the incidence rates within 
the areas where active culling was conducted. However, in adjacent regions there was 
an observed increase in the number of herd breakdowns potentially due to the 
dissemination of infected badgers (Donnelly et al., 2003). Furthermore, the initial 
reduction in incidence was not sustained following cessation of culling and would 
require a repeated long-term initiative to remove infected badgers, not considered as 
financially viable (Jenkins et al., 2010). In addition, culling strategies employed in 
Ireland revealed that the removal of infected badgers did not substantially influence 
disease prevalence within the remaining badger populations (Corner et al., 2008). 
Despite a large body of evidence suggesting badger culling may be ineffective, the UK 
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government is likely to approve further widespread trials within England. However, 
there is also a need for more effective and economical strategies to be employed in 
the control of bovine TB (1.1.3.4). 
1.1.3.3 Diagnostics 
In the UK, diagnosis is performed by the single intra-dermal comparative cervical skin 
test (SICCT) via administration of tuberculin derived from Mycobacterium avium 
subspecies avium (PPDa) and M.bovis (PPDb) (Morrison et al., 2000). Measurement of 
a delayed type hypersensitivity response (DTH) in this manner indicates the presence 
of antigen specific T cell activity, however sensitivity is often reported as being 
relatively poor ranging from 68-95% (Monaghan et al., 1994). Further testing strategies 
include the whole blood assay, BOVIGAM® measuring antigen (PPDb) specific IFNγ 
production which improves the sensitivity and specificity (96-98%) over use of the 
tuberculin skin test alone (Coad et al., 2008). Despite this, IFNγ assays are only used in 
certain circumstances as an ancillary to skin testing in cases where the results may be 
inconclusive.  
The historical incidence rates of bovine TB within different regions of the UK are used 
as a basis to determine the frequency of testing intervals. Cattle within high incidence 
areas as is the case within the south west are currently skin tested every 12 months. If 
the thickening of skin in response to PPDb is greater than 4mm over the response to 
PPDa, cattle are classified as reactors. A smaller (1-4mm) response results in an 
inconclusive status with cattle re-tested after a 60 day interval. Reactor cattle will 
subsequently be slaughtered with restrictions on herd movements placed on the farm 
in attempts to control the spread of infection. Upon slaughter, all animals undergo 
post-mortem examinations conducted at the Veterinary Laboratories Agency involving 
histological examinations of tissues for the presence of lesions, bacteriological culture 
and molecular typing of isolates to define strain identities. 
As is the case with human TB, there is substantial heterogeneity in the phenotypes 
that result following exposure to mycobacterial pathogens in cattle. For this reason, 
current testing strategies identifying reactivity to mycobacterial antigens may result in 
both false positive and false negative diagnoses. In particular, skin testing relies on the 
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development of an adequate adaptive immune response and therefore, may not be 
able to detect animals during the early stages of infection, during later stages when 
the adaptive immune response may wane (de la Rua-Domenech, 2006) or when 
immune-compromised as may be the case with concurrent infections of bovine viral 
diarrhoea virus (BVDV) (Charleston et al., 2001). Furthermore, in many instances cattle 
may respond positively in the tuberculin skin test despite no pathological evidence of 
infection. For example, environmental exposure to pathogens such as M. avium 
subspecies Paratuberculosis may result in non specific reactivity (Olsen and Storset, 
2001). A comparative skin test is therefore employed and the relative DTH response to 
PPDa and PPDb is measured with a stronger response to PPDb considered to be 
infected with M.bovis rather than other mycobacterial species. However, this does not 
entirely resolve the issue of sensitisation, with elevated responses in very young cattle 
potentially due to large numbers of NK cells (Olsen et al., 2005) or BCG vaccinated 
animals which are also able to respond non-specifically. This may also be the case 
during latent infection, the existence of which however, has not been definitively 
proven in cattle (Pollock and Neill, 2002, Van Rhijn et al., 2008). 
To a certain extent, whole blood IFNγ testing is more sensitive and can circumvent 
these issues. In particular, use of M.bovis specific antigens belonging to the ESAT-6 
(early secreted antigen 6KDa) family (Jones et al., 2010a) can differentiate between 
BCG vaccinated and M.bovis infected cattle (Vordermeier et al., 2002) and sensitivity 
of the assay can be improved by simultaneous testing of IL1β alongside IFNγ (Jones et 
al., 2010b). Yet, testing in this manner is not routinely employed due to economic 
constraints and difficulties with use in the field.  
1.1.3.4 Vaccination  
As a long-term solution, it is believed that development of a vaccine for cattle will be 
the most effective strategy in the control of bovine TB infection (Krebs et al., 1998). 
Ideally, such a prophylactic strategy would prevent the onset of infection and 
subsequent transmission yet, exposure to mycobacteria results in heterogeneous 
phenotypes and as such, complete sterilisation is an unlikely occurrence. Within cattle, 
a protective vaccine is therefore defined by its capacity to significantly reduce or 
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completely inhibit the pathological signs of TB infection (Hope and Villarreal-Ramos, 
2008, Vordermeier et al., 2002). Due to the costly nature of M.bovis experimental 
challenge studies, the identification of correlates of protection to aid selection of 
vaccine candidates has been a significant research priority. 
A Th1 immune response is believed to be imperative for protection against 
mycobacterial infection (Welsh et al., 2005, Orme, 2004). Therefore, vaccine efficacy 
has generally been determined by antigen specific IFNγ release following re-
stimulation of whole blood, yet post-vaccination levels of IFNγ do not necessarily 
correlate with protection (Mittrucker et al., 2007, Vordermeier et al., 2002, Waters et 
al., 2010, Buddle et al., 1995) and post-infection, elevated levels of PPDb or ESAT6 
specific IFNγ are indicative of increased severity of infection (Vordermeier et al., 2002). 
It has been reported that measurement of IFNγ produced specifically by central 
memory T cells within a cultured ELISPOT assay may be a more accurate correlate with 
levels corresponding with vaccine induced protection (Vordermeier et al., 2009b, Hope 
et al., 2011). However, (Buddle et al., 2005) suggested that measurement of a range of 
cytokines may be a more accurate indicator of vaccine success or failure and 
identification of novel correlates is therefore a significant focus of research.   
1.1.3.4.1 Bacille Calmette-Geurin (BCG) Vaccine  
Following serial passage of M.bovis, multiple gene deletions in the RD1 regions 
resulted in a mycobacterial strain which lacked important virulence factors and 
appeared to be protective against infection with M.tuberculosis. To date, M.bovis 
Bacille Calmette-Geurin (BCG) is the only licensed vaccine for the prevention of TB and 
is routinely administered to humans world-wide. However, the protective efficacy of 
BCG varies substantially, thought to be most effective in the prevention of severe 
disseminated TB infection within infants yet with variable levels of protection against 
pulmonary infection in both infants and adults (Fine, 1995) and waning protection with 
increasing age (Weir et al., 2008). In a similar manner, responses in cattle are also 
variable (Buddle et al., 1995, Buddle et al., 2002) with better protection following 
neonatal vaccination (Buddle et al., 1995, Hope et al., 2005b, Hope et al., 2011). BCG 
induced protective responses in cattle are associated with a reduction in the severity 
 
27 
of infection evidenced by inhibition of bacterial colonisation resulting in reduced 
spread of infection and reduction in shedding (Buddle et al., 1995, Hope et al., 2011, 
Suazo et al., 2003).    
Despite substantial research, the immunological responses that determine BCG 
efficacy are not fully understood. Several studies have defined a role of prior exposure 
to environmental mycobacteria as a compromising factor in both humans (Fine, 1995) 
and cattle (Buddle et al., 2002) resulting in inappropriate priming of the immune 
response such that subsequent vaccination with BCG is ineffective. However, the type 
of mycobacteria within the environment appears to be influential as M.avium 
exposure did not interfere with BCG vaccination and conferred a degree of protection 
to M.bovis challenge in cattle, yet did influence diagnostic testing (Hope et al., 2005a, 
Thom et al., 2008). 
Issues relating to environmental mycobacteria may be avoided by immunisation of 
neonates which has been shown to be protective in humans (Marchant et al., 1999) 
and cattle (Buddle et al., 1995, Hope et al., 2011, Hope et al., 2005b). In this case, the 
innate immune system may play a fundamental role in the early development of a Th1 
biased memory T cell immune response (Tastan et al., 2005, Marchant et al., 1999, 
Price et al., 2007, Hope and Villarreal-Ramos, 2008, Buza et al., 2009). BCG is therefore 
administered to infants world-wide and remains the only effective vaccination strategy 
for prevention of TB. However, vaccination of cattle with BCG results in non-specific 
sensitisation to the tuberculin skin test and is therefore not permitted under EU 
legislation. The use of BCG within cattle will require changes in the law alongside 
diagnostic regimes which are not compromised by vaccination. Therefore, significant 
research is being conducted to identify alternative strategies to control the incidence 
of bovine TB in the UK.  
The targeting of wildlife reservoirs directly is an appealing prospect and would 
circumvent issues related to diagnostic testing in cattle. It has been proposed that the 
oral delivery of BCG incorporated into baits would be the most cost-effective means of 
vaccine delivery to wildlife (Buddle et al., 2011). Within experimental challenge studies 
the oral administration of a lipid formulated BCG vaccine imparted protective 
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immunity to badgers with a reduced number and severity of lesions (Corner et al., 
2010). Despite promising results the implications of faecal shedding resulting in 
exposure of BCG to cattle suggests that substantial control strategies would need to be 
implemented prior to vaccine delivery by this route. Recent research has however 
proposed that subcutaneous BCG vaccination of badgers may also impart a degree of 
protection (Lesellier et al., 2009) and may be a viable strategy in attempts to control 
transmission of M.bovis to cattle. To this effect the BCG vaccine was licensed for use in 
badgers and trials are currently being conducted in high burden regions of the UK. 
1.1.3.4.2 Current research – vaccines and diagnostics for bovine TB  
Numerous strategies have been explored in the development of a vaccine against 
bovine TB and are often benchmarked against BCG as an indicator of vaccine success. 
Novel live attenuated strains of M.bovis were able to impart protection against 
subsequent challenge in cattle (Buddle et al., 2002) however; this strategy is unlikely to 
be successful due to safety concerns in the field (Hope and Villarreal-Ramos, 2008). 
Alternative strategies include the use of subunit vaccines; DNA vaccines encoding the 
immuno-dominant antigens MPB70 and MPB83 did not prevent M.bovis infection 
(Wedlock et al., 2003) with protein subunit vaccines showing more promise. 
Administration of a mixture of mycobacterial proteins in the form of culture filtrate 
protein (CFP), CpG oligodeoxynucleotides (ODN) and an oil in water adjuvant induced a 
degree of protection with the adjuvant used of significant importance (Wedlock et al., 
2005b). For this reason, identification of novel adjuvants has been a focus of vaccine 
research; water-in-oil emulsion was found to induce both effector and central memory 
T cell immune responses (Vordermeier et al., 2009a). Furthermore, the targeting of 
dendritic cells with adjuvants is considered an important approach to induce innate 
and adequately prime adaptive immune responses (Hope and Villarreal-Ramos, 2008, 
Wedlock et al., 2008).   
To date, only heterologous prime boosting strategies appear able to improve on the 
protection observed with BCG alone. DNA vaccines imparted significant protection but 
only with BCG as a booster vaccine (Skinner et al., 2003). Additionally, the efficacy of 
the CFP subunit vaccine could be improved when administered with BCG and was 
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found to be more protective than BCG alone (Wedlock et al., 2005a). The use of 
replication deficient viral vectors expressing mycobacterial antigens has been a focus 
of substantial research in the design of prime-boost vaccines in both humans and 
cattle. In particular, the use of a BCG prime followed by boosting with modified 
vaccinia virus ankara (MVA) expressing the mycobacterial antigen Ag85a is currently 
undergoing clinical trials as a protective vaccine against human TB (McShane and Hill, 
2005). In cattle, BCG vaccination was followed by administration of either MVA or 
adenovirus expressing Ag85a. Following infection with M.bovis, significant protection 
was observed over use of BCG alone with a number of cattle displaying signs of 
complete protection (Vordermeier et al., 2009b). Furthermore, the route of vaccine 
administration is likely to be a significant factor where strategies employing mucosal 
immunisation show promise. In mice, only intranasal boosting with adenovirus 
expressing Ag85a induced antigen specific T cell responses within the airways and 
subsequent protection against M.tuberculosis challenge (Santosuosso et al., 2005). It is 
not known whether this is the case in cattle, and is currently the focus of research.  
Despite significant promise vaccination strategies which employ the use of BCG will not 
be routinely administered unless there is an appropriate diagnostic testing procedure 
in place which is not compromised by BCG vaccination as is the case with the current 
tuberculin skin test. Alongside the development of a vaccine, there is therefore also a 
need to develop a test for cattle which is able to differentiate between vaccinated and 
infected animals (DIVA). To this effect, studies have targeted M.bovis specific antigens 
such as ESAT-6 and CFP-10 which are encoded within the RD1 gene regions missing 
from BCG (Jones et al., 2010a). Stimulation of whole blood with these antigens was 
able to accurately identify M.bovis infected cattle without non-specific reactivity within 
BCG vaccinated animals (Vordermeier et al., 2002). Furthermore, CD4+ T cells were 
found to up-regulate intracellular IFNγ levels, detectable only within M.bovis infected 
cattle 4 hours following re-stimulation with PPDb (Sopp et al., 2008, Sopp et al., 2006). 
In an example of a DIVA skin testing strategy, cattle infected with M.bovis produced a 
detectable DTH response following administration of a cocktail of M.bovis specific 
antigens including ESAT-6, CFP-10, MPB70 and MPB83 with no detectable response 
from BCG vaccinates (Whelan et al., 2010).  
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Whilst substantial progress has been made in the development of diagnostic and 
vaccination strategies to control TB within cattle, it is apparent that the immunological 
mechanisms that govern the balance between protection or progressive infection are 
not fully understood. Further research is required to elucidate the fundamental 
immune responses that occur during mycobacterial infection in order to aid the 
development of strategies in the future where these may be manipulated to our 
advantage. 
1.2 The immune response to mycobacterial infection 
TB causing species; M.bovis and M.tuberculosis infect via the respiratory route and a 
multifaceted immune response ensues to control the spread of infection. 
Pathologically, this can be identified by the formation of widespread bacterially loaded 
lesions surrounded by infiltrating immune effector cells (Algood et al., 2005) which can 
develop into necrotic granulomas during chronic infection (Liebana et al., 2008). 
Despite substantial research, the immune mechanisms that govern protective 
immunity have not been completely deciphered. It is known that both the innate and 
adaptive arms of the immune response are involved and Th1 polarisation is critical 
(Orme, 2004, Welsh et al., 2005). Implicit within this is the fundamental role played by 
IFNγ, in particular at early stages during the development of the immune response to 
enable containment of infection and subsequent polarisation of cell mediated 
immunity. This has been illustrated by gene knock-out studies where deficiencies of 
IFNγ result in severe dissemination and mortality following M.tuberculosis challenge 
(Flynn et al., 1993, Cooper et al., 1993). In addition, human IFNγ deficiencies correlate 
with an enhanced susceptibility to mycobacterial infections (Dorman et al., 2004).  
1.2.1 The role of antigen presenting cells  
Antigen presenting cells such as macrophages and dendritic cells (DCs) residing within 
the luminal and intra-epithelial regions of the respiratory passages and lungs are 
largely responsible for the initiation of innate immunity to mycobacterial pathogens 
and the route of cellular entry can have a substantial impact on the clearance, 
containment or onset of progressive infection (Hope et al., 2004).  
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1.2.1.1 Macrophages 
During initial immune defence mechanisms, macrophages function to rapidly kill 
invading pathogens. Expression of an array of cell surface receptors enables 
recognition of mycobacteria and induction of downstream effector responses. In 
particular, conserved antigenic regions are recognised by toll like receptors (Means et 
al., 1999), complement receptors, mannose receptors binding to mannosylated 
bacterial glycoproteins and also FC receptors able to recognise opsonised molecules 
(Ernst, 1998). Binding of receptors initiates intracellular signalling pathways leading to 
activation of transcription factors such as NFκB.  
Upon activation, macrophages are able to release reactive oxygen or nitrogen 
intermediates or can ingest mycobacteria by phagocytosis and target the bacterial 
phagosome to intracellular lysosomal degradation pathways. Furthermore, 
macrophages infected with M.tuberculosis secrete pro-inflammatory cytokines TNFα, 
IL-1 and IL-6 (Hickman et al., 2002, Giacomini et al., 2001) and M.bovis infected 
alveolar macrophages up-regulate inflammatory chemokines (Widdison et al., 2011, 
Widdison et al., 2008) to promote the recruitment and activation of immune effector 
cells and aid granuloma formation. However, macrophages also release IL-10 following 
mycobacterial infection which functions to down-modulate the inflammatory immune 
response (Hickman et al., 2002, Giacomini et al., 2001, Hope et al., 2004, Denis et al., 
2005).   
Despite this, mycobacteria have evolved to circumvent the anti-microbial activities of 
macrophages and persist within the host. The route of entry plays a central role with 
inhibition of cytotoxicity following entry via complement receptor 3 (CR3) or mannose 
receptor (reviewed by (Hope et al., 2004)). Additionally, mycobacteria can block the 
maturation of the phagosome and prevent lysosome fusion to subvert degradation by 
hydrolytic enzymes (Flynn and Chan, 2003, Rohde et al., 2007, Nguyen and Pieters, 
2005). Studies have reported that exposure of macrophages to IFNγ may prevent 
mycobacterial persistence through activation of bactericidal mechanisms and release 
of pro-inflammatory cytokines (Giacomini et al., 2001, Hickman et al., 2002, Zhang et 
al., 2010, Flynn et al., 1993). This was only true to a certain extent during in vitro 
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infection with M.bovis where treatment with IFNγ did not prevent bacterial replication 
within bovine macrophages but did promote the production of pro-inflammatory 
cytokines (Aldwell et al., 1997, Denis et al., 2005, Hope et al., 2004). A consequence of 
bacterial persistence within the phagosomes of macrophages as well as IL-10 release is 
likely to be low levels of antigen presentation and priming of T cell responses. For 
these reasons it is believed that macrophages do not play a significant role in the 
progression of the adaptive immune response and during chronic infection are the 
main reservoirs for mycobacterial pathogens.  
1.2.1.2 Dendritic cells 
Dendritic cells (DCs) are professional antigen presenting cells, specialised in their 
ability to actively take up antigen and prime naïve or activate memory T cells in the 
bridge between the innate and adaptive arms of the immune response. Originating in 
the bone marrow, DCs belong to myeloid or lymphoid lineages that form 
phenotypically and functionally heterogeneous subsets of cells (Steinman, 2003). 
Bovine DCs are predominantly of myeloid origin (Howard and Hope, 2000, Miyazawa 
et al., 2006) and the existence of a small population of plasmacytoid DCs of lymphoid 
origin, has only recently been identified (Reid et al., 2011).   
Only a small percentage of differentiated DCs are found circulating in peripheral blood 
(Miyazawa et al., 2006), with the vast majority forming resident populations in tissues. 
For example, DCs are particularly prevalent within the intra-epithelial regions of 
mucosal surfaces within the gut, respiratory tract and lungs and as such are ideally 
placed to sample large volumes of antigen pivotal to the induction of tolerance or 
immunity (Steinman, 2003). Furthermore, DCs and macrophages can be derived from 
circulating monocytes depending on the stimulus received. In vitro human (Sallusto 
and Lanzavecchia, 1994) and bovine (Werling et al., 1999) monocytes differentiate into 
immature DCs in the presence of granulocyte monocyte colony stimulating factor (GM-
CSF) and interleukin 4 (IL-4). 
In tissues, DCs exist in an immature state; highly responsive to inflammatory 
chemokines enabling accumulation at sites of infection, with increased phagocytic 
capacity and low expression of cell surface MHC class II and co-stimulatory molecules 
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(Steinman, 2003). In the murine model of mycobacterial infection, intra-nasal 
inoculation induced the recruitment of immature DCs to pulmonary regions (Wolf et 
al., 2007, Pecora et al., 2009), a proportion of which may have been of monocytic 
origin (Reljic et al., 2005). The expression of a repertoire of antigen recognition 
receptors by immature DCs enables the efficient capture and recognition of foreign 
particles. These include the C-type lectins; mannose receptor, dendritic cell specific 
intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN), macrophage 
mannose receptor 1 (DEC-205) and pattern recognition receptors for example toll-like 
receptors (Demangel and Britton, 2000). In particular, mycobacteria are able to bind to 
DC-SIGN (Yamakawa et al., 2008, Geijtenbeek and van Kooyk, 2003) and roles of TLR2, 
TLR4 (Tsuji et al., 2000, Means et al., 1999) and TLR9 (von Meyenn et al., 2006) have 
also been described in the recognition of conserved molecules expressed by 
mycobacteria. Upon recognition by endocytic receptors, DCs take up antigen through 
mechanisms involving formation of caveolae (Werling et al., 1999), clathrin coated pits, 
macropinocytosis and phagocytosis.  
Following antigen uptake DCs migrate from the periphery to draining lymph nodes via 
afferent lymphatics and undergo a process of maturation involving phenotypic and 
functional changes rendering the capacity to activate T cell responses. In gene knock-
out models, mice deficient in chemokines CCL19 and CCL21 were unable to transport 
M.tuberculosis to local lymph nodes (Wolf et al., 2007) highlighting the fundamental 
role of the chemokine receptor CCR7 and it’s ligands in the lymphoid homing capacity 
of DCs (Jakubzick et al., 2006, Martin-Fontecha et al., 2003, Saeki et al., 1999). As well 
as during an inflammatory immune response, DCs also constitutively traffic and 
transport antigen in this manner under steady-state conditions; a process associated 
with the induction of peripheral tolerance to a multitude of self-antigens (Steinman, 
2003).  
During the migration and maturation process, previously immature phagocytic DCs are 
phenotypically transformed into efficient antigen presenting cells. In particular cell 
surface expression of MHC class II, co-stimulatory molecules and adhesion molecules is 
augmented. Monocyte derived DCs from cattle up regulated MHC class II, CD40 and 
CD80 cell surface expression following infection with M.bovis; consistent with 
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pathogen induced maturation (Hope et al., 2004). During classical presentation, MHC 
class II bearing peptide complexes are presented to CD4+ T lymphocytes expressing 
the cognate T cell receptor along with co-stimulation. Antigen may also be presented 
by DCs in a non classical manner; in the context of CD1 molecules (Porcelli and Modlin, 
1999, Rosat et al., 1999) or during cross-presentation with exogenous antigens 
presented by MHC class I (Steinman, 2003).   
Cytokines produced by maturing DCs are pivotal to the effective polarisation of the 
adaptive immune response. Infection of DCs with mycobacteria is associated with the 
production of pro-inflammatory cytokines IL-12, IL-18, TNFα, IL-1, IL-6 and the 
immune-regulatory cytokine IL-10 (Demangel et al., 2002, Hickman et al., 2002, Hope 
et al., 2004, Giacomini et al., 2001, Denis and Buddle, 2008). Of fundamental 
importance is the role of IL-12, implicit to the priming of Th1 immune responses 
(Hickman et al., 2002). IL-12 released by DCs functions to enhance the IFNγ production 
and proliferation of T cells (Denis and Buddle, 2008, Hickman et al., 2002, Hope et al., 
2000, Khader et al., 2006),  NK cells (Hope et al., 2002b) and γδ T cells (Price, 2009) to 
potentiate innate and adaptive immune responses. Furthermore in an autocrine 
fashion, IL-12 was able to maintain CCR7 expression by DCs to enable efficient 
transport of M.tuberculosis to draining lymph nodes and priming of CD4+ T cells 
(Khader et al., 2006). 
Within cytokine rich environments, the balance of IL-12 and IL-10 significantly 
influences the ensuing immune response. Following aerosol infection with BCG, IL-10 
inhibited the release of IL-12 and migration of DCs to draining lymph nodes with a 
subsequent decline in IFNγ production by T cells (Demangel et al., 2002, Giacomini et 
al., 2001). Abundant release of IL-12 functions to override the down-modulatory 
effects of IL-10 (Hickman et al., 2002). For these reasons, the role of IL-10 in 
mycobacterial infection is controversial with elevated levels associated with 
persistence and progression to chronic infection (Welsh et al., 2005). Importantly, 
M.bovis infected bovine macrophages are a significant source of IL-10 (Denis et al., 
2005, Hope et al., 2004) and are therefore implicated as playing a role in the immune 
evasion by mycobacteria during chronic infection.   
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As is the case with macrophages, mycobacteria have developed mechanisms enabling 
persistence within DCs. Uptake via DC-SIGN is associated with interference of 
intracellular signalling in the subversion of DC derived immune responses (Geijtenbeek 
and van Kooyk, 2003). However, this was also the case in the absence of DC-SIGN 
(Gagliardi et al., 2005) suggesting alternative mechanisms are also involved. In 
particular, mycobacteria can inhibit the differentiation of monocytes to DCs (Gagliardi 
et al., 2004), prevent migration to draining lymph nodes, interfere with MHC class II 
presentation of antigen (Wolf et al., 2007) and influence cytokine release (Remoli et 
al., 2011, Palucka and Banchereau, 2002). As a consequence, mycobacteria induced 
subversion of DCs may be associated with advanced chronic TB infection. Alternatively, 
persistence in this manner may provide a constant source of antigen enabling 
continual stimulation of NK cells, γδ T cells and the potential priming or activation of T 
cells (Hope et al., 2004). 
1.2.2 Chemokines 
Chemokines are proteins that upon binding initiate the directional migration of cells 
bearing cognate G-protein coupled receptors and are therefore fundamental to almost 
every aspect of the immune system. Genomic analysis within humans has identified 
over 40 different chemokines with 18 functional receptors (Zlotnik et al., 2006). Both 
of these are classified according to the number and position of the cysteine residue 
into the families; C, CC, CXC, CX3C with ligands expressed as XCL, CCL, CXCL, CX3CL and 
receptors as XCR, CCR, CXCR, CX3CR (Murphy, 2002, Murphy et al., 2000). In cattle, 
homologues to all known human chemokine receptors were identified and found to be 
well conserved with varying homology (60-90%) at nucleotide and amino acid level 
(Widdison et al., 2010, Blumerman et al., 2007, Boyd et al., 2010).  
Functionally, gradients of chemokines and the repertoire of cell-surface chemokine 
receptor expression determine migratory ability. However, complexity arises within 
this system as chemokines are able to bind to more than one receptor and any given 
receptor can bind multiple ligands; a mechanism which enables redundancy. There are 
two major subclasses of chemokines; homeostatic chemokines which establish and 
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maintain resident cellular populations and inflammatory chemokines which induce 
recruitment of cells upon insult (Murphy, 2002, Murphy et al., 2000). 
Major roles for chemokines have been defined in the recruitment of immune effector 
cells in particular; migration to inflammatory sites, to draining lymph nodes and also in 
the organisation of distinct cellular regions within secondary lymphoid tissue (Cyster, 
2005, Luther et al., 2002). Chemokines are secreted by numerous cells and may be 
present in the extracellular milieu, or loosely tethered to the surface of endothelial 
cells. In this manner, lymphocytes bearing the appropriate chemokine receptor may be 
recruited from neighbouring regions or from the periphery in a sequence of adhesion 
and migratory events. Initially, circulating lymphocytes are arrested by adhesion 
molecules such as selectins and shear forces induce rolling over endothelial layers 
(Sallusto et al., 2000). Tethered lymphocytes bearing chemokine receptors may come 
into contact with chemokines (Sallusto and Baggiolini, 2008), triggering intracellular 
signalling events to induce integrin mediated firm adhesion and trans-endothelial 
migration. During this process lymphocytes respond to the gradient of chemokine 
created between inter-endothelial cell junctions to migrate into tissues (Bromley et al., 
2008).  
Numerous studies have illustrated the importance of chemokine signalling in the 
immune response to mycobacterial infection. For example, in the accumulation of 
effector cells contributing to the formation of granulamatous lesions (Peters and Ernst, 
2003) and also in the migration of lymphocytes to secondary lymphoid organs to 
promote the induction of adaptive immune responses (Orme and Cooper, 1999). 
Infection of macrophages and dendritic cells with mycobacteria results in a rapid 
release of inflammatory chemokines. In vitro, macrophages secreted elevated levels of 
CCL2, CCL3, CCL4, CCL5, CCL20 and CXCL8 (Saukkonen et al., 2002, Scott and Flynn, 
2002, Mendez-Samperio et al., 2003). In a similar manner, DCs infected with 
M.tuberculosis up-regulated CCL2, CCL3, CCL4, and CXCL8 followed by increasing levels 
of CXCL9 and CXCL10 (Gustafsson et al., 2008, Lande et al., 2003). In cattle, 
inflammatory chemokines were up-regulated as early as 4 hours following M.bovis 
infection of alveolar macrophages (Widdison et al., 2011), supernatants from which 
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induced the recruitment of granulocytes (Widdison et al., 2008). Furthermore, during 
inflammatory conditions, epithelial cells within the respiratory tract are believed to 
respond to macrophage derived cytokines (TNFα and IL1β) to produce chemokines 
such as CCL2, CXCL8 and CCL20 which may be important for the recruitment of DCs 
(Thorley et al., 2007, Thorley et al., 2005). Whether this is also the case with 
mycobacterial infection is yet to be determined.  
Murine gene knock-out models have shed significant light into the roles of specific 
chemokines and receptors; M.tuberculosis infection in CCR2 negative mice resulted in 
severe and rapid onset of infection as a consequence of deficiencies in lymphocyte 
migration to the lungs and to mesenteric lymph nodes (Peters et al., 2001, Scott and 
Flynn, 2002). Furthermore mice lacking CCR1 were unable to recruit NK cells to the site 
of infection (Shang et al., 2000). Importantly CCR7 appears to pivotal; expression of 
which confers the capacity to migrate to lymph nodes. Mice lacking in CCR7 
succumbed to M.tuberculosis infection at faster rates as a consequence of impaired 
trafficking of DCs resulting in delayed CD4+ T cell responses (Olmos et al., 2010, Wolf 
et al., 2007). Conversely, deficiencies in CXCR3 were found to be beneficial with 
increased retention of Th1 effector T cells within the lungs of M.tuberculosis infected 
mice. However this was only the case during chronic infection (Chakravarty et al., 
2007). Additionally, DCs were retained in lymph nodes of mice lacking CCR5, 
potentiating adaptive immune responses (Algood and Flynn, 2004).  
It is clear that chemokine mediated recruitment during mycobacterial infection is a 
complex and intricate process which involves the balance of signalling between 
multiple ligands and receptors. Whilst inflammatory chemokines are implicit to the 
efficient recruitment of effector lymphocytes, elevated levels may exacerbate 
immuno-pathological responses. Elevated levels of CCL2, CCL3, CXCL8, CXCL9 and 
CXCL10 are often found within the pleural fluid of chronically infected TB patients 
(Hasan et al., 2009, Pokkali et al., 2008). Similarly, elevated expression of CCL3, CCL4, 
CCL5, CXCL8, CXCL10 within lymph nodes of M.bovis infected cattle were found to 
correlate positively with increased severity of infection (Widdison et al., 2009).   
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1.2.3 Cell mediated immune responses  
1.2.3.1 Conventional αβ T cells 
Antigen specificity in the immune response is conferred by conventional T cells bearing 
the highly divergent αβ T cell receptor and MHC restricted co-receptors; CD4 or CD8. In 
the priming of adaptive immune responses, peptide antigens complexed with MHC 
molecules are presented to T cells within secondary lymphoid tissue; a process 
involving binding of a cognate TCR, co-stimulation and cytokine release. Cytokines 
produced by antigen presenting cells are fundamental to the effective polarisation of T 
cells such that Th1 priming was found to be reliant on IL-12 production from DCs 
infected with M.tuberculosis (Hickman et al., 2002). In this manner, Th1 polarised T 
cells secrete IFNγ, IL-2 and TNFα with IFNγ production pivotal to the control of TB 
infection (Cooper et al., 1993, Flynn et al., 1993). Whilst the role that IFNγ may play in 
mycobacterial infection is a debated issue (1.1.3.4), within cattle infected with M.bovis 
a Th1 biased cytokine profile was found to correlate with an augmented capacity to 
control the spread of infection (Welsh et al., 2005).   
T cells bearing the CD4 co-receptor are restricted by MHC class II presentation 
pathways and are able to secrete IFNγ upon activation. For this reason, numerous 
studies have illustrated the implicit nature of CD4+ T cells in the protective immune 
response to mycobacterial infection. CD4 knock-out mice infected with M.tuberculosis 
were unable to control bacterial replication within the lungs (Mogues et al., 2001) as a 
consequence of reduced cellular infiltration and defects in granuloma formation 
(Saunders et al., 2002). In addition, immune deficiencies of CD4+ T cells as is the case 
in HIV afflicted individuals’ renders sufferers highly susceptible to mycobacterial 
infections. Within cattle, proliferation and antigen specific recall responses within the 
CD4 population can be detected following both BCG vaccination (Hope et al., 2000) 
and M.bovis infection (Sopp et al., 2008, Sopp et al., 2006, Walravens et al., 2002). 
Furthermore, percentages of circulating CD4+ T cells were significantly increased in 
M.bovis infected cattle (Buza et al., 2009, Pollock et al., 1996).  
In contrast, CD8+ T cells are restricted by MHC class I presentation pathways and are 
therefore commonly activated by intracellular peptides. However, in alternative 
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mechanisms exogenous antigens may be cross-presented via hijacking of MHC class I 
pathways (Liebana et al., 1999). In addition, CD1 molecules are able to present lipids 
antigens to non-classically restricted CD8+ T cells (Hope et al., 2001, Porcelli and 
Modlin, 1999, Rosat et al., 1999). Upon activation, CD8 expressing T cells are 
predominantly cytotoxic but are also able to proliferate and produce IFNγ. It has been 
reported that BCG vaccination in mice induces antigen specific CD8+ T cells which are 
able to accumulate within the lungs following M.tuberculosis infection (Begum et al., 
2009). Similarly within cattle, CD8+ T cells produced IFNγ in the antigen specific recall 
response following BCG vaccination (Hope et al., 2000) and M.bovis infection 
(Walravens et al., 2002). Additionally, upon re-stimulation CD8+ T cells from BCG 
vaccinated cattle produced perforin and were able to kill BCG or M.bovis infected 
macrophages (Hogg et al., 2009). However, whilst CD8+ T cells appear to be responsive 
during mycobacterial infection, their relative importance to protection has been 
challenged. In gene knock-out mice the loss of CD4+ T cells or MHC class II was far 
more detrimental than the loss of CD8+ T cells or MHC class I (Mogues et al., 2001). 
Within cattle, antigen specific IFNγ release was consistently greater in the CD4+ T cell 
population (Liebana et al., 1999). Importantly, cattle depleted of CD8+ T cells 
presented with lower lesion scores in head lymph nodes following infection with 
M.bovis (Villarreal-Ramos et al., 2003). Therefore, whilst CD8+ T cell specific release of 
IFNγ and cytotoxicity may contribute to the initial control of infection, it is not 
considered essential for long-lived protective immunity (Liebana et al., 1999) and may 
contribute to the immuno-pathology associated with chronic TB infection (Villarreal-
Ramos et al., 2003) 
1.2.3.2 B cell responses and humoral immunity 
Th2 polarisation of the immune response results in B cell derived antibody production, 
with prominent roles of cytokines such as IL-4 and IL-10. It has long been regarded that 
this response is driven by extracellular pathogens and therefore, antibody responses 
are generally believed not to be associated with protection in the context of 
intracellular mycobacterial infection (Johnson et al., 1997). In cattle, mycobacteria 
specific IgG and IgM were detected within the sera as early as 4 weeks post-M.bovis 
infection (Waters et al., 2006). However within humans and cattle, Th2 polarisation 
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and elevated antibody titres are often indicative of chronic progressive infection and 
high bacterial burden (Waters et al., 2010). For example, IgG levels within the sera of 
M.bovis infected cattle positively correlated with disease induced pathology (Welsh et 
al., 2005). Furthermore, BCG vaccination induced antibody responses were not 
associated with protection (Buddle et al., 2005).  
Despite this, B cells appear to participate in the immune response to mycobacterial 
infection and are particularly prevalent within pulmonary granulomas (Maglione et al., 
2007). Following M.tuberculosis infection, B cell knock-out mice were unable to 
contain bacteria with deficiencies in granuloma formation (Maglione et al., 2007) and 
reduced cellular infiltration to the lungs (Bosio et al., 2000). In addition, immune 
responses associated with Th1 and Th2 polarisation are unlikely to be mutually 
exclusive with a balance of signalling likely to determine the outcome of infection 
(Abebe and Bjune, 2009). De Valliere et al., (2005) reported that antibody mediated 
opsonisation and phagocytosis of mycobacteria potentiated the expansion of IFNγ 
producing CD4+ and CD8+ T cells. For these reasons, it has been proposed that 
immunotherapeutic approaches may be beneficial in the treatment of TB infection and 
development of novel monoclonal antibodies has shown promise (Balu et al., 2011).  
1.2.3.3 Unconventional T Cells 
1.2.3.3.1 γδ T cells 
Lymphocytes expressing the γδ T cell receptor (TCR) represent a small population in 
humans and mice however, in comparison may constitute up to 60% of all circulating 
lymphocytes within young calves (Davis et al., 1996, Kampen et al., 2006) and are also 
particularly prevalent within tissues such as the intra-epithelial regions of the gut and 
respiratory tract.  The expression of multiple receptors enables recognition of a diverse 
array of antigens such that γδ T cells participate in both innate and adaptive immune 
responses. As is the case with conventional T cells, recombination events of the V, D 
and J genomic regions confers specificity however, γδ T cells also express invariant 
TCRs or pattern recognition receptors and are therefore not always restricted by 
classical presentation pathways. In particular, lipid antigens may be presented in the 
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context of CD1 molecules (Porcelli and Modlin, 1999, Van Rhijn et al., 2006) or γδ T 
cells may respond directly to pathogen associated molecular patterns.  
Substantial evidence exists to suggest that γδ T cells play a prominent role in the 
immune response to mycobacterial infection. Following BCG infection in mice, γδ T 
cells were recruited to the lungs and were an early innate source of IFNγ, potentiating 
CD8+ T cell effector responses (Caccamo et al., 2006). In cattle and other ruminants, a 
significant proportion of γδ T cells uniquely express workshop cluster 1 (WC1) and 
expression of isoforms of this molecule define functionally distinct subsets (Rogers et 
al., 2005). Percentages of WC1+ γδ T cells increased in response to BCG, with levels 
peaking at 2 weeks post-vaccination. Importantly, a corresponding increase in IFNγ 
was also observed (Buza et al., 2009). In contrast, as early as 5 days post-M.bovis 
infection, WC1+ γδ T cells decreased in numbers from the periphery (Kennedy et al., 
2002, Pollock et al., 1996) and following BCG inoculation, percentages of IFNγ 
producing WC1+ γδ T cells increased within the tissues of the lungs and upper 
respiratory tract (Price et al., 2010). Furthermore, WC1+ γδ T cells reciprocally 
interacted with M.bovis infected DCs to produce IFNγ and enhanced IL-12 release from 
DCs (Price and Hope, 2009). In depletion studies, the loss of WC1+ γδ T cells influenced 
the early innate levels of IFNγ observed however, did not substantially alter the 
progression of M.bovis infection highlighting the existence of redundancy within the 
immune system (Kennedy et al., 2002).  
1.2.3.3.2 NKT cells 
Natural Killer T cells exist as a small distinct sub-population of lymphocytes within 
humans and mice, phenotypically and functionally related to T cells and NK cells. The 
most widely studied of which express an invariant TCR, restricted to antigen 
recognition via CD1d molecules presenting glycolipids such as α-galactosylceramide (α-
GalCer) (Bendelac et al., 2007, Lantz and Bendelac, 1994). NKT cells can be 
phenotypically distinguished from NK cells by the expression of conserved TCRs and 
lack of expression of natural cytotoxicity receptor NKp46 (Walzer et al., 2007a). In the 
murine model of M.tuberculosis infection invariant NKT cells were able to augment the 
bactericidal activity of macrophages to reduce bacterial burden within the lungs; a 
 
42 
process which involved recognition of antigen in the context of CD1d (Sada-Ovalle et 
al., 2008). Furthermore, NKT cells may restrict mycobacterial growth through release 
of cytolytic proteins such as granulysin (Gansert et al., 2003) and promote pro-
inflammatory immune responses through cytokine and chemokine production (Kim 
and Chung, 2011).  
Activation of NKT cells in this manner requires the presentation of antigen in the 
context of CD1d. However cattle do not express functional CD1d molecules, with 
genomic homologues identified as pseudogenes. Furthermore, bovine lymphocytes did 
not respond to tetramers of human and murine CD1d molecules loaded with α-GalCer 
antigen (Van Rhijn et al., 2006). It has therefore been suggested that cattle may lack 
functional CD1d restricted NKT cells (Boysen and Storset, 2009, Van Rhijn et al., 2006). 
It is yet to be determined whether NKT cells exist within cattle and recognise antigen 
through novel mechanisms distinct from humans and mice.  
1.2.3.4 Natural Killer Cells  
Natural Killer (NK) cells are multi-functional lymphocytes that have been widely 
studied with respect to their diverse roles and interplay within the immune system. 
Expression of germ-line encoded receptors confers responsiveness without prior 
stimulation enabling innate cytolytic effector responses towards transformed or 
infected cells. Upon stimulation NK cells are able to produce immuno-modulatory 
cytokines, interact with antigen presenting cells and may also be capable of memory-
like responses. It is therefore hypothesised that NK cells function as a bridge between 
the innate and adaptive immune systems.  
As innate effectors, NK cells contain preformed granules of lytic proteins (Reefman et 
al., 2010), released upon recognition of target cells. During this process membranous 
protrusions extend to form immunological synapses to enable polarised delivery of 
perforin and granulysin (Chauveau et al., 2010, Culley et al., 2009, Davis and Dustin, 
2004, Reefman et al., 2010). In addition, NK cells express cytotoxic effector molecules 
to induce apoptotic events within target cells. The functional responses of NK cells are 
however far more diverse. Upon activation, NK cells produce abundant cytokines such 
as IFNγ, TNFα and GM-CSF (Cooper et al., 2001, Boysen et al., 2006b, Fehniger et al., 
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1999b) and have also been reported as source of inflammatory mediators IL-10 
(Fehniger et al., 1999b, Cooper et al., 2001) and IL-22 (Cella et al., 2009, Dhiman et al., 
2009). Furthermore, cytokine stimulated NK cells are able to secrete inflammatory 
chemokines (Dorner et al., 2002, Fehniger et al., 1999b, Nieto et al., 1998), to aid 
accumulation of effector cells during early innate immune responses.  
In further complexity, the role of NK cells within adaptive immune responses is the 
focus of intense research. Following vaccination and re-infection, NK cells respond 
indirectly to CD4+ T cell derived IL-2 (Bihl et al., 2010, Horowitz et al., 2010a). 
However, (O'Leary et al., 2006) demonstrated direct antigen specific recall responses 
of NK cells in the murine model of contact hypersensitivity. This has subsequently been 
demonstrated in viral infections (Sun et al., 2009, Paust et al., 2010) with memory-like 
responses restricted to a small sub-population of CXCR6 expressing hepatic NK cells 
(Paust et al., 2010). In addition, discrete subsets of NK cells have been reported to 
express MHC class II molecules (Burt et al., 2008, Evans et al., 2011) and may possess 
the capacity to present antigen to CD4+ T cells (Burt et al., 2008, Hanna et al., 2004, 
Roncarolo et al., 1991). However the mechanisms that enable acquisition, 
internalisation and presentation of antigen are not understood. 
NK cell derived IFNγ is believed to be implicit to the Th1 polarisation of the immune 
response (Martin-Fontecha et al., 2004). Considerable evidence exists to suggest that 
NK cells play a role in the immune response to mycobacterial infection. In addition, 
abundant numbers of NK cells within neonates may participate in the enhanced 
efficacy of BCG vaccination (Endsley et al., 2009). Following M.tuberculosis or BCG 
infection in mice, numbers of activated NK cells within the lungs increased with 
augmented IFNγ release (Junqueira-Kipnis et al., 2003, Feng et al., 2006, Saxena et al., 
2002). Importantly, the IFNγ functioned to regulate macrophage activation and control 
bacterial replication and dissemination (Feng et al., 2006). In vitro, M.tuberculosis 
infected antigen presenting cells were able to recruit NK cells (Lande et al., 2003) and 
augment cytolytic activity and IFNγ release (Vankayalapati et al., 2002). Furthermore, 
BCG may bind directly to NK cells to induce proliferation, IFNy production and cytolytic 
activity (Esin et al., 2004, Esin et al., 2008, Batoni et al., 2005, Marcenaro et al., 2008). 
In cattle, NK cells are also present in large numbers in neonates (Graham et al., 2009) 
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and were a source of IFNγ following stimulation with mycobacterial antigens (Olsen et 
al., 2005) or BCG (Hope et al., 2002b). In addition, NK cells were able to produce IFNγ 
and kill M.bovis (Denis et al., 2007) and BCG (Endsley et al., 2006) infected 
macrophages.  
1.2.3.4.1 Human NK cells 
NK cells originate in the bone marrow as CD34+ hematopoietic progenitor cells, 
responsive to growth factors and cytokine stimulation (Mrozek et al., 1996). The 
precise pathways that govern commitment to an NK lineage have not been fully 
defined however; the identification of developmental intermediates suggests that 
precursor cells may undergo a process of differentiation and maturation within 
secondary lymphoid tissue (Freud et al., 2006, Juelke et al., 2010). This process 
involves acquisition of an NK cell specific repertoire and induction of tolerance to 
prevent self-reactivity (Colucci et al., 2003).  
Mature NK cells represent a heterogeneous population of cells that are widely 
distributed but found in large numbers within tissues underlying mucosal surfaces, 
within lymph nodes (Ferlazzo et al., 2004b, Fehniger et al., 2003) and as a constituent 
of the peripheral blood lymphocyte population. Human NK cells can be primarily 
defined by lack of expression of CD3 and varying levels of expression of CD56 and CD16 
(Cooper et al., 2001) to form functionally distinct subsets. CD56dim CD16+ NK cells are 
more commonly found within the blood and are predominantly cytotoxic in nature 
(Jacobs et al., 2001). In comparison CD56bright CD16- NK cells found within lymph nodes 
are competent cytokine producers (Ferlazzo et al., 2004a, Ferlazzo et al., 2004b, 
Fehniger et al., 2003, Fehniger et al., 1999b, Jacobs et al., 2001, Cooper et al., 2001). 
Studies have proposed that the CD56bright NK cells may be precursors to the CD56dim 
subset (Chan et al., 2007), with expression of CD94 identifying a functional 
intermediary (Yu et al., 2010), yet the precise mechanisms that may enable 
differentiation in vivo have not been determined. In addition, human NK cell subsets 
may not be as functionally distinct as previously believed with CD56dim NK cells also 
able to produce cytokines such as IFNγ at early time-points following activation (De 
Maria et al., 2011).   
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1.2.3.4.2 Murine NK cells 
Murine NK cells also exist as a heterogeneous population of cells existing within tissues 
at differing stages of maturation (Gregoire et al., 2007). Due to the lack of a murine 
homologue for CD56, NK cells are identified by unique phenotypic characteristics for 
example; expression of NK1.1 or CD49b (DX5) (Arase et al., 2001). Subsets can further 
be divided by expression of CD11b and CD27 with blood derived CD27low CD11bhigh NK 
cells representing the most mature population (Chiossone et al., 2009, Hayakawa and 
Smyth, 2006). As is the case within humans, murine NK cells are also widely distributed 
however importantly during resting conditions have been shown to be largely excluded 
from lymph nodes (Bajenoff et al., 2006), potentially as a consequence of the lack of 
expression of the lymphoid homing receptor CCR7 (Gregoire et al., 2007).   
1.2.3.4.3 Bovine NK cells 
In cattle, NK cells constitute 0.5-10% of the total leukocyte population, with calves 
possessing higher numbers than adults in order to compensate for an immature 
adaptive immune response (Graham et al., 2009, Kampen et al., 2006, Kulberg et al., 
2004). Bovine NK cells do not express CD56 (Endsley et al., 2006), but can be 
accurately identified and purified by expression of the natural cytotoxicity receptor 
NKp46 (Storset et al., 2004) which has also been shown to be constitutively expressed 
and highly conserved by NK cells within humans, mice (Walzer et al., 2007a) and other 
ruminant species (Connelley et al., 2011, Elhmouzi-Younes et al., 2010). Phenotypic 
analysis has revealed that the vast majority of NKp46+ NK cells are CD3 negative, 
express variable levels of CD8, CD16, CD44 and CD25 and have been reported to exist 
as distinct sub-populations, most effectively differentiated by expression of CD2 
(Boysen et al., 2006b). Whilst the majority of peripheral blood derived NK cells within 
cattle express CD2, the opposite is true within lymphoid tissue, with larger populations 
of CD2-/low NK cells (Boysen et al., 2008, Boysen et al., 2006b).   
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Illustration of the phenotypic and functional differences between NK cell subsets in cattle – 
Adapted from (Boysen, 2006) 
 
Whilst the CD2 molecule is widely expressed within lymphocyte populations, in 
particular by T cells and NK cells, its functional role is largely unknown. Studies have 
reported involvement as an adhesion receptor or co-receptor for activation (McNerney 
and Kumar, 2006, Tangye et al., 2000). However, blocking of CD2 had little effect on 
bovine NK cells and therefore, expression appears to be redundant for effective NK cell 
derived functional responses. Furthermore, the CD2-/low population has been shown 
to be the more functionally activated population following IL-2 stimulation with faster 
proliferation, elevated IFNγ production and cytolytic activity (Boysen et al., 2006b).   
1.2.3.4.4 The control of NK cell derived effector responses 
NK cells express a diverse array of receptors which function to control cytolytic and 
cytokine producing effector responses through an intricate balance between activatory 
and inhibitory signalling mechanisms. During the process of ‘education’ NK cells 
acquire germ-line encoded receptors, such that mature NK cells are tolerant to self 
antigens whilst competent to respond as effector cells. Under steady-state conditions, 
NK cell responses are dampened by inhibitory receptors bound to MHC class I 
molecules. The precise mechanisms which enable peripheral tolerance are not known; 
theories suggest inhibitory receptors may engage with MHC class I molecules to 
‘license’ NK cells and enable functional competence of activatory receptors (Kim et al., 
2005); a process that may be aided by cytokines (Juelke et al., 2009). Alternative 
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hypotheses suggest that NK cells lacking inhibitory receptors exist in an auto-reactive 
state and are ‘disarmed’ to become hyporesponsive as a consequence of chronic 
stimulation without inhibition (Bolanos and Tripathy, 2011).   
During an immune response, the ‘missing self hypothesis’ proposes that down-
modulation of MHC class I by transformed or infected cells may initiate NK cell effector 
responses resulting from the lack of an inhibitory signal, an event commonly 
associated with viral infection or tumour transformation (Lanier, 2005). However, it is 
increasingly apparent that co-stimulatory signals are required and may be provided via 
activatory receptors and cytokines (Ortaldo and Young, 2003). Furthermore, the 
existence of a threshold has been proposed such that activatory signals must outweigh 
inhibition prior to induction of NK cell effector responses (Ortaldo and Young, 2003, 
Holmes et al., 2011) and it is therefore, a complex integration of signals that 
determines the response. 
1.2.3.4.4.1 Activatory and inhibitory receptors of NK cells 
The MHC restricted killer immunoglobulin-like receptors (KIRs) are encoded by 
polymorphic genes to give both activatory and inhibitory receptors, distinguishable by 
the presence of differing intracellular tyrosine based motifs. The variable extracellular 
region of these receptors confer diversity in the discrimination of allelic variants of 
MHC class I (Lanier, 2005). Multiple KIR genes have been identified in humans and 
primates (Vilches and Parham, 2002, Wilson et al., 2000) whereas rodents express 
distinct Ly49 c-type lectin receptors, encoded by novel genes yet functionally related 
to KIRs (Lanier, 2005). It has been reported that cattle express both KIR and Ly49 genes 
conferring a high degree of diversity in the recognition of MHC class I ligands and a 
possible reflection of the complexity of cattle MHC (Storset et al., 2003, Dobromylskyj 
and Ellis, 2007, Dobromylskyj et al., 2009, McQueen et al., 2002). Additional inhibitory 
receptors include the heterodimeric CD94/NKG2 complexes which recognise non-
classical MHC molecules and are widely expressed by NK cells in numerous species 
(Braud et al., 1998, Lanier, 2005). In particular CD94/NKG2A was found to be highly 
expressed by CD56bright NK cells (Jacobs et al., 2001, Cooper et al., 2001) and multiple 
genes have also been identified in cattle (Birch and Ellis, 2007, Storset et al., 2003).  
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In contrast, NKG2D activatory receptors derived from a single gene, function in the 
recognition of stress related molecules encoded by MHC class I (MIC) related genes 
(Lanier, 2005). NKG2D receptors are widely expressed by NK cells within numerous 
species and may be highly expressed by NKp46+ cells in cattle, activation through 
which was shown to induce IFNγ release (Guzman et al., 2010). Roles within 
mycobacterial infection have also been reported with NK cell mediated lysis of 
M.tuberculosis infected alveolar macrophages via NKG2D recognition of stress induced 
ULBP1 ligand (Vankayalapati et al., 2005). In addition CD16 is variably expressed by 
human NK cells (Cooper et al., 2001) and highly expressed in cattle (Boysen et al., 
2008, Boysen et al., 2006b). As a low affinity IgG receptor, CD16 functions in the 
recognition of opsonised molecules to induce antibody dependent cell mediated 
cytotoxicity responses of NK cells (Lanier, 2005).  
Further activatory receptors of NK cells include NKp46, NKp30 and NKp44 belonging to 
the natural cytotoxicity complex. In humans, both NKp46 and NKp30 are highly 
expressed by NK cells whereas expression of NKp44 is augmented following activation 
(Pessino et al., 1998, Walzer et al., 2007a). Triggering via these receptors induces 
cytotoxic responses, yet the ligands are largely unknown. However, viral 
haemagglutinin has been shown to bind to NKp46 (Mandelboim and Porgador, 2001)  
with the position of binding found to be implicit in determining whether a cytolytic 
effector response is induced (Mandelboim et al., 2001, Achdout et al., 2010). 
Furthermore, NKp46 was reported to play a role in the induction of NK cell mediated 
lysis of M.tuberculosis infected monocytes (Garg et al., 2006, Vankayalapati et al., 
2005, Vankayalapati et al., 2002). In addition, NKp44 expressed by CD56bright NK cells 
was able to bind directly to BCG to induce proliferation, IFNγ production and 
augmented cytolytic activity (Esin et al., 2008, Batoni et al., 2005, Esin et al., 2004). 
Bovine NK cells have also been reported to possess the capacity to interact directly 
with Neospora caninum to produce IFNγ (Boysen et al., 2006a). This may be through 
recognition via natural cytotoxicity receptors or toll-like receptors which are known to 
be expressed by NK cells (Lauzon et al., 2006), with BCG reported to interact directly 
with human NK cells via TLR2 to trigger NK cell mediated cytolytic activity (Marcenaro 
et al., 2008).  
 
49 
1.2.3.4.4.2 Cytokine control 
NK cells are responsive to a multitude of cytokines during both homeostatic and 
inflammatory immune conditions. For example IL-15 has been shown to be 
fundamental to the effective differentiation, maturation and maintenance of 
peripheral NK cells (Cooper et al., 2002, Mrozek et al., 1996). During an immune 
response cytokines are potent stimulants for NK cells, with the capacity to override 
inhibitory signals (Orr et al., 2010, Ortaldo and Young, 2006) with the cytokine milieu 
influencing the resulting NK cell phenotype and response. IL-12 functions to induce 
IFNγ release, in particular with a co-stimulus such as IL-18 (Cooper et al., 2001, 
Fehniger et al., 1999b). Bovine NK cells produced abundant IFNγ in response to IL-12 
released following stimulation with mycobacterial antigens (Olsen et al., 2005). 
However, the combination of IL-12 and IL-15 has been reported to induce IL-10 and 
TNFα release from NK cells (Cooper et al., 2001, Fehniger et al., 1999b) and augment 
the cytolytic activity of bovine NK cells (Endsley et al., 2006).  
Several reports suggest that subsets of NK cells may respond differentially to cytokine 
stimulation with CD56bright NK cells found to produce abundant levels of IFNγ following 
IL-12 and IL-18 stimulation (Fehniger et al., 1999b). In a similar manner, IL-2 
augmented the proliferative, cytolytic and IFNγ responses of both human CD56bright NK 
cells (Ferlazzo et al., 2004b, Fehniger et al., 2003) and CD2- NK cells in cattle (Boysen et 
al., 2006b). This may be particularly relevant within lymph nodes where abundant T-
cell derived IL-2 may contribute to the presence of resident populations of activated 
and cytolytic NK cells (Boysen et al., 2008).  
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1.3 Aims and Objectives  
The innate immune system is important in the early control of mycobacterial infection 
but has also been demonstrated to play a prominent role in the shaping of adaptive 
immunity. Th1 biased cell mediated immune responses are required for protective 
immunity during TB infection and early innate production of IFNγ is implicit within this. 
NK cells function as cytolytic effectors but are also a significant source of immuno-
modulatory cytokines such as IFNγ. Human and murine studies have demonstrated the 
prevalence of NK cells within tissues afflicted by mycobacterial infection. However, 
fully functional effector responses of NK cells are reliant upon signals from accessory 
cells. In particular, DC derived chemokines function to recruit NK cells to within a close 
proximity enabling interactions to ensue. Importantly, the interactions are reciprocal in 
nature influencing the effector functions of NK cells and the maturation status of DCs 
to promote subsequent Th1 polarisation.  
Bovine NK cells exist as distinct heterogeneous subsets with differential functions and 
anatomical localisations. Given that within human and murine studies, the interactions 
between NK cells and DCs have been shown to substantially influence the immune 
responses during mycobacterial infection; this thesis sought to explore these 
interactions further within the bovine system. In particular, whether functionally 
distinct subsets of bovine NK cells played differing roles in M.bovis infection.  
This thesis therefore had four main aims; (1) to comprehensively analyse the patterns 
of chemokine receptor expression with a view that this would provide insight into the 
migratory behaviour of NK cells, (2) to determine the capacity of M.bovis infected DCs 
to recruit and (3) reciprocally interact with subsets of bovine NK cells. Finally (4), to 
determine whether models of mycobacterial infection and vaccination could be 
utilised to demonstrate the in vivo responsiveness of bovine NK cells. 
 
  
 
52 
 
  
 
53 
Chapter 2 
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2 Materials and Methods 
2.1 Media and Suppliers 
Media used is specified in (9.1) and all suppliers of reagents and equipment in (9.9) 
2.2 Animals 
Experiments were carried out on British Holstein-Friesian calves housed at the Institute 
for Animal Health (IAH), Compton according to Home Office guidelines and with full 
ethical approval. The herd at the IAH has been certified free of bovine TB for over 10 
years. The majority of animals were below 6 months of age and calves were age-
matched within experimental groups. For isolation of blood derived leukocytes, blood 
was collected by jugular venepuncture into sodium heparin (10u/ml).  
2.2.1 Subcutaneous BCG vaccination  
In vaccination experiments, calves received 1x106 cfu BCG Pasteur (2.7.1) in 2ml 
phosphate buffer saline (PBS) delivered subcutaneously into the left shoulder.  
For BCG time course experiments, blood was sampled at regular time points up until 
12 weeks post-vaccination and NK cell number and phenotype were assessed as 
described (2.12.1). Whole blood stimulation was employed to confirm the antigen 
specific response to BCG vaccination at week 7 post-vaccination; 5ml of blood was 
either left unstimulated or supplemented with purified protein derivative from M.bovis 
(PPD-b) 10μg/ml and incubated overnight at 37°C with 5% CO2. Following stimulation, 
cells were pelleted and the collected supernatant was assessed for IFNγ levels by ELISA 
(2.8) 
To assess recruitment of NK cells in vivo, BCG Pasteur was administered 
subcutaneously as described above and prescapular lymph nodes (PSLN) were 
obtained at post-mortem at days 1, 3, 7 and 14 post-vaccination for experimental 
analysis of NK cell number and phenotype (2.12) within the draining LN. PSLN from the 
right shoulder served as a control.  
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2.2.2 Intranasal BCG inoculation 
For intranasal inoculation, age matched calves were challenged with 1.5x107 cfu (Price 
et al., 2010) of BCG Pasteur suspended in 2ml PBS through a catheter inserted into the 
left nostril. Age matched naive calves were used as controls. After 7 days the head 
associated lymph nodes, lung tissue, lung associated lymph nodes and peripheral 
lymph nodes as specified in Table 2.1 were recovered at post-mortem.  
 
 Tissue Location 
RPLN R Retropharyngeal right lymph node Head associated lymph nodes 
RPLN L Retropharyngeal left lymph node 
Pall R Pallatine right tonsil 
Pall L Pallatine left tonsil 
Ph Ton Pharyngeal tonsil 
Apical R Apical right lung Lung tissue 
Apical L Apical left lung 
Int Intermediate lung 
Medial R Medial cardiac right lung 
Medial L Medial cardiac left lung 
Diaph R Diaphragmatic right lung 
Diaph L Diaphragmatic left lung 
CLN Cervical lymph node Lung associated lymph nodes 
BLN Bronchus associated lymph node 
MLN Mediastinal lymph node 
PS R Prescapular right lymph node Peripheral lymph nodes 
PS L Prescapular left lymph node 
 
Table 2.1 Tissues collected at post-mortem 
 
2.2.3 M.bovis infection 
Samples were obtained from M.bovis infected cattle which were a part of a larger 
duration of BCG induced immunity trial (unpublished) conducted by the Institute for 
Animal Health in collaboration with the Veterinary Laboratories Agency. Within this 
experiment, cattle were challenged at 24 months of age with 1.9x102 cfu M.bovis 
strain AF 2122/97 delivered via bronchoscope to the bifurcation of the trachea to 
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mimic the natural route of infection (Vordermeier et al., 2002). For evaluation of NK 
cells, blood was received at days 2, 5, 7, 14 and 21 days post-infection in line with the 
samples which were taken as a part of the trial. All handling and experimentation with 
samples from M.bovis infected animals was conducted at ACDP containment level III. 
Animals were slaughtered at 12 weeks post-infection followed by post-mortem 
examination to determine the number and size of lesions in the head and respiratory 
tract as an indicator of the severity of infection (Vordermeier et al., 2002). Pathology 
scores are specified in appendices table (9.8).   
2.3 Isolation of cells  
2.3.1 Peripheral blood leukocytes (PBLs) 
Erythrocytes from bovine blood were lysed using 0.1M Ammonium Chloride lysis 
buffer (9.1) followed by three washes (first wash at 400g for 10 minutes at 4°C 
followed by 300g for 8 minutes at 4°C and all subsequent washes at 400g for 5 minutes 
at 4°C) with PBS to obtain a leukocyte population. Viable cell numbers were 
established using a haemocytometer and 0.1% Trypan Blue exclusion. The PBL 
population was resuspended to approximately 1x108 cells/ml in tissue culture medium 
(TCM) (9.1) prior to further experimentation.  
2.3.2 Peripheral blood mononuclear cells (PBMCs) 
15ml of heparinised blood was diluted with 15ml PBS, underlayed with 15ml 
Histopaque 1083 followed by centrifugation at 1200g, 30-40 minutes, 20°C without 
brake, to obtain a buffy coat. Peripheral blood mononuclear cells (PBMCs) were 
retrieved from the interface, washed three times with PBS and viable cells assessed as 
described (2.3.1). The PBMC population was resuspended to approximately 1x108 
cells/ml in TCM.  
2.3.3 Mononuclear cells (MNCs) from tissues and lymph nodes 
Tissue samples from the head and respiratory tract were cut into small pieces and 
completely homogenised into PBS using a pestle and mortar. Lymph nodes were sliced 
in half and scored to expose the inner regions of the tissue. Using a blunt scalpel, cells 
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were gently teased away from the capsule and into PBS. The resulting cell suspensions 
were filtered through 40µm cell strainers and washed once with PBS. Cells were then 
diluted to approximately 2x107 cells/ml in PBS and placed over a Histopaque density 
gradient (2.3.2). Live cells were removed from the interface, washed three times and 
resuspended to approximately 1-2x108 cells/ml in PBS prior to further analysis.  
2.4 Isolation of bovine NK cells 
It has previously been established that NKp46 (CD335) is a highly restricted NK cell 
marker and can be used to accurately identify and isolate bovine NK cells (Storset et 
al., 2004). Mononuclear cells (MNCs) obtained from peripheral blood or lymph nodes 
as described (2.3), were resuspended in PBS at approximately 1-2x108 cells/ml and 
labelled for bovine NKp46 using mouse anti-bovine CD335 (3μg/ml). Cells were rolled 
gently for 10 mins followed by three washes (400g for 5 minutes at 4°C) in PBS to 
remove unbound antibody. Bovine NK cells were isolated using the MACS cell 
separation system via indirect labelling. MNCs stained for NKp46, were further 
incubated for 10 minutes with Rat Anti-Mouse IgG1 MicroBeads at 2.5µl/107cells, 
washed once and resuspended in approximately 5ml solution of FACSFlow/Bovine 
Serum Albumin (FF/BSA, 0.5%). NK cells were positively selected by passing the 
labelled MNCs through MACS LS columns and were eluted into TCM. Viable cell 
numbers were established by trypan blue exclusion. 
Purity of the MACS sorted NK cell population was assessed by staining the positively 
selected cells using goat anti-mouse IgG-RPE (9.4) and analysing the percentage of 
positively stained cells by flow cytometry. Only cell populations with over 95% purity 
were selected for further experimentation (3.2.1) 
2.4.1 Bovine NK cell subsets 
Blood or lymph node derived NKp46+ cells isolated by MACS sorting, were further 
labelled for CD2 to enable the isolation of NK cell subsets. NKp46+ cells were 
incubated with the CD2 specific monoclonal antibody IL-A43 (Howard and Naessens, 
1993) which was transiently coupled to IgG2a-FITC (Zenon® labelling kit) prior to 
labelling. Cells were rolled gently for 10 minutes followed by two washes in FF/BSA 
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(0.5%). Labelled cells were filtered and purified using the FACSAria™ to obtain NKp46+ 
CD2+ and NKp46+ CD2- subsets. Following sorting cells were washed 4-5 times in TCM 
to remove contaminating sheath fluid. This resulted in NK cell subset populations with 
over 98% purity which were resuspended in TCM at 2x106 cells/ml. 
2.5 NK cell stimulation 
Previous work within the group has established that bovine NK cells are optimally 
stimulated by IL-12 + IL-18 (M. Thom, unpublished data). Within experiments utilising 
stimulated cells, NKp46+ cells were cultured with COS cell derived recombinant bovine 
(rbo) IL-12 (20U/ml) (Hope et al., 2002a) and recombinant human (rhu) IL-18 (20ng/ml) 
in 24-well tissue culture plates at 1x106 cells/ml in TCM for 24 hours at 37°C and 5% 
CO2. 
2.6 Isolation and culture of monocyte derived dendritic cells (DC)   
CD14+ monocytes were isolated using the MACS cell separation system. PBMCs were 
labelled with anti-human CD14 coupled magnetic beads at 2.5µl/107cells, incubated 
for 10 minutes followed by positive selection using MACS LS columns. Monocytes 
isolated were washed twice in PBS (400g for 5 minutes at 4°C) and viable cell number 
was determined by trypan blue exclusion. Cells were cultured at 37C + 5% CO2 in 
media supplemented with COS cell derived recombinant bovine GM-CSF (0.2u/ml) and 
IL-4 (200u/ml) (9.1) for 3 days to obtain immature DCs (Sallusto and Lanzavecchia, 
1994, Werling et al., 1999).    
2.7 In vitro mycobacterial infection  
2.7.1 Mycobacterial cultures 
All bacterial cultures were handled at appropriate bio-security levels; ACDP 
containment level II (BCG) and level III (M.bovis). BCG Pasteur (P3) and M.bovis AF2122 
(P3) cultures were obtained by inoculating 1ml bacteria (1x106 to 1x107 cfu) into 9ml 
7H9 medium (9.1) which was cultured for one week at 37°C with shaking at 100rpm. 
This was further bulked up to 100ml in 7H9 medium and grown for an additional 3-4 
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days at 37°C, 100rpm. After sufficient growth was visually observed, mycobacterial 
samples were aliquoted and stored at -80°C.    
Bacterial titre was determined after a single freeze-thaw cycle using the droplet 
enumeration technique where bacteria were serially diluted (10-fold) in 7H9 medium 
(9.1). 50µl droplets of bacteria were spotted onto 7H10 (BCG) or 7H11 (M.bovis) agar 
plates (9.1) in triplicate and incubated at 37°C for 3-4 weeks. After growth was 
observed and seen not to be increasing, colonies were counted to determine the titre 
of the bacterial culture.  
2.7.2 Infecting DCs and macrophages 
Antigen presenting cells (APCs), cultured as described (2.6) were removed from plates 
by incubating adherent cells with 1ml cell dissociation fluid at 37°C for 30 minutes. 
Cells were washed in PBS and resuspended to 1x106 cells/ml in TCM without 
antibiotics, prior to infection with either M.bovis at a multiplicity of infection (MOI) of 
1:1 or BCG Pasteur at a MOI of 10:1. It has previously been established that these 
ratios give an equivalent rate of infection as determined by infecting DCs with GFP 
labelled bacteria (Thom, 2005). Cells were infected overnight at 37C + 5% CO2. 
2.8 Enzyme Linked Immunosorbent Assay (ELISA) 
ELISAs were conducted to detect the presence of bovine IFNγ, IL-12 (Hope et al., 
2002a), IL-10 (Kwong et al., 2002), TNFα (Kwong et al., 2010), IL-6 and IL-2. Reagents 
used are specified in (Table 2.2). Supernatants from various experiments were 
retrieved and stored at 4°C prior to analysis.  96-well transparent plates (IFNγ, IL-6, IL-
2) or black plates (TNFα, IL-12, IL-10) were coated with the monoclonal capture 
antibody diluted in carbonate/bicarbonate buffer at previously established optimal 
concentrations. Plates were sealed and incubated overnight at room temperature. 
Non-specific binding of the antibody was blocked using Casein at 1mg/ml in PBS for 1 
hour at room temperature and plates were washed with PBS/Tween-20 (0.05%) after 
every incubation step. Following washing, supernatants (100μl) and recombinant 
cytokine standards (dilution series) were added in triplicate and left for 1 hour. Plates 
were washed again, and incubated with the biotinylated secondary antibody for a 
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further hour. After washing, Streptavidin Horseradish peroxidase; 1:500 with Tween-
20 (0.05%) was added to the wells and left for 45 minutes. For IFNγ, IL-6 and IL-2 
assays, plates were developed using 0.1mg/ml 3,3’-5,5’ tetramethylbenzidine (TMB) 
diluted in sodium acetate buffer (pH 6.0). The reaction was stopped using 50μl/well of 
1M Sulphuric Acid after the appearance of a blue colour in the wells containing the 
standards. For all other luminescent assays, plates were washed three times with 5 
minute soaks in PBS/Tween-20 and were developed using supersignal ELISA Femto 
Maximum Sensitivity luminescent substrate at 100μl per well. Absorbance was 
measured at 450nm subtracted from the non specific absorbance at 690nm using the 
FLUOstar Optima Luminometer. Concentrations of cytokines within supernatants were 
extrapolated after plotting a curve from the standards. Where precise concentrations 
could not be calculated (IL-12 and IL-10), protein levels were expressed as biological 
units (bu) of activity as has previously been described (Hope et al., 2002a, Kwong et al., 
2002).  
 
 
Capture monoclonal 
antibody 
Secondary biotinylated 
antibody 
Cytokine standards 
IFNγ 
Mouse anti-bovine 
CC330 (IgG1) 
Mouse anti-bovine CC302 
(IgG1) 
COS cell derived recombinant 
bovine IFNγ 
(IAH, Compton) 
TNFα 
Mouse anti-bovine 
CC327 (IgG2b) 
Mouse anti-bovine CC328 
(IgG2a) 
COS cell derived recombinant 
bovine TNFα 
(IAH, Compton) 
IL-10 
Mouse anti-bovine 
CC318 (IgG2b) 
Mouse anti-bovine CC320 
(IgG1) 
CHO cell derived recombinant 
bovine IL-10 
(Moredun Research Institute) 
IL-12 
Mouse anti-bovine 
CC301 (IgG2a) 
Mouse anti-bovine CC326 
(IgG2b) 
COS cell derived recombinant 
bovine IL-12 
(IAH, Compton) 
IL-6 
Mouse anti-bovine 
CC310 (IgG2b) 
Anti-ovine IL-6 polyclonal 
rabbit serum, sheep anti-
rabbit IgG biotin 
COS cell derived recombinant 
bovine IL-6 
(IAH, Compton) 
IL-2 
 
Bovine IL-2 ELISA detection kit                                          (R&D systems) 
 
 
Table 2.2 ELISA reagents  
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2.9 Chemotaxis Assays 
Chemotaxis assays were carried out using Costar tissue culture treated transwells 
(5 μm pore size, 6.5 mm membrane diameter) in duplicate or triplicate. Input 
migrating cells (2.9.1) were placed on the transwell membrane at 2x105 cells per well 
suspended above the chemotactic agent. Plates were incubated at 37°C + 5% CO2 for 4 
hours. Recombinant human CXCL12 (200ng/ml) was used as a positive control (3.2.6). 
Following incubation, the migrated and input cells were diluted; 80µl of input cells 
were diluted in 520µl PBS to match the 600µl migrated cell suspension. Cells were 
counted for one minute using a FACSCalibur flow cytometer. Live cells were gated and 
identified by their FSC and SSC properties and migration was expressed as a 
percentage of the input population.  
2.9.1 Input cells  
Migration of PBLs or PBMCs was tested in response to recombinant chemokines (Table 
3.3). Prior to testing within chemotaxis assays, cells isolated as described were 
stimulated for 24 hours with Concanavlin A (ConA) at 5μg/ml and cultured at 2x106 
cells/ml in TCM for 3 days at 37°C + 5% CO2. Migrated populations of granulocytes, 
monocytes and lymphocytes were identified by their FSC and SSC properties. 
For all other migration experiments, input cells were NKp46+ cells, NKp46+ CD2+ or 
NKp46+ CD2- subsets isolated as described (2.4.1). All NK cell populations were 
resuspended in TCM at 2x106 cells/ml and left to rest overnight before use in 
chemotaxis assays to prevent interference from MACS beads bound to the cell. 
Migrated cell numbers were analysed and cell populations were also assessed for 
expression of NK cell surface receptors where replicate wells were pooled and labelled 
as described (2.12.1). Cell death within migrated populations was determined by 
labelling with Propidium Iodide (PI - 25μg/ml) and analysis by flow cytometry. 
2.9.2  Attractants  
Recombinant human and murine chemokines were used in chemotaxis assays to 
establish cross-reactivity (Table 3.3) at concentrations ranging from 50ng/ml to 1µg/ml 
diluted in TCM. A positive result was a significant increase in cell migration above 
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background. Of those chemokines found to cross react; dilution curves were used to 
establish optimal concentrations for cell migration of purified NK cells.  
Supernatants from M.bovis infected DCs (2.7.2) were also used within chemotaxis 
assays. DCs were cultured and infected as described and supernatants retrieved and 
filtered (0.1μm) before being used at several dilutions as chemoattractants. 
Within co-cultured chemotaxis experiments, DCs were cultured and infected with 
either BCG or M.bovis (2.7.2) within 24 well Costar chemotaxis plates. After overnight 
infection, purified NK cells or NK cell subsets were assessed for migratory responses 
towards infected antigen presenting cells left in situ. Cells within wells containing 
bacteria, were fixed with 2% paraformaldehyde (PFA) prior to analysis.  
2.10 Co-culture of NK cells with antigen presenting cells  
Monocyte derived DCs cultured as described (2.6), were diluted to 4x105 cells/ml in 
TCM without antibiotics and placed in  96 ‘U’ well plates at 50μl cells per well. Cells 
were infected with either BCG or M.bovis at 10:1 or 1:1 respectively (2.7.2). Total NK 
cells or NK cell subsets were diluted to 2x106 cells/ml and added to the co-culture at 
100μl per well. Each well was made up to a 200μl volume with TCM to give a final 
NK:DC ratio of 5:1 which was previously determined to result in optimal activation of 
NK cells.  
For blocking experiments, the mAb CC326 was also supplemented into the co-culture 
at concentrations determined to be optimal (10μg/ml) to diminish the IL-12 produced 
(5.2.2.2). Within stimulated co-cultures, rbo IL-12 and rhu IL-18 were added into the 
co-culture at concentrations known to be optimal for NK cell activation (2.5). Each 
culture condition was replicated in triplicate and cells were incubated for 
approximately 18 hours (overnight) at 37°C and 5% CO2. After an overnight co-culture 
period, cells were pelletted and supernatants retrieved for analysis of cytokine 
production by ELISA (2.8). Triplicate wells were analysed independently.  
To determine phenotypical changes after co-culture; expression levels of CD16, CD27, 
CD8, CD62L, CD25 and Perforin by NK cells and MHC class II, CD40, CD80 and CD86 by 
DCs (2.12.1) were analysed by flow cytometry. 
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In contact dependent assays, co-cultures were set up in 96 well flat bottomed plates 
and NK cells were separated from infected antigen presenting cells using a transwell 
insert (0.2μm). 
2.11 Killing Assays 
Murine tumour (P815) cells are known in vitro target for NK cells (Boysen et al., 2006b) 
and were used to assess NK cell killing activity. P815 cells were cultured in T75 tissue 
culture flasks in TCM at 37°C for approximately 1 week and were sub-cultured every 48 
hours and also one day prior to use. For killing assays, the P815 target cells were 
washed and labelled with Vybrant® CFDA-SE cell tracer kit (1μm final) for ease of 
identification. Effector cells used included IL-12 and IL-18 stimulated NK cells (2.5) or 
NK cells from co-cultures (2.10). Stimulated NK cells were cultured with the labelled 
target cells in triplicates either at a range of effector target ratios or at 12.5:1 which 
was determined as optimal to assess killing activity of NK cells from co-cultures 
(5.2.2.2). Cells were incubated for 3 hours at 37°C and 5% CO2 and NK cell specific 
killing was analysed by labelling with PI (25μg/ml) followed by analysis of the 
proportions of CFDA-SE and PI positive populations by flow cytometry.  
2.12 Multi-colour immunofluorescent staining   
All antibodies and fluorochromes are specified in table (9.2) and were used at 
previously determined optimal concentrations. Where possible, single stained cell 
populations, isotype controls (IC) or unstained cells were used as compensation and 
negative controls. Each 10 minute incubation step was followed by two washes 
(100μl/well) with PBS/BSA/Azide (9.1). Blocking steps were performed with 2% Normal 
Mouse Serum (NMS). 
For intracellular staining of perforin (Hogg et al., 2009) and cytokines, cells were pre-
incubated with TCM supplemented with Brefeldin A (BFA) 10μg/ml and left overnight 
at 37°C with 5% CO2 prior to further labelling. Fixation was performed using 50μl 2% 
PFA and permeabilisation with 50μl BD FACSPerm solution (1X). Labelled cells were 
analysed by flow cytometry using the BD FACSCalibur.  
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2.12.1 Staining protocols  
2.12.1.1 Intracellular labelling of PBMCs 
 Step 1 Step 2 Step 3 Step 4 
1 Unstained 
2 NKp46 (CD335-FITC) + CD2 (CC42-647) 
PFA 
 
3 IgG1-FITC + IgG1-647 (IC) 
4 
NKp46 (CD335-FITC) + CD2 (CC42-647) Permeabilise 
IFNγ (CC330-PE) 
5 Perforin-PE 
6 IgG2b-PE (IC) 
 
2.12.1.2 NK cell phenotyping   
 Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 
1 
NMS 
- - - - 
PFA 
2  
IgG-RPE NMS 
NKp46 (CD335-
FITC) + CD2 (CC42-
647) 
3 CD3 (MM1A) 
4 CD4 (CC30) 
5 CD8αα (CC63) 
6 CD8αβ (CC58) 
7 γδ TCR (GB21A) 
8 WC1 (CC39) 
9 CD16 (KD1) 
10 CD27 (MT-271) 
11 CD14 (CCG33) 
12 CD25 (IL-AIII) 
13 MHC II (CC158) 
14 CD11b (CC94) 
15 CD21 (CC21) 
16 CD62L (CC32) 
17 SIRPα (CC149) 
18 AV20 (IC) 
19 AV29 (IC) 
20 AV37 (IC) 
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2.12.1.3 Labelling NK cells for CD25 and intracellular Perforin   
 Step 1 Step 2 Step 3 Step 4 Step 5 
1 
NMS 
 
NMS 
NKp46 (CD335-PE) + 
CD2 (CC42-647) 
PFA 2 CD25 (CACT108A) - FITC* 
3 AV37(IC) - FITC* 
*Purified mAbs CACT108A (CD25) and AV37 (IC) were transiently coupled to IgG2a Alexa Fluor -
488 using a Zenon® labelling kit prior to use. 
 
 Step 1 Step 2 Step 3 Step 4 Step 5 
1 
NMS 
NKp46 (CD335-PE) 
+ CD2 (CC42-647) 
PFA 
 
2 
Permeabilise 
Perforin-FITC 
3 IgG2b-FITC (IC) 
 
2.12.1.4 DC phenotype  
 Step 1 Step 2 Step 3 Step 4 Step 5 
1 - - 
NMS SIRPα (CD172a 647/PE) PFA 
2 MHC II (CC158) 
IgG2a-FITC 
3 AV37 (IC) 
4 CD40 (IL-A156) 
IgG1-FITC 
5 CD80 (N32/52-3) 
6 CD86 (IL-A190) 
7 AV20 (IC) 
*All wash steps were performed with ice cold PBS/BSA/Azide to promote the release of 
adherent cells.  
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2.13 Isolation of RNA and synthesis of cDNA 
NK cells (2.4) or DCs (2.6); isolated, cultured and infected (2.7.2) by the methods 
described were lysed and stored at -80°C in 1ml GTC buffer (9.1) with 2-
mercaptoethanol (0.1M) prior to RNA extraction.  
Lysed cells were thawed and homogenised using Qiashredders and RNA was extracted 
using RNeasy mini or micro kits according to the manufacturer’s instructions. RNA 
samples were eluted into nuclease free water and DNase treated (DNAfree kit) to 
remove any genomic DNA contaminants. The quality and concentration of the RNA 
was assessed using the NanoDrop 1000 spectrophotometer. When necessary, RNA was 
further cleaned using RNeasy mini columns and re-eluted into RNase free water and 
stored at -80°C. 
100ng RNA was reverse transcribed using the SuperScript® III Reverse Transcriptase 
system and concentrations were analysed using the NanoDrop spectrophotometer. 
The cDNA was then further diluted to 50ng/µl with nuclease free water prior to further 
analysis. 
2.14 Identification and cloning of chemokine receptors and toll like receptors 
As a collaborative effort with the bovine genomics research group at the Institute for 
Animal Health, the bovine chemokine receptors and toll like receptors were identified, 
cloned and sequenced. Briefly, primers were designed to span full length regions of the 
coding sequence and PCR amplified from a variety of cDNA sources using GoTaq DNA 
polymerase and the Expand High FideltyPlus PCR system. PCR products were cleaned 
using the Qiaquick PCR purification kit and cloned into TA vectors; pCR2.1-TOPO, 
pGEM-T Easy or pDrive. Plasmid DNA was generated by transforming competent E-coli 
and purification using the Qiaprep spin miniprep kit. Inserted sequences were 
confirmed as described (Widdison et al., 2010). 
2.15 Quantitative (TaqMan) polymerase chain reaction (PCR)  
Primers and probes were designed based on already established sequences or those 
predicted from the bovine genome (Sequences - 9.5), designed to span at least one 
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intron-exon boundary. Probes were labelled with the FAM (6-carboxyfluorescein) dye 
at the 5’ end and the quencher dye TAMRA (6-carboxytetramethyl-rhodamine) at the 
3’ end. Quantitative PCR analysis was carried out using TaqMan FAST Universal PCR 
Master Mix on an ABI Prism 7500 Fast Real-Time PCR System. Each sample was tested 
in triplicate using 100ng cDNA. All results were quantified against a standard curve 
created through use of known copy number plasmid DNA containing the gene of 
interest. Data was normalised to the housekeeping gene BoPo (Bovine homologue of 
the large fragment of RNA polymerase) to establish the efficiency of conversion of RNA 
to cDNA.  
In addition quantitative PCR assays for the detection of Ly49 and NKp30 were designed 
as described (2.15) based on published sequences and are specified in section 9.5. 
Plasmid DNA standards were provided as a gift from Melanie Dobromylskyj, IAH (Ly49) 
and Tim Connelly, Edinburgh (NKp30).  
2.16 Data Analysis  
Data analysis was carried out using the software programs; Microsoft Excel 2007, FCS 
Express 3, Primer3 v0.40, 7500 Fast System SDS Software, Sequencher™ v4.14. 
Statistical analysis was carried out using Minitab v16 or GraphPad Prism v5. Data was 
transformed appropriately prior to assessment for normality and variance and 
statistical methods employed included paired T-tests, 1-Way ANOVA and general linear 
models (GLM), where appropriate with Tukey post-hoc comparisons at 95% confidence 
intervals.   
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3 The chemokine receptor repertoire of bovine NK cells 
3.1 Introduction  
The discovery that NK cells and their subsets reside in many different compartments 
has given rise to the theory that complex trafficking mechanisms may be involved both 
under steady state conditions as well as during an inflammatory immune response. NK 
cells express receptors for the lipids lysophosphatidic acid (LPA) (Jin et al., 2003) and 
sphingosine-1-phosphate (Kveberg et al., 2002) both of which have been implicated in 
the induction of migratory responses of NK cells. In particular, binding to sphingosine-
1-phosphate enables egress from bone marrow and lymph nodes and deficiency within 
this system resulted in aberrant trafficking of NK cells (Walzer et al., 2007b). 
Furthermore, NK cells migrate in response to Chemerin binding to ChemR23 receptors 
(Parolini et al., 2007) as well as IL-15 (Allavena et al., 1997). However, it is believed that 
chemokine signalling is fundamental to the retention of NK cells within tissues to form 
resident populations as well as the effective recruitment of NK cells to the site of 
infection and it is the repertoire of chemokine receptors that confers migratory ability.  
Under steady-state conditions, the homeostatic control of NK cell migration is 
influenced by a number of chemokine receptors. Immature NK cells express high levels 
of CXCR4 contributing to retention within the bone marrow (Bernardini et al., 2008, 
Luther et al., 2002) and CX3CR1 enables adhesion of NK cells to endothelial cells 
bearing the CX3CL1 ligand (Barlic et al., 2003). In addition, functionally distinct 
populations of NK cells are differentially distributed as a consequence of their 
chemokine receptor repertoire. For example, murine NK cells with a memory 
phenotype expressed CXCR6 and were selectively located within the liver (Paust et al., 
2010) and a discrete sub-population of IL-22 producing NK cells expressing CCR6 were 
identified within mucosal associated lymphoid tissue (Cella et al., 2009).   
Chemokine receptor expression patterns also vary substantially between subsets of 
human NK cells  resulting in altered migratory responses with implications for selective 
recruitment and tissue localisation (Robertson, 2002). Most significantly, the lymphoid 
homing receptor CCR7 is highly expressed by CD56bright CD16- NK cells (Berahovich et 
al., 2006) conferring responsiveness to high endothelial venule (HEV) cell derived 
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CCL21 and stromal cell derived CCL19 (Luther et al., 2002, Campbell et al., 2001, Kim et 
al., 1999, Martin-Fontecha et al., 2008) such that this population may selectively 
migrate towards and be retained within secondary lymphoid tissue (Fehniger et al., 
2003). Furthermore, CD56bright  CD16- NK cells express high levels of CCR5 and CXCR3 
and are able to migrate in response to the ligands CCL4, CCL5, CCL7, CXCL10 and 
CXCL11 (Berahovich et al., 2006, Campbell et al., 2001, Taub et al., 1995). In 
comparison the CD56dim CD16+ subset preferentially express CCR4, CCR9, CXCR1 and 
CX3CR1 and migrate in response to CXCL8 and CX3CL1 (Berahovich et al., 2006, 
Campbell et al., 2001).  
Phenotypically and functionally heterogeneous subsets of NK cells, defined by 
expression of NKp46 and CD2 (Storset et al., 2004, Boysen et al., 2006b) have also 
been identified in cattle. As is the case in humans (Sundstrom et al., 2007) percentages 
of NK cells in the periphery are highest within neonates with a rapid decline with 
increasing age (Graham et al., 2009, Kulberg et al., 2004). This may be as a 
consequence of re-distribution to tissues with bovine NK cells found as resident 
populations in numerous compartments. In particular, large numbers are located 
within the lungs, spleen, liver and lymph nodes as well as a constituent of the 
circulating lymphocyte population (Boysen et al., 2008, Storset et al., 2004). 
Importantly, the patterns of NK cell subset distribution vary between the different 
compartments such that CD2+ NK cells are predominantly localised within peripheral 
blood whereas CD2- NK cells constitute the major NK cell population within lymph 
nodes. It has been proposed that this may be as a result of selective expansion of CD2- 
NK cells within lymph nodes (Boysen et al., 2008, Boysen et al., 2006b) however; the 
chemokine receptor expression patterns or migratory characteristics of bovine NK cells 
may also account for these observed differences, but have previously not been 
investigated. 
In recent years, there have been significant advances in the discovery of bovine 
chemokines and their corresponding receptors. Genomic analysis identified bovine 
homologues for all known human chemokine receptors with varying similarities (on 
average between 60-90%) to their human counterparts (Widdison et al., 2010, 
Blumerman et al., 2007). For example, both bovine CCR7 and CXCR3 are over 80% 
 
73 
homologous at nucleotide and amino acid level to their corresponding human 
receptors (Blumerman et al., 2007) and cross reactivity of human and murine 
chemokines has been reported in the induction of bovine lymphocyte migration 
(Wilson et al., 2002). 
Initial investigations therefore sought to confirm the reported phenotypic 
characteristics of bovine NK cells and to further extend these studies by defining the 
chemokine receptor expression patterns of NK cell subsets derived from peripheral 
blood and prescapular lymph nodes as an insight into their potential migratory 
characteristics.  
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3.2 Results  
3.2.1 Identifying and isolating bovine NK cells and subsets  
Expression of the natural cytotoxicity receptor NKp46 is highly restricted to NK cells 
and lymphocytes from cattle which express this receptor display NK-like 
characteristics. NKp46 has therefore been shown as an accurate marker by which 
bovine NK cells can be identified and isolated (Storset et al., 2004). Blood or lymph 
node derived MNCs were labelled with the mAb mouse anti-bovine CD335-FITC, 
identifying a small population (1-5%) of NKp46+ lymphocytes (Figure 3.1.2). As  
previously observed, the percentages of NK cells in peripheral blood varied 
substantially; in particular with the age of the animal (Graham et al., 2009) however, 
the intensity of NKp46 expression within animals remained stable over time. 
Total NK cells were isolated by positively selecting NKp46 labelled cells with IgG1 
coated magnetic beads (2.4) to purities >95% (Figure 3.2.1). Whilst negative selection 
was investigated as an option to isolate bovine NK cells, a variety of depletion 
techniques did not result in adequate enough purities to continue with this method 
(data not shown). 
NKp46+ NK cells can be divided into phenotypically and functionally distinct subsets 
based on expression of CD2 (Boysen et al., 2006b). MNCs were further labelled using 
mAb mouse anti-bovine CD2 (CC42-647) to identify sub-populations of NK cells. This 
confirmed that blood derived NK cells formed two distinct populations with 70-80% of 
NK cells found to express high levels of CD2, referred to as NKp46+ CD2+ (CD2+ NK 
cells) whereas 20-30% of NK cells expressed low levels of CD2 (Figure 3.1.3). Whilst 
CD2 was not completely absent from this population, in line with the published 
literature this population will be referred to as NKp46+ CD2- (CD2- NK cells). 
In comparison to the distinct sub-populations of NK cells found in peripheral blood, the 
CD2 expression profile of NK cells derived from lymph nodes was less well defined with 
varying degrees of expression. In this case, CD2- NK cells were the predominant 
population (40-60%), with a smaller population of CD2+ NK cells (Figure 3.1.4).  
 
75 
To purify subsets, positively selected NK cells from peripheral blood and lymph nodes 
were labelled for CD2 using mAb mouse anti-bovine IL-A43 transiently coupled to 
IgG2a-FITC (2.4.1) and analysed by flow cytometry. By gating on the relevant 
population (Figure 3.1.3 and 3.1.4), labelled cells could be sorted into CD2+ and CD2- 
sub-populations using the FACSAria™ cell sorter (BD) to purities >98% (Figure 3.2.2 and 
3.2.3).  
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3.1.3           3.1.4 
 
Figure 3.1 Identification of bovine NK cells  
PBMCs were isolated by density gradient centrifugation and live lymphocytes identified by their 
FSC and SSC properties (Fig 3.1.1). Cells were labelled with the mAb CD335-FITC to define the 
NKp46+ population (Fig 3.1.2) assessed by flow cytometry. To identify bovine NK cell subsets, 
MNCs were further labelled with mAb CC42-647 with plots representing the CD2+ and CD2- 
populations of NK cells within the NKp46+ population from peripheral blood (Fig 3.1.3) or 
prescapular lymph nodes (Fig 3.1.4). Representative plots from 2 animals are shown. 
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3.2.1 
 
3.2.2           3.2.3 
  
Figure 3.2 Isolating bovine NK cells  
PBMCs were isolated by density gradient centrifugation and labelled for NKp46 with the mAb, 
mouse anti- bovine CD335 at 3μg/ml. Total NK cells were isolated  by positive MACS selection 
(2.4) and cells were assessed for purity by labelling the sorted population with IgG-RPE (Fig 
3.2.1) and comparing with unstained cells by flow cytometry. Populations with purities >95% 
were selected for further experimentation. To obtain subsets, NK cells isolated by positive 
MACS selection were further labelled for CD2 using the mAb mouse anti-bovine IL-A43 
transiently coupled to IgG2a-FITC (Zenon® labelling kit). NK cells could be purified into CD2+ 
(Fig 3.2.2) and CD2- (Fig 3.2.3) subsets by gating on the relevant sub-populations (Fig 3.1.3 and 
3.1.4) and sorting using the FACSAria™ (BD) cell sorter to purities >98%. Representative plots 
from one animal are shown.  
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3.2.2 Phenotyping bovine NK cells 
The lymphocyte population identified by expression of NKp46 and CD2 was further 
characterised to confirm an NK cell phenotype. PBMCs from four animals were labelled 
with monoclonal antibodies for T cell, B cell, monocyte and DC related surface 
molecules and expression within the NKp46+ CD2+ and NKp46+ CD2- subsets was 
analysed.  
As has been previously reported (Boysen et al., 2006b, Storset et al., 2004) the vast 
majority of NK cells did not express the T cell specific receptors; CD3 (MM1A), CD4 
(CC30), γδ TCR (GB21A) or WC1 (CC39). In addition NK cells were negative for 
monocyte receptor; CD14 (CCG33), B cell receptor; CD21 (CC21) and further myeloid 
cell related molecules; SIRPα (CC149) and MHC class II (CC158) (data not shown). 
However, both CD8αα (CC63) (Figure 3.3.1) and CD8αβ (CC58) (Figure 3.3.2) receptors 
were expressed by bovine NK cells and predominantly found on the NKp46+ CD2- 
subset. The low affinity FC receptor; CD16 (KD1) has been reported to define subsets 
of human NK cells (Cooper et al., 2001) and was found to be expressed by both the 
CD2+ and CD2- NK cell subsets in cattle (Figure 3.3.3). In comparison, only a small 
percentage of NK cells were found to express CD27 (MT-271) (Figure 3.3.4) and were 
largely negative for CD11b (CC94) (Figure 3.3.5); receptors which commonly 
differentiate subsets of human and murine NK cells (Chiossone et al., 2009, Hayakawa 
and Smyth, 2006).  
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Figure 3.3 Phenotyping bovine NK cells  
PBMCs were isolated by density gradient centrifugation and labelled with the mAb, mouse anti-
bovine CD335-FITC (NKp46) and CC42-647 (CD2) to identify the NKp46+ CD2+ and NKp46+ CD2- 
populations by flow cytometry. Cells were further labelled with mAbs for T cell, B cell, NK cell, 
monocyte and DC related surface molecules to phenotype NK cells (2.12.1.2). FACS plots 
demonstrate the expression of CD8αα (mAb; CC63), CD8αβ (CC58), CD16 (KD1), CD27 (MT-271) 
and CD11b (CC94); (monoclonal antibodies are specified in section 9.2) within the NKp46+ 
population of lymphocytes. Isotype controls and cells labelled with fluorochrome alone were 
used as controls to set the quadrants. Representative plots from one animal are shown.  
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3.2.3 Designing quantitative PCR assays for chemokine receptor analysis 
In collaboration with the bovine genomics group at the Institute for Animal Health, 
chemokine receptor genes were identified using published sequences (Blumerman et 
al., 2007) or those predicted from the bovine genome. Homologues to all known 
human chemokine receptors were identified in cattle and appeared to share a high 
degree of similarity with the corresponding human receptors. The genes for CCR1-10, 
CXCR1-CXCR6, CX3CR1 and XCR1 were cloned and sequenced and gene specific 
plasmid DNA standards were developed (Widdison et al., 2010).  
To detect transcript levels of chemokine receptors, primers and probes were designed 
(9.5) using Primer3 software; in order to amplify gene specific regions between 50 and 
150 base pairs in length and spanning over at least one exon boundary to prevent 
amplification of contaminating genomic DNA. Regions to be amplified were analysed 
by a basic nucleotide local alignment search tool (BLASTn) to confirm specificity and 
primers and probes were optimised using the ABI Prism 7500 Fast Real-Time PCR 
System and gene specific plasmid DNA standards (2.14).    
3.2.4 The chemokine receptor repertoire of bovine NK cells 
Bovine NK cells display varied tissue distribution with phenotypically distinct subsets of 
cells found within different anatomical locations. It is thought that the chemokine and 
chemokine receptor axis plays a significant role within a homeostatic context; enabling 
NK cells to migrate and exist within tissues, as well as during an inflammatory immune 
response; initiating re-distribution of NK cells to effector sites. Therefore, elucidating 
the chemokine receptor profiles of bovine NK cell subsets will enable insight into their 
potential migratory characteristics.   
NK cell subsets were isolated from peripheral blood of eight animals and prescapular 
lymph nodes from seven animals (2.4.1). RNA was isolated and reverse transcribed 
into cDNA prior to quantitative PCR analysis for the bovine chemokine receptors CCR1-
CCR10, CXCR1-6, CX3CR1 and XCR1 (2.15). 
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Transcripts for all of the measured chemokine receptors were detected in bovine NK 
cells. Within the blood derived NK cell population CCR8, CXCR6 and CX3CR1 were 
found to be transcribed at high levels (log2 copy number (CN) within the range of 0 to -
6). CCR1, CCR2, CCR5, CCR6, CCR7, CCR9, CXCR2, CXCR3, CXCR4 and XCR1 at 
intermediate levels (log2 CN within the range of -6 to -12) and CCR3, CCR4, CCR10 and 
CXCR1 at comparatively lower levels (log2 CN below -12) (Figure 3.4). The pattern of 
expression was considerably different in NK cells derived from prescapular lymph 
nodes with the majority of receptors being expressed at high levels; CCR1, CCR2, CCR5, 
CCR6, CCR7, CCR8, CXCR3 CXCR4, CXCR5, CXCR6 and CX3CR1 or intermediate levels; 
CCR3, CCR4, CXCR1, CXCR2 and relatively few at low levels; CCR9, CCR10 and XCR1 
(Figure 3.4). Despite these observations, statistical analysis conducted using a general 
linear model (GLM) with Tukey post-hoc comparisons (95% CI) revealed that within 
both peripheral blood and prescapular lymph node NK cells populations, no one 
receptor was transcribed at significantly higher or lower levels than any other 
receptor.  
However, comparison between the CD2+ and CD2- subsets of NK cells, assessed using 
pair-wise T-Tests (95% CI), indicated significant differences in the transcript levels of a 
large number of chemokine receptors (Table 3.1). NKp46+ CD2- NK cells were found to 
transcribe significantly higher levels of CCR2, CCR5, CCR6, CCR7, CCR10, CXCR3, CXCR4 
and CXCR5 when compared with their CD2+ counterparts. However, higher levels of 
CCR1, CCR8, CXCR6 and CX3CR1 were found on CD2+ NK cells. The differences 
between the subsets of NK cells were far less apparent within prescapular lymph 
nodes. In a similar statistical comparison, CD2+ NK cells were found to transcribe 
significantly higher levels of CCR1, CCR7, CCR8 and CX3CR1 when compared with the 
expression levels of CD2- NK cells (Table 3.1). 
Having established that subsets of NK cells expressed unique chemokine receptor 
transcript profiles, further comparisons were made to determine whether the 
anatomical location may also have an influence. T-Tests (95% CI) were conducted for 
each chemokine receptor to compare the observed transcript levels between 
peripheral blood and prescapular lymph nodes (Table 3.2). Generally, transcript levels 
for most chemokine receptors were  significantly higher in NK cells derived from lymph 
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nodes including; CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CXCR3, CXCR4, CXCR5, CXCR6 
and CX3CR1 on CD2+ NK cells and CCR3, CCR5, CCR6, CXCR1, CXCR3, CXCR4, CXCR5, 
CXCR6 and CX3CR1 on CD2- NK cells. 
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Figure 3.4 The chemokine receptor repertoire of NK cell subsets 
NK cell subsets (NKp46+ CD2+ and NKp46+ CD2-) were isolated from peripheral blood from 
eight animals and prescapular lymph nodes from seven animals using the FACSAriaTM cell sorter 
to purities >98%. RNA was reverse transcribed and subjected to quantitative PCR analysis for 
the cloned and sequenced bovine chemokine receptors. Transcription levels from blood derived 
NK cells CCR1-10 (Fig 3.4.1), CXCR1-XCR1 (Fig 3.4.2) and from prescapular lymph nodes CCR1-
10 (Fig 3.4.3) and CXCR1-XCR1 (Fig 3.4.4) are shown. Each sample was tested in triplicate, 
quantified against a plasmid DNA standard curve and normalised to the housekeeping gene 
BoPo. Data represents the Log2 normalised copy number (CN), CD2+ NK cells are shown in red 
and CD2- in blue with each point denoting the transcriptional value obtained from one animal. 
Copy numbers between -6 and 0 were considered high, -6 to -12 intermediate and below -12 as 
low. Significance between receptors was assessed using a GLM and between subsets using the 
paired T-test p<0.05 *, p<0.01**. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
  
Blood  
  
Prescapular lymph nodes  
  
CD2+  CD2-  
  
CD2+  CD2-  
CCR1  
 
+  
   
+  
 CCR2  
  
++  
    CCR3  
       CCR4  
       CCR5  
  
+  
    CCR6  
  
+  
    CCR7  
  
++  
  
+  
 CCR8  
 
++  
   
+  
 CCR9  
       CCR10  
  
++  
    CXCR1  
       CXCR2  
       CXCR3  
  
++  
    CXCR4  
  
++  
    CXCR5  
  
++  
    CXCR6  
 
++  
     CX3CR1  
 
++  
   
++  
 XCR1  
        
Table 3.1 Comparison of chemokine receptor expression by NK cell subsets 
NK cell subsets from peripheral blood and prescapular lymph nodes were analysed for 
chemokine receptor expression levels by quantitative PCR. Significance between the CD2+ and 
CD2- subsets was assessed at each location using the pair-wise T-Test with p<0.05 considered 
significant (+) and p<0.01 considered highly significant (++). P values are specified in Table 9.7. 
Pooled data from all animals is summarised in the table above.    
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Table 3.2 Comparison of chemokine receptor expression by location 
NK cell subsets from peripheral blood and prescapular lymph nodes were analysed for 
chemokine receptor expression levels by quantitative PCR. Significance between the values 
obtained for peripheral blood and prescapular lymph node (PSLN) was assessed for each subset 
using the Students T-Test with p<0.05 considered significant (+) and p<0.01 considered highly 
significant (++). P values are specified in Table 9.7. Pooled data from all animals is summarised 
in the table above.    
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3.2.5 Testing recombinant chemokines  
Whilst the transcript levels of chemokine receptors on NK cells varied substantially, the 
cell surface expression could not be confirmed due to lack of commercially available 
bovine antibodies. However, phylogenetic analysis has suggested that both 
chemokines and chemokine receptors are highly conserved and bovine sequences 
cluster well with both human and other related species (Widdison et al., 2010). In 
addition, recombinant murine (mu) CCL19, CCL21 and human (hu) CXCL12 were 
reported to induce the migration of bovine lymphocytes (Wilson et al., 2002).  
To determine whether the observed transcriptional differences between subsets of NK 
cells could influence their capacity to migrate, human and murine chemokines were 
tested for cross-reactivity in chemotaxis assays. Chemokines to be tested were 
selected based on previously published evidence suggesting that they may be 
influential in the induction of NK cell migration or chemokines with reported cross-
reactivity within the bovine system. Whilst recombinant bovine chemokines became 
available (Kingfisher Biotech) at later stages during these studies, their biological 
activity could not be confirmed and were therefore not used for chemotaxis 
experiments. The tested human and murine recombinant chemokines are shown in 
Table 3.3.  
Human  Murine  
CCL1 (I-309)  CCL3 (MIP-1α)  
CCL2 (MCP-1)  CCL5 (RANTES)  
CCL3 (MIP-1α)  CCL19 (ELC)  
CCL17 (TARC)  CCL21 (SLC)  
CCL19 (ELC)  CXCL10 (IP-10)  
CCL22 (MDC)  CXCL13 (BCA-1)  
CXCL8 (IL-8)  CXCL16  
CXCL9 (MIG)   
CXCL10 (IP-10)   
CXCL11 (I-TAC)   
CXCL12 (SDF-1α)   
CXCL13 (BCA-1)   
CXCL16   
CX3CL1 (Fractalkine)   
Table 3.3 Recombinant chemokines tested for cross-reactivity 
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Initial experiments to establish cross-reactivity of chemokines, used bovine PBMCs 
stimulated for three days with ConA (5μg/ml) as input cells within chemotaxis assays 
(2.9.1). Migration was assessed in response to recombinant chemokines at a range of 
dilutions (50ng/ml-1μg/ml) and media (TCM) alone (9.1) was used as a negative 
control. A positive result was considered as a significant induction of migration above 
background assessed by a 1-Way ANOVA with Tukey post-hoc comparisons (95% CI). 
Of the chemokines tested, only recombinant huCXCL9, CXCL10, CXCL12 and muCCL19 
(Figure 3.5) appeared to induce detectable levels of migration above the background 
levels observed with media alone. As has previously been shown (Wilson et al., 2002), 
muCCL19 was chemotactic for bovine PBMCs and the migration followed a typical 
‘bell-shaped’ dose-response. At concentrations of 500ng/ml, CCL19 specific 
recruitment peaked at about 30% PBMCs migrating and at concentrations above this, 
migration was significantly reduced indicating receptor saturation may have been 
reached (Figure 3.5.1). Despite previous observations suggesting muCCL21 may also 
cross-react with bovine receptors and induce the migration of lymphocytes (Wilson et 
al., 2002), no migration was observed in chemotaxis assays with this chemokine.   
In comparison, PBMCs migrated towards huCXCL9 but only in significant numbers (5-
15%) at concentrations above 200ng/ml (Figure 3.5.2). The migratory response was 
still elevated at 1μg/ml and higher concentrations were not tested to determine if the 
saturation point had been reached. Whilst low levels of migration towards huCXCL10 
(500ng/ml) were observed, this was not found to be significant at any of the 
concentrations analysed (Figure 3.5.3).  
The highest level of chemokine induced recruitment was in response to recombinant 
huCXCL12 (Figure 3.5.4). In a typical dose-response, migration of stimulated PBMCs 
was significantly elevated at all concentrations tested (50ng-1μg/ml). At the peak of 
the response (500ng/ml), huCXCL12 was able to induce migration of over 50% of the 
PBMC population. 
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Figure 3.5 Migration of stimulated PBMCs towards recombinant chemokines 
PBMCs were stimulated with ConA (5μg/ml) for three days before being assessed for migration 
in a transwell chemotaxis assay. Recombinant chemokines; murine (mu) CCL19 (Fig 3.5.1), 
human (hu) CXCL9 (Fig 3.5.2), CXCL10 (Fig 3.5.3) and CXCL12 (Fig 3.5.4) were used as 
attractants at concentrations ranging from 50ng/ml to 1μg/ml with media (TCM) alone as a 
negative control. Each concentration was assayed in duplicate and data represents the average 
migration, expressed as a percentage of the input population from three animals, with error 
bars denoting the standard deviation between animals. Significance was assessed using a 1-
Way ANOVA with Tukey post-hoc comparisons (95% CI) to determine significantly increased 
migration above the media control; p<0.05 *, p<0.01**.  
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3.2.6 NK cell migration to recombinant chemokines  
Initial migration assays suggested that recombinant muCCL19, huCXCL9 and huCXCL12 
may be cross-reactive with bovine MNCs derived from peripheral blood. To determine 
whether NK cells were migrating in response to these chemokines, the migrated cells 
from these experiments were pooled and analysed by immuno-fluorescent labelling. 
Input and migrated cells were labelled with the mAbs (9.2) CD335-PE (NKp46) and 
CC42-647 (CD2) to identify the percentage of NK cells and proportions of subsets 
within each population.  
NK cells were not detected within migrated populations of PBMCs responding to 
muCCL19 and huCXCL9, however were found to migrate in response to huCXCL12. A 
representative plot from one animal is shown in Figure 3.6. Comparison of the 
percentage of NK cells in the input (3.36%) and migrated (1.43%) populations 
suggested that in this instance, 40% of the NK cells within the total PBMC population 
migrated in response to huCXCL12. 
To determine whether the observed migration was optimal, further chemotaxis assays 
were conducted utilising purified NK cells from peripheral blood and a dilution range 
(50ng/ml to 1µg/ml) of the recombinant chemokines. As was observed in previous 
assays, NK cells did not migrate in response to muCCL19 or huCXCL9. This was also the 
case when IL-12 and IL-18 stimulated NK cells (2.5) were used as input cells in 
chemotaxis assays (data not shown). In comparison, significant percentages of purified 
NK cells migrated in response to huCXCL12 at all concentrations tested (Figure 3.7). 
The response was optimal at 200ng/ml with an average 35-45% of the NK cells 
migrating. For this reason, huCXCL12 was employed as positive control for NK cell 
migration in all subsequent chemotaxis assays. 
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Figure 3.6 Identification of recombinant huCXCL12 induced NK cell migration     
PBMCs from three animals were stimulated with ConA 5µg/ml for three days before being 
assessed for migration in transwell chemotaxis assays in response to recombinant huCXCL12. 
Duplicate wells for both the input and migrated cell populations were pooled separately, 
labelled with the mAb CD335-PE and analysed by flow cytometry. NKp46+ cells were identified 
by gating against unstained PBMCs and the percentage of NK cells in the input and migrated 
populations were compared. Representative plots from one animal are shown.  
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Figure 3.7 Migration of NK cells in response to recombinant huCXCL12  
NKp46+ cells were isolated from peripheral blood of three animals by positive MACS selection 
and left to rest overnight in TCM at 37°C. Chemotaxis assays were used to assess the migratory 
responses of NK cells towards recombinant huCXCL12 at concentrations ranging from 50ng/ml 
to 1μg/ml. Media alone was used as negative control and each concentration was assayed in 
duplicate. Data represents the average migration, expressed as a percentage of the input 
population from three animals, with error bars denoting the standard deviation between 
animals. Significance was assessed using the 1-Way ANOVA with Tukey post-hoc comparisons 
(95% CI) p<0.05 *, p<0.01**.  
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3.3 Discussion 
NK cells are a small population of lymphocytes with multifunctional responses in the 
innate and adaptive immune systems. Both human and murine NK cells are commonly 
defined by unique phenotypic characteristics (1.2.3.4) however, the natural 
cytotoxicity receptor NKp46 is highly conserved and has been reported to represent a 
unifying marker by which NK cells can be identified across many mammalian species 
(Walzer et al., 2007a). This is also the case within cattle, with expression restricted to a 
small percentage of granular lymphocytes with cytolytic and cytokine producing 
properties. Storset et al., (2004) reported that NKp46 was highly and stably expressed 
and therefore isolation of lymphocytes bearing this receptor was an accurate method 
by which bovine NK cells could be identified and purified. Despite this, recent studies 
have proposed that NKp46 may also be expressed by a minor sub-population of bovine 
splenic γδ T cells. However, this was only the case following long term stimulation with 
IL-15 (Johnson et al., 2008) or very transient expression on a small population of WC1+ 
γδ T cells in Foot and Mouth Disease Virus (FMDV) infected cattle (Toka et al., 2009). 
As such, NKp46 bearing lymphocytes are primarily defined as NK cells with phenotypic 
and functional characteristics corroborating this definition.  
Within initial studies, we confirmed published reports that bovine NK cells from 
peripheral blood positively selected by NKp46, were phenotypically distinct from T 
cells, B cells, monocytes and γδ T cells. This technique has therefore been employed in 
all subsequent experiments as a method to isolate bovine NK cells to a high degree of 
purity. It should be noted however, that positive selection of NK cells in this manner 
may exclude discrete NK-like populations which do not express NKp46. These have 
been reported to exist within humans (Ferlazzo and Munz, 2004) and may also be 
found in the peripheral blood of cattle; predicted to be an immature population of NK 
cells (Graham et al., 2009). In addition, it is important to consider that NKp46 functions 
as an activatory receptor, signalling through which induces NK cell effector responses. 
In cytotoxicity studies, cross-linking of NKp46 augmented the killing responses against 
target cell populations; yet cells within this study were also pre-stimulated with IL-2 
(Storset et al., 2004). Additionally, the binding of haemagglutinin to NKp46 has been 
reported to initiate cytolytic activity against virally infected cells (Mandelboim et al., 
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2001). However (Achdout et al., 2010) further elucidated that binding did not 
necessarily lead to activation with an NK cell response determined by the distinct site 
at which the ligand bound to the NKp46 molecule. Furthermore, it has also been 
reported that monoclonal antibodies to NKp46 may mask interactions with natural 
ligands and function to block cytolytic activity (Pessino et al., 1998, Sivori et al., 1999). 
It is therefore not known the degree to which the use of monoclonal antibodies 
against NKp46 may influence NK cell effector responses. However, despite these 
factors, positive selection utilising NKp46 was found to be the only definitive technique 
by which bovine NK cells could be isolated with numerous attempts at negative 
selection failing to provide sufficient purities. 
In further phenotypic analysis, we confirmed that significant numbers of bovine NK 
cells expressed CD16 and in contrast to human NK cells, the levels of expression were 
not variable (Boysen et al., 2008). Most significantly, blood derived NK cells could be 
divided into sub-populations with a larger proportion (70-80%) of cells expressing CD2. 
CD2 is primarily defined as an adhesion molecule but studies have also suggested roles 
as a co-receptor for activation (McNerney and Kumar, 2006, Tangye et al., 2000). 
Despite this, CD2 expression has been reported to be redundant for effective NK cell 
derived effector responses with blocking mAbs having little effect. In addition it is the 
NKp46+ CD2-/low subset of bovine NK cells that is the more functionally responsive 
with augmented cytolytic activity, cytokine production and faster proliferation 
following IL-2 stimulation (Boysen et al., 2006b).  
As such, parallels have been drawn between subsets of bovine and human NK cells 
with CD56bright CD16- human NK cells demonstrating similar functional responses and 
localities to bovine NKp46+ CD2- NK cells. However, it is not possible to draw direct 
comparisons between populations of cells defined by differing phenotypic 
characteristics. Therefore, whilst emerging reports in the human field suggest that 
human NK cell subsets may represent populations of cells at differing stages of 
maturation (Marquez et al., 2010, Juelke et al., 2010, Yu et al., 2010); it is not known 
whether this may also be the case in the bovine field. Both CD2+ and CD2- NK cells 
possess the capacity for mature NK cell derived effector responses (Boysen et al., 
2006b). It is possible that specific stimulatory signals may be required as was found to 
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be the case for human NK cells in contact with fibroblasts (Chan et al., 2007) or 
through cross-linking of CD16 (Marquez et al., 2010) and is an area where further 
research is required.  
In this thesis significant numbers of NK cells were observed within resting prescapular 
lymph nodes with varying levels of CD2 expression such that the distinction between 
subsets was less clear. Nevertheless, NKp46+ CD2-/low NK cells constituted the 
predominant population within lymph nodes (Figure 3.1.4). It has been proposed that 
this may be as consequence of selective expansion of CD2- NK cells which are known 
to be highly proliferative within IL-2 rich environments (Boysen et al., 2006b), as would 
be the case within lymph nodes. Yet it is not known whether the observed distribution 
may also be as a result of selective recruitment of CD2- NK cells from the periphery. 
Bovine NK cells are known to express L-Selectin (CD62L) (Boysen et al., 2008), an 
adhesion receptor which confers the ability to home to secondary lymphoid tissue via 
HEVs. However, the migratory responses of leukocytes are more commonly 
determined by expression of an array of chemokine receptors which function in 
synergy to initiate migration in response to gradients of locally produced chemokines. 
This study therefore sought to gain an insight into the migratory characteristics of 
bovine NK cells with initial investigations conducted to determine the patterns of 
chemokine receptor expression between subsets of NK cells in the blood and 
prescapular lymph nodes.  
Transcripts for both homeostatic and inflammatory chemokine receptors could be 
detected in bovine NK cells. Whether the observed levels equate to translation is not 
known as at present there are no antibodies to detect their surface expression. Despite 
this, it has been suggested that the functional levels of chemokine receptors are well 
reflected at mRNA level (reviewed by (Widdison et al., 2010)). Results herein 
demonstrated considerable variations in the patterns of chemokine receptor 
expression between subsets of bovine NK cells. NKp46+ CD2+ NK cells which constitute 
the larger population within peripheral blood, expressed significantly higher levels of 
homeostatic receptors CXCR6 and CX3CR1 in comparison to their CD2- counterparts 
(Table 3.1). The expression of homeostatic chemokine receptors is associated with the 
formation of resident populations with NK cells bearing CXCR6 preferentially retained 
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within murine hepatic regions (Paust et al., 2010) and CX3CR1 functioning as an 
adhesion receptor to potentiate the retention of lymphocytes to endothelial cells 
bearing CX3CL1 ligands (Barlic et al., 2003, Fraticelli et al., 2001). In addition, during in 
vivo studies we have observed significant numbers of CD2+ NK cells within the lung 
tissue of cattle (6.2.1). Functional expression of homeostatic chemokine receptors may 
therefore contribute to the selective localisation or retention of CD2+ NK cells within 
non-lymphoid compartments.  
In comparison, CD2- NK cells derived from peripheral blood transcribed significantly 
higher levels of a number of inflammatory and lymphoid homing chemokine receptors 
(Table 3.1). In particular, elevated expression of CCR2, CCR5 and CXCR3 would confer 
responsiveness to multiple inflammatory chemokines produced rapidly at the site of 
infection. Both virally (Piqueras et al., 2006) and bacterially (Lande et al., 2003) 
infected antigen presenting cells have been reported to up-regulate expression of 
inflammatory chemokines CCL2, CCL3, CCL4, CCL5 and CXCL10 to aid the accumulation 
of effector cells, with NK cells migrating in a CXCR3 dependent manner. In addition, the 
significantly increased expression of CXCR3 and CCR7 by CD2- bovine NK cells may 
influence the lymphoid homing capacity of this subset. This has previously been 
demonstrated within human CD56bright CD16- NK cells expressing CCR7 enabling 
migration in response to CCL19 and CCL21 and preferential accumulation within 
secondary lymphoid tissue (Berahovich et al., 2006, Campbell et al., 2001, Robertson, 
2002, Kim et al., 1999, Fehniger et al., 2003). Furthermore, murine NK cells migrated to 
draining lymph nodes in response to CXCR3 ligands produced by infected DCs (Martin-
Fontecha et al., 2004). The observed chemokine receptor repertoire of CD2- NK cells 
may therefore contribute to the preferential accumulation of this subset within 
lymphoid tissue, as well as recruitment to the site of infection during an inflammatory 
immune response. These responses were further investigated as a part of this thesis 
within the context of mycobacterial infection.  
In further phenotypic analysis, the patterns of chemokine receptor expression within 
prescapular lymph nodes was far more uniform, with fewer receptors being 
preferentially expressed by either subset of bovine NK cells (Table 3.1). This is also the 
case with CD2 expression levels and may be as a consequence of a more 
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heterogeneous population of NK cells. Despite this, CD2+ NK cells within lymphoid 
tissue preferentially expressed CCR7 and CX3CR1. Local conditions within lymph nodes 
favour CD2- NK cells enabling proliferation and persistence (Boysen et al., 2008) thus; 
elevated expression of these receptors within lymph nodes may aid the retention of 
the minor population of CD2+ NK cells. Overall, the transcript levels for the majority of 
chemokine receptors were significantly higher in NK cells derived from prescapular 
lymph nodes when compared with the levels seen within the blood (Table 3.2). It has 
previously been reported that bovine NK cells within lymph nodes possess a more 
activated phenotype with elevated expression of CD25 and this may be as a 
consequence of exposure to T cell derived IL-2 which is found in abundant levels within 
lymph nodes (Boysen et al., 2008). Human NK cells stimulated with IL-2 expressed 
enhanced levels of inflammatory chemokine receptors; CCR2, CCR5 (Nieto et al., 1998) 
and CXCR3 (Beider et al., 2003) and in further studies IL-2 augmented the migratory 
response to multiple inflammatory and lymphoid homing chemokines (Inngjerdingen 
et al., 2000, Maghazachi et al., 1997, Berahovich et al., 2006, Beider et al., 2003, 
Allavena et al., 1996). It should be noted however, that the comparison between 
chemokine receptor expression levels of NK cells derived from blood and prescapular 
lymph nodes was made between different animals. Whilst this factor was taken into 
consideration within the statistical analysis, a more accurate comparison would be to 
directly compare NK cells from multiple compartments within the same animal.  
To corroborate the findings by quantitative PCR, further experimentation involved the 
development of chemotaxis assays to evaluate the migratory responses of bovine NK 
cells. When these studies were conducted, functional bovine chemokines were not 
commercially available therefore; we sought to identify cross-reactive human and 
murine recombinants. The chemokine family of receptors and ligands is well conserved 
between species and genomic analysis demonstrated a high degree of homology 
between certain human, murine and bovine sequences. In general, similarities at both 
nucleotide and amino acid level range from 60-90%, with the most conserved 
receptors CCR7 (91%), CXCR3 (87%) and CXCR4 (92%) found to be highly homologous 
between humans and cattle (Boyd et al., 2010, Blumerman et al., 2007, Widdison et 
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al., 2010). Additionally, muCCL19, muCCL21 and huCXCL12 were reported to mediate 
the migration of bovine lymphocytes within chemotaxis assays (Wilson et al., 2002).   
Following testing of multiple chemokines (Table 3.3), bovine lymphocytes migrated in 
response to the CCR7 ligand; muCCL19 and the CXCR3 ligand; huCXCL9. Despite the 
use of a range of concentrations, percentages of migrating cells were considerably low 
and NK cells did not appear to be recruited. It is likely that the relative affinity and 
avidity of receptor-ligand interactions also plays a significant role in determining 
activity. For example, it has been reported that human CXCL10 binds CXCR3 with lower 
affinity than CXCL9, through occupation of alternative binding sites (Cox et al., 2001) 
and may therefore explain the different responses between these two chemokines 
observed herein. Overall, cross-reactivity was deemed to be relatively low and no 
further experimentation was conducted with these recombinants. In contrast, at 
optimal concentrations the CXCR4 ligand; huCXCL12 recruited 50-70% of bovine 
lymphocytes. Both CXCL12 and its receptor CXCR4 are highly conserved across many 
species (Basu et al., 2002) and human and bovine sequences are 92% similar at amino 
acid level. Therefore, the highly homologous receptor/ligand pair induced substantial 
migratory responses of bovine lymphocytes.  
Resting human NK cells constitutively express CXCR4 (Inngjerdingen et al., 2001) and 
murine studies have demonstrated homeostatic roles for CXCR4/CXCL12 associated 
with the retention or release of NK cells from the bone marrow (Beider et al., 2003, 
Bernardini et al., 2008). Herein, peripheral blood derived bovine NK cells expressed 
CXCR4 and migrated in significant numbers in response to huCXCL12. Thus, in all 
further chemotaxis experiments, huCXCL12 was utilised as a positive control to 
evaluate efficient migratory responses of NK cells. Given the substantial heterogeneity 
in the levels of chemokine receptor transcript between subsets of bovine NK cells, 
further experimentation within this thesis was conducted to determine whether this 
may influence migratory capacity in particular within models of mycobacterial 
infection.   
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4 The migratory responses of NK cells during M.bovis infection 
4.1 Introduction 
During mycobacterial infection, the recruitment of leukocytes to the site of infection as 
well as re-distribution to draining lymph nodes are pivotal events in the induction of 
innate and adaptive immune responses. Within the respiratory tract, infiltrating 
lymphocytes enable the formation of lesions and granulomas to restrict the replication 
and spread of mycobacteria (Peters and Ernst, 2003, Algood et al., 2003). Whilst this 
process contributes to the immuno-pathology associated with chronic TB infection, it is 
also essential to the formation of an appropriate early immune bias for the induction 
of protective immunity.  
NK cells are prevalent at the site of an inflammatory immune response as well as 
within the draining lymph nodes of humans and cattle (Boysen et al., 2008, Fehniger et 
al., 2003, Ferlazzo et al., 2004b). Murine models of Cytomegalovirus (Salazar-Mather 
and Hokeness, 2003), Leishmania major (Vester et al., 1999), Toxoplasma gondii (Khan 
et al., 2006) and Klebsiella pneumonia (Zeng et al., 2003) have demonstrated 
accumulation of NK cells upon antigenic insult. Furthermore, intranasal challenge with 
BCG or M.tuberculosis induced increases in the absolute numbers of activated, IFNγ 
producing NK cells within the lungs (Feng et al., 2006, Junqueira-Kipnis et al., 2003, 
Saxena et al., 2002). A similar response was also seen within the localised lymphoid 
tissue following administration of mycobacterial antigens; Ag85 and ESAT6 (Hall et al., 
2010). In particular, CD56bright NK cells are often reported as abundant within 
inflammatory sites (Maghazachi, 2005, Dalbeth et al., 2004). This has also been 
reported to be the case during TB infection, with selective enrichment of CD56bright NK 
cells within the pleural fluid (Schierloh et al., 2005). 
Whilst the observed increase in the proportions of NK cells may at least in part be 
attributed to localised expansion, NK cells are highly responsive to chemokines and 
have been reported to possess a higher migratory capacity during TB infection (Pokkali 
et al., 2009). Numerous studies have demonstrated the fundamental role that 
chemokines play in the recruitment of NK cells. For example, NK cell accumulation 
following Leishmania major infection in mice was dependent on CXCL10 release 
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(Vester et al., 1999) and a role of CCL3 during Klebsiella pneumonia infection has been 
shown (Zeng et al., 2003). Prlic et al., (2005) reported that upon antigenic challenge, 
NK cells were expanded within the spleen and recruited from the periphery to the site 
of infection in a process reliant on G-protein coupled receptor signalling. Within gene 
knock-out mice, lack of CCR1 (Shang et al., 2000) or CCR5 (Khan et al., 2006) had a 
substantial impact on the migratory responses of NK cells with impaired trafficking to 
the site of infection. Additionally, expression of CXCR3 has been demonstrated as 
implicit for NK cell migration to draining lymph nodes (Martin-Fontecha et al., 2004, 
Watt et al., 2008).  
The recruitment of lymphocytes such as NK cells is controlled by inflammatory 
chemokines rapidly secreted by alveolar macrophages, DCs and also epithelial cells. 
However, it has been reported that DCs in particular play a fundamental role in the 
effective recruitment of both NK cells and also CD4+ T cells (Uchida et al., 2007). The 
release of chemokines by DCs has been reported to be a dynamic process in order to 
orchestrate the differential recruitment of effector cells in a time-dependent fashion 
(Piqueras et al., 2006, Sallusto et al., 1999). DCs infected with M.tuberculosis rapidly 
up-regulated the inflammatory chemokines CCL2, CCL3, CCL4, and CXCL8 followed by 
increasing levels of CXCL9 and CXCL10 (Gustafsson et al., 2008, Lande et al., 2003) over 
the course of the infection period.  
Of particular importance is the co-localisation of NK cells with DCs (5.1), a process 
which enables reciprocal interactions to ensue such that DC maturation and NK cell 
effector responses are potentiated both at the inflammatory site and within draining 
lymph nodes to influence the shaping of the adaptive immune response. In this 
manner, DCs exposed to influenza virus recruited NK cells in significant numbers by 
chemokine mediated mechanisms (Piqueras et al., 2006). Furthermore, following 
M.tuberculosis infection the migration of NK cells towards DCs was reliant on CXCR3 
expression and CXCL10 secretion (Lande et al., 2003) with an important role of CCR5 
also described in the DC derived recruitment of NK cells (Van Elssen et al., 2010). In 
vivo, LPS matured DCs mediated the rapid recruitment of NK cells from the periphery 
to draining lymph nodes, mediated by CXCR3 expression by NK cells (Martin-Fontecha 
et al., 2004), ligands for which are readily produced by DCs (Gustafsson et al., 2008). 
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Herein, we have demonstrated significant variations in the chemokine receptor 
expression patterns between subsets of bovine NK cells (3.2.4) however their 
migratory responses, in particular during mycobacterial infection have previously not 
been investigated. This study therefore sought to elucidate whether M.bovis infected 
DCs could recruit NK cells and whether the previously observed patterns of chemokine 
receptor expression could be reflected within the migratory responses of NK cells 
subsets.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
108 
4.2 Results 
4.2.1 Chemotactic activity of supernatants from M.bovis infected DCs 
DCs were cultured from peripheral blood derived monocytes for three days and 
infected with M.bovis overnight at a MOI of 1:1 (2.7.2). Supernatants were retrieved 
and their migratory capacity was evaluated using chemotaxis transwell assays with 
PBLs as input cells. Specific migration at each dilution could be ascertained by flow 
cytometry and FSC/SSC differentiation of granulocytes, monocytes and lymphocytes.    
Within total PBLs, gating of a high SSC population of cells (Figure 4.1.1) identified 
granulocytes, which demonstrated an inherent capacity to migrate with over 40% of 
cells non-specifically responding to the media (TCM) control (Figure 4.1.2). Significant 
migration over background (media-control) was assessed using log transformed data 
within a GLM (95% CI) with p<0.05 considered significant. The highest level of 
migration was observed in the granulocyte population of cells (vs monocytes p=0.004 
and vs lymphocytes p=<0.001) with supernatants from M.bovis infected DCs able to 
specifically recruit an additional 30-40% of cells at optimum (1:2) (peak) supernatant 
dilutions (vs media p=0.021). Monocytes were identified by their high FSC and SSC 
properties and 20-30% of cells migrated (p=0.012) at the peak of the response (1:2). In 
contrast, no significant migration of lymphocytes was observed at any of the tested 
dilutions. 
To clarify optimal conditions for lymphocyte migration, supernatants from M.bovis 
infected DCs were obtained at 24, 36 and 72 hours post-infection and assessed in 
further chemotaxis assays with either ConA stimulated PBMCs or NK cells (un-
stimulated or IL-12 + IL-18 stimulated) as input cells. As previously observed, PBMCs or 
purified NK cells did not migrate in response to supernatants from M.bovis infected 
DCs and extending the period of infection appeared to have no effect (data not 
shown).  
It has previously been suggested that, M.bovis infected DCs could induce the activation 
and migration of bovine γδ T cells, however only when infected DCs were in direct 
culture with the γδ T cells (Price, 2009). In light of this, chemotaxis assays were 
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adapted to include the M.bovis infected DC population and the resultant supernatant 
in situ and subsequent lymphocyte migration was assessed. Initial studies utilising this 
co-culture format indicated an induction of NK cell migration. Further experiments to 
optimise the time period for the chemotaxis assay suggested that the peak of the NK 
cell migratory response could be observed after 4 hours and that time periods longer 
than this (up to 24 hours) did not significantly alter the percentages of migrating cells 
(data not shown). Therefore, these conditions were used in all subsequent migration 
assays.  
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Figure 4.1 Migration of PBLs towards supernatants from M.bovis infected DCs  
Monocytes were isolated from peripheral blood and cultured for three days to obtain DCs. 
Supernatants from DCs were retrieved after overnight infection with M.bovis and migration of 
PBLs was assessed in transwell chemotaxis assays (Fig 4.1.2). Granulocytes, monocytes and 
lymphocytes could be differentiated within the total PBL population, by flow cytometry based 
on FSC and SSC properties (Fig 4.1.1). Supernatants were used as attractants at a variety of 
concentrations ranging from neat to 1:100 and media (TCM) alone was used as a negative 
control. Each dilution was assayed in duplicate and data represents the average migration, 
expressed as a percentage of the input population from three animals, with error bars denoting 
the standard deviation between animals. Significance was assessed using a GLM with Tukey 
post-hoc comparisons (95% CI) to determine significantly increased migration above the media 
control; p<0.05 * 
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4.2.2 Co-cultured chemotaxis assays 
4.2.2.1 Migration of peripheral blood derived NK cells  
Having established optimum conditions for NK cell migration, in vitro co-cultured 
chemotaxis assays were used to determine to what extent mycobacterial infection of 
DCs induced the recruitment of NK cells. Monocytes were isolated from peripheral 
blood and cultured for three days to obtain DCs (2.6). Within initial chemotaxis assays, 
DCs were infected with the attenuated mycobacterial strain BCG overnight (2.7.2) and 
peripheral blood derived NK cells (2.4), were assayed for migratory responses. 
Statistical significance was assessed using the 1-Way ANOVA with Tukey post-hoc 
comparisons (95% CI).  
The control conditions; media (TCM) or BCG alone ((MOI 10:1) (2.7.2)) were not able to 
induce the migration of NK cells (Figure 4.2.1). In contrast, a small percentage of the 
total NK cell population (5-20%) migrated towards uninfected DCs, significantly above 
the migratory responses observed with media (p=0.001) or BCG alone (p=0.004). 
Whilst NK cells (15-25%) were recruited by BCG infected DCs, for the majority of 
animals no significant increase was seen in comparison to that observed with 
uninfected DCs. NK cells from all animals responded to the rhu CXCL12 positive control 
(data not shown).  
In further chemotaxis assays, NK cells did not respond to the media or M.bovis alone 
(MOI 1:1) (2.7.2)) control conditions (Figure 4.3.1). As previously shown, a small 
induction of migration was observed in response to uninfected DCs; however in this 
case this was found not to be significantly different to media or M.bovis alone. Upon 
infection of DCs with M.bovis, NK cells from three out of six animals were recruited 
with an increase in the percentage of migrated NK cells (15-25%). However, analysis of 
data across all six animals revealed no significant response towards M.bovis infected 
DCs despite NK cells from each of the animals responding to the rhu CXCL12 positive 
control (data not shown). 
To further clarify how subsets of NK cells may be responding within these assays, 
migrated fractions from each chemotactic condition were labelled with the mAb CC42-
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647 and analysed by flow cytometry to determine the proportions of CD2+ and CD2- 
NK cells. Statistical significance between different chemotactic conditions was assessed 
using a GLM with Tukey post-hoc comparisons (95% CI).  
As has been described previously, bovine NK cells consist of subsets defined by their 
expression of CD2. The majority (70-80%) of blood derived NK cells are CD2+ and a 
comparatively smaller population (20-30%) have lower levels of CD2 expression (3.2.2). 
NK cells used as input populations within chemotaxis assays were consistent with this 
distribution and proportions of CD2+ and CD2- subsets did not change within migrated 
fractions of cells responding to media alone (Figure 4.2.2). Whilst a minor increase in 
the proportion of CD2- NK cells within the migrated fractions responding to BCG was 
often detected, this was found not to be a significant increase compared to the media 
control. In contrast, analysis of NK cells recruited by DCs revealed considerable 
alterations in the proportions of NK cell subsets; with significantly increased 
percentages of CD2- NK cells compared with the input NK cell population (p=0.001). 
Infection of DCs with BCG induced a similar effect, with increased CD2- NK cells 
(p=0.002) compared to media however, the response was similar to that observed with 
DCs alone and was therefore, not significantly altered upon infection with BCG.  
Further chemotaxis assays with M.bovis infected DCs showed a similar redistribution of 
subsets within migrated fractions of NK cells (Figure 4.3.2); with significantly increased 
proportions of CD2- NK cells in response to DCs (p=<0.001) or DCs infected with 
M.bovis (p=<0.001). Importantly, the percentage of CD2- NK cells in migrated fractions 
recruited by M.bovis infected DCs was significantly elevated compared with M.bovis 
(p=<0.001) or DCs alone (p=0.006) suggesting M.bovis specific preferential recruitment 
of CD2- NK cells. 
Chemotaxis data from blood derived NK cells suggested that M.bovis infected DCs may 
preferentially recruit CD2- NK cells. However, labelling of total NK cells in this manner 
was not sufficient to determine whether the CD2- population was selectively 
migrating, whether the CD2+ NK cells were down-regulating expression of CD2 or 
selectively dying in culture; all of which could potentially result in the observed 
increase in proportions of CD2- NK cells. Labelling of migrated fractions with Propidium 
 
114 
Iodide (2.9.1) indicated no significant cell death within either population of NK cells. In 
further analysis, no significant alterations in the mean fluorescence intensity of CD2 
could be detected, therefore suggesting that CD2- NK cells are likely to be selectively 
recruited.  
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Figure 4.2 Migration of NK cells in response to BCG infected DCs 
Monocyte derived DCs were infected with BCG (MOI 10:1) and after overnight infection were 
used as attractants in chemotaxis transwell assays. Input NK cells were isolated from peripheral 
blood by positive MACS selection and migration was assessed in response to BCG infected DCs 
(Fig 4.2.1) with Media (TCM), DCs or BCG alone as controls. Each condition was assayed in 
triplicate and data represents the average migration, expressed as a percentage of the input 
population from a group of five animals with each data point denoting the individual responses 
of animals. Rhu CXCL12 was used as a positive control (data not shown).  
To determine proportions of migratory NK cells subsets, triplicates of input and migrated 
fractions from each condition were pooled independently and labelled for CD2 (CC42-647) and 
analysed by flow cytometry (Fig 4.2.2). Data represents the proportions of NKp46+ cells that 
were CD2+ (red) or CD2- (blue) in migrated populations with error bars demonstrating the 
standard deviation between animals. Statistical significance between conditions was assessed 
using the 1-Way ANOVA (Fig 4.2.1) or a GLM (Fig 4.2.2) with Tukey post-hoc tests with 95% CI 
p<0.05*, p<0.01** 
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Figure 4.3 Migration of NK cells in response to M.bovis infected DCs 
Monocyte derived DCs were infected with M.bovis (MOI 1:1) and after overnight infection were 
used as attractants in chemotaxis transwell assays. Input NK cells were isolated from peripheral 
blood by positive MACS selection and migration was assessed in response to M.bovis infected 
DCs (Fig 4.3.1) with Media (TCM), DCs or BCG alone as controls. Each condition was assayed in 
triplicate and data represents the average migration, expressed as a percentage of the input 
population from a group of six animals with each data point denoting the individual responses 
of animals. Rhu CXCL12 was used as a positive control (data not shown).  
To determine proportions of migratory NK cells subsets, triplicates of input and migrated 
fractions from each condition were pooled independently and labelled for CD2 (CC42-647) and 
analysed by flow cytometry (Fig 4.3.2). Data represents the proportions of NKp46+ cells that 
were CD2+ (red) or CD2- (blue) in migrated populations with error bars demonstrating the 
standard deviation between animals. Statistical significance between conditions was assessed 
using the 1-Way ANOVA (Fig 4.3.1) or a GLM (Fig 4.3.2) with Tukey post-hoc tests with 95% CI 
p<0.05*, p<0.01** 
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4.2.2.2 Migration of NK cell subsets 
Previous assays with total NK cell populations derived from peripheral blood implied 
migratory responses may be subset specific however, did not fully clarify the individual 
responses of sub-populations of NK cells (4.2.2.1). For this reason, CD2+ and CD2- NK 
cell subsets were purified and analysed for migratory response to DCs infected with 
M.bovis using conditions which had previously demonstrated a specific induction of NK 
cell migration (4.2.2.1).  
Small percentages of NK cells expressing CD2 migrated in response to M.bovis infected 
DCs, (Figure 4.4) but observed levels were not significantly above those found in 
response to the control conditions of media, DCs or M.bovis alone. In comparison, 
M.bovis infected DCs specifically recruited CD2- NK cells with significantly higher 
percentages of migrating cells compared with media (p=<0.001), DCs (p=0.004) or 
M.bovis (p=0.042). Furthermore, significantly higher percentages of CD2- NK cells 
migrated in response to M.bovis (p=<0.001) or M.bovis infected DCs (p=<0.001) when 
compared with their CD2+ counterparts. Further analysis of migrated fractions of NK 
cells indicated no alterations in the intensity of CD2 expression prior to and after 
migration and no significant cell death within either population.  
Whilst M.bovis infected DCs were able to specifically recruit CD2- NK cells, only a 
proportion of the overall NK cell population (25-35%) responded in this manner (Figure 
4.4). In order to further phenotype this population, migrated fractions (DC+M.bo) were 
labelled for NK cell associated molecules; CD16, CD27, CD8αα, CD8αβ and CD62L 
(2.12). No significant differences were found in either the percentage of cells, or the 
intensity of expression for any of the NK cell surface expressed molecules (data not 
shown). Further analysis will be required to determine the specific functional or 
phenotypic attributes of the small proportion of NKp46+ CD2- cells that preferentially 
migrate towards M.bovis infected DCs.  
 
 
 
120 
 
Figure 4.4 Migration of NK cell subsets in response to M.bovis infected DCs 
Monocyte derived DCs were infected with M.bovis and after overnight infection were used as 
attractants in chemotaxis transwell assays. Input NK cell subsets were purified from peripheral 
blood and migration was assessed in response to M.bovis infected DCs (Fig 4.4) with Media 
(TCM), DCs or M.bovis alone as controls. Each condition was assayed in triplicate and data 
represents the average migration of CD2+ (red) and CD2- (blue) NK cells, expressed as a 
percentage of the input population, from a group of six animals - error bars denote standard 
deviation between animals. Rhu CXCL12 was used as a positive control (data not shown). 
Statistical significance between subsets and conditions was assessed using the GLM with Tukey 
post-hoc comparisons (95% CI) p<0.05*, p<0.01** 
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4.2.3 Chemokine expression by BCG or M.bovis infected DCs  
Within migratory assays, infected DCs were able to selectively recruit sub-populations 
of NK cells. Recruitment of cells in this manner is commonly associated with gradients 
of chemokines able to induce the migration of neighbouring cells expressing cognate 
receptors. In the absence of assays to detect protein levels within the supernatants of 
infected DCs, chemokine expression was assessed by quantitative PCR. Monocyte 
derived DCs were infected with either BCG or M.bovis and chemokine transcripts were 
analysed at 3, 6, 12 and 24 hours post-infection. Chemokines to be analysed were 
selected based on known involvement in NK cell migration during an inflammatory 
immune response or during lymphoid homing. 
Uninfected DCs transcribed high basal levels of the inflammatory chemokines CCL2, 
CCL3, CCL4, CCL5 and CXCL8 (Figure 4.5). In comparison, CCL8, CCL20, CXCL9 and 
CXCL10 were present at comparatively lower levels. Upon infection with M.bovis, DCs 
underwent significant transcriptional changes with the inflammatory chemokines; 
CCL3, CCL4, CCL5, CCL20 and CXCL8 augmented within 3-6 hours post-infection (Figure 
4.6). After the initial increase in transcription at 3 hours post-infection, levels of CCL4 
(Figure 4.6.2) and CCL5 (Figure 4.6.3) remained elevated over the 24 hour period, with 
no further increase in expression (Table 4.2). In comparison transcription of CCL3 
(Figure 4.6.1), CCL20 (Figure 4.6.4) and CXCL8 (Figure 4.6.5) continued to increase over 
time, with levels of CCL3 and CXCL8 at 24 hours post-infection significantly augmented 
compared with levels at 3 and 6 hours (Table 4.2). Following M.bovis infection, CCL20 
was the most highly induced chemokine with transcripts peaking at 12 hours post-
infection (Table 4.2). In contrast, M.bovis infection of DCs did not affect the expression 
levels of CCL2, CCL8, CXCL9 or CXCL10 (Table 4.1), with no detectable levels of CCL19 at 
any time points.  
Infection with BCG did not induce large transcriptional changes of chemokines with 
only CCL5 (Figure 4.6.6) and CCL20 (Figure 4.6.7) up-regulated after 6-12 hours of 
infection. However, despite up-regulation, the levels of CCL5 (p=0.035) and CCL20 
(p=0.001) induced with BCG were significantly lower than those transcribed after 
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M.bovis infection suggesting the virulent mycobacterial strain resulted in greater  
transcriptional induction of chemokines by DCs.  
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Figure 4.5 Chemokine expression by uninfected DCs 
Peripheral blood derived monocytes from four animals were cultured for 3 days to obtain DCs. 
RNA was obtained from uninfected samples at 3hr and was reverse transcribed to cDNA for 
analysis of chemokine transcripts by quantitative PCR. Data represents the Log2 copy number 
(CN) of CCL2, CCL3, CCL4, CCL5, CCL8, CCL20, CXCL8, CXCL9 and CXCL10. Significance between 
chemokines was assessed using a GLM with Tukey post-hoc comparisons (95%) CI p<0.05* 
P<0.01** 
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Figure 4.6 Chemokine expression by BCG or M.bovis infected DCs  
Peripheral blood derived monocytes from four animals were cultured for 3 days to obtain DCs 
which were infected with BCG (MOI 10:1) or M.bovis (MOI 1:1). RNA was obtained from 
samples at 3, 6, 12 and 24 hours post-infection with uninfected DCs at each time point serving 
as a negative control. The RNA was reverse transcribed to cDNA and analysed for chemokine 
transcripts by quantitative PCR. Data represents the Log2 copy number (CN) of CCL3 (Fig 4.6.1), 
CCL4 (Fig 4.6.2), CCL5 (Fig 4.6.3), CCL20 (Fig 4.6.4), CXCL8 (Fig 4.6.5) from M.bovis infected DCs 
and CCL5 (Fig 4.6.6) and CCL20 (Fig 4.6.7) from BCG infected DCs. Significance between 
chemokines, infections or between uninfected (black) and infected DCs (red) was assessed 
using a GLM with Tukey post-hoc comparisons (95%) CI p<0.05* P<0.01** 
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Table 4.1 Summary of chemokines up-regulated by infected DCs   
DCs infected with BCG or M.bovis were analysed for chemokine expression levels by 
quantitative PCR. Significance between uninfected and infected samples was assessed at each 
time point using a GLM with Tukey post-hoc comparisons; p<0.05 (+), p<0.01(++) or no 
significance (NS). Pooled data from four animals is summarised in the table above.    
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Table 4.2 Summary of changes in chemokine transcripts over time within 
infected DCs  
DCs infected with BCG or M.bovis were analysed for chemokine expression levels by 
quantitative PCR. Significance between the different time points (3/6/12/24 hours) was 
assessed using a GLM with Tukey post-hoc comparisons; p<0.05 (+), p<0.01(++) or no 
significance (NS). Pooled data from four animals is summarised in the table above.    
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4.2.4 Cytokine production by infected DCs 
Infection of DCs with M.bovis induced up-regulation of chemokine transcripts and 
recruitment of NK cells within in vitro chemotaxis assays. Previous research has 
suggested that upon mycobacterial infection, DCs are also able to produce cytokines 
(Hickman et al., 2002, Hope et al., 2004) such as IL-12 or IL-10 which can mediate the 
subsequent immune response and in this instance may influence the activation of 
recruited NK cells.  
Supernatants were obtained at 3, 6, 12 and 24 hours post-infection (M.bovis or BCG) 
and were assayed for IL-12 and IL-10 protein levels by ELISA (2.8). Differences between 
infected and uninfected samples were evaluated using a GLM with Tukey post-hoc 
comparisons (95% CI). DCs infected with BCG produced IL-12 at significant levels 
(Figure 4.7.1) at 12 and 24 hours (p=<0.001) post-infection. However, infection with 
M.bovis resulted in a much larger induction of IL-12 production compared with BCG 
and levels were significantly elevated after 6, 12 and 24 hours (p=<0.001). Whilst 
significant increases in IL-10 were observed (Figure 4.7.2) after 6, 12 and 24 hours 
(p=<0.001) post-M.bovis infection, comparative to IL-12 the levels of protein detected 
were negligible.   
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Figure 4.7 Cytokines produced by infected DCs  
Peripheral blood derived monocytes were cultured for 3 days to obtain DCs which were infected 
with BCG or M.bovis. Supernatants were retrieved at 3, 6, 12 and 24 hours post-infection with 
uninfected DCs at each time point serving as a negative control. Supernatants were subjected 
to analysis for IL-12 (Fig 4.6.1) and IL-10 (Fig 4.6.2) by ELISA. Data represents the average 
cytokine levels from 4 animals in biological units (bu) with error bars denoting the standard 
deviation between animals. Significance was assessed using log transformed data within a 
GLM with Tukey post-hoc comparisons (95% CI) p<0.05* P<0.01** 
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4.3 Discussion 
A prerequisite to the effective containment and development of protective immunity 
against mycobacterial pathogens is the recruitment of leukocytes to the site of 
infection as well as to draining lymph nodes. Chemokines are central to this process 
with gradients created within the local milieu or across endothelial junctions able to 
induce the directional migration and recruitment of cells bearing cognate receptors. As 
such, chemokines are produced by numerous cells in a highly complex and redundant 
system that functions to orchestrate the localisation of immune effector cells. Antigen 
presenting cells, prevalent within the respiratory tract are a significant source of 
inflammatory chemokines with alveolar macrophages reported to up-regulate 
expression as early as 4 hours following M.bovis infection (Widdison et al., 2011). 
Importantly, chemokines produced by maturing DCs function to recruit NK cells (Lande 
et al., 2003) enabling co-localisation and initiation of bi-directional interactions 
resulting in skewing of Th1 mediated immunity (Martin-Fontecha et al., 2004). Murine 
models have demonstrated the fundamental role that DCs play, with deficiencies 
resulting in aberrant recruitment of both NK cells and CD4+ T cells (Uchida et al., 
2007). Experiments conducted herein sought to establish whether mycobacterially 
infected DCs mediated the recruitment of bovine NK cells and whether differential 
responses could be observed between subsets given that the patterns of chemokine 
receptor expression also varied significantly (3.2.4).  
The release of chemokines by DCs is a dynamic process that occurs in a time-ordered 
fashion to induce the differential recruitment of leukocytes. Within this study, a range 
of chemokines were selected with roles in inflammation and lymphoid homing to 
determine expression levels over 24 hours following infection of DCs with M.bovis or 
BCG. It has been reported that the early secretion of inflammatory chemokines by 
maturing DCs (Piqueras et al., 2006, Sallusto et al., 2000, Sallusto et al., 1999) aids the 
accumulation of innate effector cells in attempts to rapidly control infection. DCs 
infected with M.tuberculosis up-regulated expression of CCL2, CCL3, CCL4 and CXCL8 
within 3 hours of infection (Lande et al., 2003); receptors for which are widely 
expressed, in particular by granulocytes, macrophages and NK cells (Inngjerdingen et 
al., 2001, Ferrero et al., 2003). In a similar manner, transcript levels of inflammatory 
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chemokines CCL3, CCL4, CCL5, CXCL8 and CCL20 were augmented within 3-6 hours 
following infection of bovine DCs with M.bovis (Figure 4.6). In contrast M.bovis did not 
alter expression levels of CCL2 or CCL8; however these chemokines have been 
associated with anti-inflammatory immune responses (Chensue et al., 1996) and may 
not play a significant role during M.bovis infection. Maturing DCs sustained elevated 
expression of both CCL4 and CCL5 (Figure 4.6), a response likely to enable sustained 
recruitment of CCR5 expressing leukocytes (Sallusto et al., 1999) and levels of CCL3, 
CXCL8 and CCL20 continually increased over the 24 hour infection period (Figure 4.6). 
Interestingly, CCL20 was the most highly induced chemokine following M.bovis 
infection. Studies suggest that CCL20 plays a prominent role during an inflammatory 
immune response with rapid release by airway epithelial cells contributing to the early 
accumulation of DCs bearing CCR6 (Thorley et al., 2005). As such, elevated levels of 
CCL20 have readily been detected within supernatants from PBMCs and BAL fluid of TB 
infected patients (Lee et al., 2008).    
The balance of chemokines produced by DCs changes during the advancing stages of 
maturation that occur following infection, to alter the populations of cells recruited. In 
particular, DCs secrete CXCL9, CXCL10 and CCL19 (Gustafsson et al., 2008, Lande et al., 
2003) to promote the lymphoid homing of CXCR3 and CCR7 bearing T cells and NK cells 
(Yoneyama et al., 2002, Martin-Fontecha et al., 2004). It has been reported that in 
vitro, these chemokines are only detected at later time-points (8-48 hours) following 
infection of DCs (Piqueras et al., 2006, Sallusto et al., 1999). Within the 24 hour period, 
despite maturation, M.bovis infected DCs did not up-regulate expression of CXCL9 and 
CXCL10 with no detectable transcripts for CCL19. This may therefore be as a 
consequence of time and further experimentation would be required to determine 
whether the expression of lymphoid homing chemokines is augmented after 24 hours.  
It is known that the nature of the maturation stimuli which DCs receive substantially 
influences the effector response. Hope et al., (2004) reported that DCs infected with 
BCG secreted reduced levels of IL-12 and IL-10 when compared with the levels 
observed with M.bovis; a response which has also been confirmed here (Figure 4.7). 
Similarly, a significantly reduced induction of chemokine expression by DCs infected 
with BCG was observed, with only CCL5 and CCL20 augmented at 6-12 hours post-
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infection. Comparison of the transcript levels of CCL5 and CCL20 suggest that whilst 
up-regulated, the response to BCG was markedly reduced compared with M.bovis. 
However, it may be that the response to BCG is slower and both cytokines and 
chemokines may be augmented at time-points later than 24 hours. Alternatively BCG 
may induce the release of different chemokines which were not measured in this 
study. Further experimentation would need to be conducted to determine whether 
this is the case. In addition, whilst transcript levels appear to be significantly altered, 
there are no bovine antibodies to detect these chemokines therefore, it is not possible 
at this time to determine whether the observed levels equate to actual protein 
produced. In light of this factor, we utilised in vitro chemotaxis assays to clarify 
whether the observed induction of chemokine transcripts could be reflected within 
migratory responses. 
Both granulocytes and monocytes migrated in response to supernatants from M.bovis 
infected DCs (Figure 4.1). This has previously also been reported to occur following 
M.bovis infection of alveolar macrophages (Widdison et al., 2008). Granulocytes are 
highly migratory and as such represent one of the first populations of cells to 
accumulate during an inflammatory immune response. Migration in this manner 
occurs as a consequence of CXCR1 and CXCR2 expression conferring responsiveness to 
CXCL8 (Ferrero et al., 2003). (Widdison et al., 2010) demonstrated that transcripts for 
CXCR1, CXCR2 and important inflammatory receptors could also be detected in 
monocytes derived from the peripheral blood of cattle. In addition, mycobacterially 
infected DCs rapidly produce CXCL8 (Lande et al., 2003) and data presented herein 
demonstrated significant increases in expression levels following M.bovis infection 
(Figure 4.6.5). Thus, the granulocyte/monocyte migration observed is likely to be as a 
consequence of inflammatory chemokines including CXCL8, produced by M.bovis 
infected DCs. Despite this fact, in agreement with previously published evidence 
(Ferrero et al., 2003, Widdison et al., 2008) significant lymphocyte migration was not 
observed and increasing the period of infection to potentially alter the balance of 
chemokines within the supernatant did not alter this response. Reports suggest that in 
vitro, lymphocytes require extensive stimulation prior to induction of chemotactic 
activity (Ferrero et al., 2003, Lande et al., 2003). Additionally, bovine γδ T cells were 
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not responsive to supernatants but migrated when M.bovis infected DCs were left in 
situ (Price, 2009). Similarly, bovine NK cells could be recruited in this manner. It is not 
known why this is the case however, may be as a result of a continuous activatory 
signal delivered by the M.bovis infected DCs which may not be present or at high 
enough concentrations within supernatants. In addition, migrated NK cells may directly 
interact with DCs to potentiate chemokine release and enhance the further 
recruitment of additional NK cells.   
NK cells are highly responsive to chemokines and prevalent both as resident 
populations and also as infiltrating cells during inflammatory immune responses. 
Murine models have demonstrated important roles of CCR1 (Shang et al., 2000), CCR5 
(Khan et al., 2006) and CXCR3 (Martin-Fontecha et al., 2004, Vester et al., 1999) 
expression by NK cells enabling accumulation at sites of infection as well as within 
draining lymph nodes. Importantly, it has been shown that DC derived chemokines 
function to recruit NK cells. Within chemotaxis assays, significant migration of NK cells 
towards uninfected DCs was evident however; this response was highly variable 
between different groups of animals. Transcript analysis has revealed that DCs express 
high basal levels of important inflammatory chemokines CCL2, CCL3, CCL4, CCL5 and 
CXCL8 (Figure 4.5) and may therefore demonstrate chemokines which are 
constitutively secreted by DCs (Vissers et al., 2001). Data presented in Chapter 3 
showed that NK cells derived from peripheral blood transcribe the chemokine 
receptors CCR1, CCR2, CCR3, CCR5, CXCR1 and CXCR2; expression of which would 
confer responsiveness to constitutively produced chemokines. It is possible that NK 
cells migrate in this manner to exert cytolytic responses upon autologous immature 
DCs; a mechanism by which NK cells can select appropriately primed DCs for the 
development of the immune response (Ferlazzo et al., 2003).  
Following M.bovis infection, DCs recruited NK cells in significant numbers. The 
response was highly variable in chemotaxis assays that utilised the total NK cell 
population derived from peripheral blood which are predominantly CD2+ with a 
smaller sub-population of CD2- NK cells. Detailed investigations utilising purified 
subsets clarified that the minor CD2- NK cell population was preferentially recruited by 
M.bovis infected DCs (Figure 4.4). Variations in the migratory responses of subsets of 
 
135 
human NK cells have also been reported (Berahovich et al., 2006, Campbell et al., 
2001) with CD56bright NK cells selectively enriched at inflammatory sites (Dalbeth et al., 
2004) and within draining lymph nodes (Fehniger et al., 2003). Bovine CD2- NK cells 
from peripheral blood preferentially expressed the majority of the inflammatory 
chemokine receptors including CCR2, CCR5, CCR6 and CXCR3 (3.2.4). In particular CCR5 
is a promiscuous receptor and expression confers responsiveness to multiple 
inflammatory chemokines including CCL3, CCL4 and CCL5; transcripts for which were 
found to be augmented by M.bovis infected DCs (Figure 4.6). Expression of CCR5 was 
found to be implicit for the accumulation of NK cells to the site of parasitic (Khan et al., 
2006) infection. In addition, Klebsiella pnuemonia infected human DCs recruited NK 
cells in a CCR5 dependent manner (Van Elssen et al., 2010). As such, it is possible that 
CCR5 and its ligands play a prominent role in the induced recruitment of bovine CD2- 
NK cells. There may also be a further role of CCR6; which was expressed at significantly 
higher levels by bovine CD2- NK cells, (3.2.4) and its ligand CCL20; transcription of 
which was highly induced following M.bovis infection of DCs (Figure 4.6.4).  
In contrast to the responses observed with M.bovis, within the conditions investigated 
herein, DCs infected with BCG failed to recruit NK cells in significant numbers above 
the response that was already observed prior to infection. This is corroborated by the 
earlier finding that DCs infected with BCG did not up-regulate transcripts for select 
inflammatory chemokines. However, it has previously been demonstrated that CCL2, 
CCL3, CXCL10 and CCL22 can be readily detected within human PBMCs stimulated with 
BCG (Luo et al., 2007) and therefore, NK cells may still be able to respond to gradients 
of chemokines produced following administration of BCG. In addition, whilst it appears 
that there may be differences in the migratory response of NK cells to BCG or M.bovis 
infected DCs; these experiments utilised different groups of animals. We have 
previously observed significant variability between animals (Figure 4.3) and therefore, 
in order to further clarify true differences between BCG and M.bovis, migratory 
experiments would have to be repeated whilst accounting for this factor.  
Interestingly, within chemotaxis assays bovine NK cells appeared to migrate in 
response to mycobacteria alone with a more prominent response observed within the 
CD2- population (Figure 4.4). Studies have suggested that NK cells express functional 
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formyl peptide receptors which confer migratory responsiveness to bacterial peptides 
(Kim et al., 2009). It is not known whether this is also the case for bovine NK cells and 
would require further investigation. In addition, NK cells can be directly activated by 
mycobacteria, without the need for co-stimulatory signals from accessory cells. Human 
NK cells cultured with BCG in the absence of a cytokine stimulus; up-regulated 
activation markers CD69 and CD25, increased production of IFNγ and TNFα, and NK 
mediated cytolytic activity was induced, with a more prominent effect on CD56bright NK 
cells (Batoni et al., 2005, Esin et al., 2008, Esin et al., 2004, Marcenaro et al., 2008). 
Further research elucidated roles of TLR2 (Marcenaro et al., 2008), TLR3, TLR9 (Sivori 
et al., 2004) and NKp44 (Batoni et al., 2005, Esin et al., 2008) in the direct recognition 
of bacterial antigens by NK cells. Similar responses have also been observed within 
bovine NK cells directly responding to Neospora caninum to produce IFNγ (Boysen et 
al., 2006a). It is possible that the direct activation of NK cells in this manner may 
induce migratory responsiveness. In addition, emerging evidence suggests that NK cells 
are also an important source of chemokines and upon activation have been reported 
to secrete CCL3, CCL4 and CCL5 (Dorner et al., 2002, Nieto et al., 1998); chemokines 
which induce migration of cells bearing CCR5. Furthermore, discrete populations of NK 
cells produced CCL20 and functioned to recruit additional NK cells expressing CCR6 to 
maintain resident populations within mucosa associated lymphoid tissue (Cella et al., 
2009). Thus, it is possible that NK cells directly activated by M.bovis may secrete 
chemokines and contribute to their own accumulation.  
Importantly, percentages of CD2- NK cells recruited by M.bovis infected DCs were 
significantly higher compared with the numbers migrating in response to mycobacteria 
alone indicating an additional chemotactic response derived from infected DCs. In 
further investigations, definitive evidence for the role of chemokines could be 
provided by utilising NK cells incubated with pertussis toxin as a mechanism by which 
G-protein signalling may be inhibited. In previous studies, bovine CD2- NK cells have 
been reported to represent the more activated population with faster proliferation, 
IFNγ release and cytolytic activity following cytokine stimulation (Boysen et al., 2006b). 
Therefore, the selective recruitment of this population may have implications for 
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reciprocal interactions between NK cells and DCs and will be investigated further 
within this thesis. 
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5 Interactions of NK cells and DCs during M.bovis infection  
5.1 Introduction 
The precise requirements for protective immunity to mycobacterial infection are yet to 
be established however, the early production of IFNγ plays an important role in   
potentiating the innate immune response and effectively shaping adaptive immunity. 
NK cells are a significant source of IFNγ which functions to regulate macrophage 
bactericidal activity within M.tuberculosis infected lungs (Feng et al., 2006) as well as 
playing an implicit role in the priming of CD4+ and CD8+ T cells to polarise Th1 biased 
immunity (Mailliard et al., 2003, Martin-Fontecha et al., 2004). Increasingly the 
recruitment of NK cells and subsequent interplay with DCs is thought to play a 
fundamental role within this process. This may occur both at the site of infection as 
well as within draining lymph nodes with reciprocal interactions influencing the 
activation of both cell populations.   
Immune interactions between NK cells and DCs were first described over a decade ago 
with mature DCs directly triggering cytolytic responses of NK cells to restrict tumour 
growth (Fernandez et al., 1999). The interaction has subsequently been the focus of 
intense research, with depletion of DCs found to result in the impaired activation of NK 
cells (Lucas et al., 2007). It has become apparent that initiation of effector responses of 
both NK cells and DCs requires multiple co-stimulatory signals (Fehniger et al., 1999a, 
Ortaldo and Young, 2003). NK cells produced IFNγ in response to M.tuberculosis 
infected DCs (Gerosa et al., 2002), however the response was only optimal following 
stimulation from DC derived cytokines as well as direct cell-cell contact. Importantly, it 
has been reported that the DC induced IFNγ production and proliferative responses of 
NK cells may be restricted to the CD56bright sub-population, depletion of which resulted 
in a loss of IFNγ release (Ferlazzo et al., 2004a, Vitale et al., 2004). In addition, DCs are 
able to trigger NK cell derived cytolytic activity to augment the killing of M.tuberculosis 
infected monocytes and alveolar macrophages (Vankayalapati et al., 2005) or 
immature DCs (Hayakawa et al., 2004, Wilson et al., 1999, Yu et al., 2001). BCG 
infected DCs promoted NK cell derived lytic activity against autologous immature DCs 
(Ferlazzo et al., 2003), with susceptibility reduced upon maturation following up-
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regulation of HLA class I (Ferlazzo et al., 2003, Ferlazzo et al., 2001). Consequently NK 
cells function to bias the immune response to those DCs which have undergone 
appropriate maturation.  
Bacterially infected DC readily produce abundant levels of IL-12 (Hickman et al., 2002, 
Hope et al., 2004), which promote NK cell derived IFNγ production and cytolytic 
activity (Gerosa et al., 2002, Van Elssen et al., 2010). Roles for IL-18 (Artavanis-
Tsakonas et al., 2003, Artavanis-Tsakonas and Riley, 2002, Bastos et al., 2008, Van 
Elssen et al., 2010), IL-15 (Lucas et al., 2007, Van Elssen et al., 2010) and TNFα 
(Humann and Lenz, 2010) have also been described, however only the inhibition of IL-
12 functioned to completely abrogate NK cell proliferation and IFNγ release (Ferlazzo 
et al., 2004a, Gerosa et al., 2002, Van Elssen et al., 2010, Vitale et al., 2004). In 
addition, during antigen specific recall responses CD4+ T cell derived IL-2 induced NK 
cell effector responses which were further augmented by IL-12 derived from myeloid 
cells (Bihl et al., 2010, Horowitz et al., 2010a, Horowitz et al., 2010b). 
Separation of NK cells from DCs has demonstrated that as well as soluble mediators, 
direct cell-cell contact is required for optimal activation of NK cells (Gerosa et al., 2002, 
Humann and Lenz, 2010, Vitale et al., 2004, Yu et al., 2001) with numerous studies 
attempting to elucidate the exact nature of the contact-dependent signals. In 
particular, NK cells in close proximity to DCs form immunological synapses to enable 
the polarised delivery of IL-12 (Borg et al., 2004) and potentially IL-18 (Semino et al., 
2005) with an important role of CX3CR1 expression by NK cells to facilitate tethering to 
DCs (Pallandre et al., 2008). Furthermore, IL-15 bound to the surface of DCs may be 
trans-presented to promote proliferative responses of NK cells (Ferlazzo et al., 2004a, 
Humann and Lenz, 2010, Lucas et al., 2007). Additional interactions may include 
CD40/CD40L (Carbone et al., 1999) or activating KIR binding to MHC class I peptide 
complexes (Newman et al., 2006). Importantly, the recognition and killing of immature 
or infected DCs has been reported to be reliant on expression of CD94/NKG2A (Della 
Chiesa et al., 2003), NKp30 (Ferlazzo et al., 2002, Marcenaro et al., 2005) and 
potentially also NKG2D recognising MICA/B ligands expressed by DCs (Jinushi et al., 
2003).  
 
143 
During reciprocal interactions, NK cells have been reported to influence the maturation 
and effector responses of DCs and in this manner act as a bridge between the innate 
and adaptive immune systems. NK cell derived TNFα and IFNγ functioned to promote 
the maturation of DCs (Mailliard et al., 2003), a process which also required NKp30 
mediated signalling (Vitale et al., 2005). Consequently DCs matured in this manner 
produced elevated levels of CXCL9, CXCL10 (Lande et al., 2003) and IL-12 (Mailliard et 
al., 2003). Yet perhaps most significantly, IFNγ release by CD4+ (Van Elssen et al., 2010) 
and CD8+ T cells (Mailliard et al., 2003, Morandi et al., 2009) was augmented following 
DC interactions with NK cells. 
Within the bovine system, it has been reported that NK cells secrete IFNγ and restrict 
mycobacterial replication within M.bovis infected macrophages (Denis et al., 2007). 
However the extent to which these reciprocal interactions may occur between bovine 
NK cells and DCs has previously not been investigated. It is known that M.bovis 
infected DCs are a major source of IL-12 (Hope et al., 2004) and IFNγ release from 
bovine NK cells was at least in part mediated by IL-12 derived from infected antigen 
presenting cells (Olsen et al., 2005). In addition BCG infected DCs induced the 
proliferation and IFNγ production from CD3- CD8+ lymphocytes believed to be NK cells 
(Hope et al., 2002b); responses which required both cytokine production and cell-cell 
contact (Bastos et al., 2008). In light of these factors, experimental co-cultures were 
utilised to investigate whether reciprocal interactions may occur between blood 
derived NK cells and monocyte derived DCs during M.bovis infection. In particular, 
these studies focussed on whether the heterogeneity in the migratory responses 
observed between subsets of bovine NK cells could also be observed in their 
interactions with DCs.  
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5.2 Results 
5.2.1 Activation of NK cells following culture with M.bovis infected DCs  
To investigate the interactions of NK cells with M.bovis infected DCs, we utilised in 
vitro co-culture assays and initially determined whether there were alterations in the 
CD25 expression levels of NK cell subsets. The IL-2 receptor-α-chain (CD25) is widely 
expressed by lymphocytes and its up-regulation is commonly used as an indicator of T 
cell or NK cell activation. Monocyte derived DCs from four animals were infected with 
M.bovis and cultured with peripheral blood derived NK cells overnight prior to analysis 
of CD25 cell surface expression (2.12.1). NK cells cultured alone, with uninfected DCs 
or with M.bovis, served as control conditions.  
A very small percentage of CD2- NK cells were found to constitutively express CD25; 
however this was not significantly higher than their CD2+ counterparts. Therefore, the 
majority of NK cells from peripheral blood did not express CD25 (Figure 5.1.1) and this 
was not significantly altered after either subset was cultured alone, with uninfected 
DCs or with M.bovis (Figure 5.1.3). In contrast, after NK cells were cultured with 
M.bovis infected DCs a significant increase in the percentages of CD2+ (p=<0.001) and 
CD2- (p=<0.001) NK cells expressing CD25 was observed when compared with all other 
control conditions (Figure 5.1.2 and 5.1.3). Analysis of the proportions of CD25 positive 
NK cells within each subset, expressed as a percentage of the total proportion of CD2+ 
or CD2- NK cells highlighted that similar percentages of NK cells within each subset 
were activated.  
Detailed analysis of the mean fluorescence intensity of CD25 (Figure 5.1.4) indicated 
that whilst percentages of CD2+ and CD2- NK cells expressing CD25 were similar, the 
intensity of expression by CD2- NK cells was significantly augmented following culture 
with M.bovis infected DCs compared with control conditions (p=<0.001) and also 
compared with the intensities observed with CD2+ NK cells (p=<0.001) under all 
conditions. Furthermore, visual investigation of the FACS data (Figure 5.1.2) 
highlighted the presence of a population of CD2- NK cells within the total CD2- 
population (29% - gated in red) which was expressing CD25 at higher intensities after 
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contact with M.bovis infected DCs and may therefore indicate differential levels of 
activation within this subset of NK cells.  
Further phenotypic examination of CD25 expressing NK cells indicated no alterations in 
the expression levels of NK cell markers; CD16, CD27, CD8αα, CD8αβ or CD62L. 
Additionally, no changes in NKp46 or CD2 expression levels were observed and no 
significant proliferation or cell death of either subset was observed after co-culture 
with M.bovis infected DCs (data not shown).  
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5.1.4 
 
 
Figure 5.1 Activation of NK cells following co-culture with M.bovis infected DCs 
Monocyte derived DCs were cultured for three days and infected with M.bovis. NK cells were 
purified from peripheral blood and cultured with the infected DCs at previously determined 
optimal ratios (2.10). Each culture condition was replicated in triplicate with NK cells cultured 
alone, with uninfected DCs or with M.bovis alone serving as controls. After overnight co-culture 
cells were labelled with mAbs for NKp46, CD2 and CD25 and analysed by flow cytometry. FACS 
plots from one representative animal display the percentages of CD2+ or CD2- NK cells 
expressing CD25 within the total gated NK cell population; NK cells alone (Fig 5.1.1) or NK cells 
after co-culture with M.bovis infected DCs (Fig 5.1.2) with a population of CD2- NK cells 
expressing high intensities of CD25 gated in red. Quadrants were set based on isotype controls 
and unstained cells. Pooled data from four animals (Fig 5.1.3) indicates the percentage of CD25 
positive NK cells expressed as a percentage of the total CD2+ or CD2- population and the mean 
fluorescence intensity of CD25 (Fig 5.1.4)  with error bars representing the standard deviation 
between animals. Significant changes in CD25 expression between culture conditions were 
assessed using log transformed data and a GLM with Tukey post-hoc comparisons (95%CI); 
p<0.05*, p<0.01**. 
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5.2.2 Cytokine production in co-cultures of NK cells and DCs 
Upon activation, NK cells are able to produce immuno-modulatory cytokines such as 
IFNγ and TNFα and this contributes to their implicit role in the early appropriate 
priming of the subsequent immune response. DC derived cytokines are fundamental to 
the control of this response. Since M.bovis infected DCs appeared to induce the 
activation of NK cells, as determined by up-regulation of CD25 expression, further 
analysis was conducted to evaluate the cytokines produced by both NK cells and DCs 
to indicate which factors may be influencing the observed activation.  
Supernatants were retrieved from co-culture experiments (5.2.1) and assayed for 
cytokines; IFNу, TNFα, IL-12, IL-10, IL-6 and IL-2 by ELISA (2.8). Within initial 
experiments, peripheral blood derived NK cells isolated by positive selection of NKp46 
expressing lymphocytes (2.4) were cultured with M.bovis infected DCs overnight prior 
to retrieval of supernatants. Further experiments involved use of NK cell subsets, 
identified and purified by differential expression of CD2 (2.4.1). NK cells cultured alone, 
with uninfected DCs or with M.bovis alone served as control conditions.    
As highlighted previously (4.2.4), upon mycobacterial infection DCs produced elevated 
levels of the important inflammatory mediator IL-12 (Figures 5.2.1 and 5.2.2) when 
compared with the control conditions of DCs alone (p=0.005) or M.bovis alone 
(p=0.003). Within the co-culture conditions, either addition of total NK cells (Figure 
5.2.1) or CD2+ and CD2- NK cell subsets (Figure 5.2.2) did not significantly influence the 
IL-12 levels that were already induced after infection of DCs with M.bovis. Neither IL-6 
nor IL-2 were detected within any of the co-culture conditions and as previously 
described (4.2.4) only very low levels of IL-10 were found after infection. These levels 
were not altered after culture with NK cells (data not shown). 
Analysis of supernatants by ELISA for NK cell derived cytokines indicated no detectable 
levels of TNFα. In contrast, total populations of NKp46+ NK cells produced significantly 
elevated levels of IFNγ but only after contact with M.bovis infected DCs (Figure 5.2.3) 
with no detectable levels produced within any of the control conditions of NK cells 
alone or in culture with uninfected DCs or M.bovis alone (p=<0.001). Further analysis 
to determine the contribution of CD2+ and CD2- NK cell subsets to this response, 
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established that only CD2- NK cells produced IFNу (p=<0.001) compared with all 
controls, with no detectable levels produced by CD2+ NK cells under any conditions 
(Figure 5.2.4). Furthermore, purification of CD2- NK cells resulted in augmented levels 
of IFNγ (Figure 5.2.4) when compared with the levels observed with total NK cells 
(Figure 5.2.3), a reflection of an increase in the proportion of IFNу producing cells 
within the purified cell co-cultures.   
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Figure 5.2 Cytokine production within co-cultures of NK cells and DCs  
Monocyte derived DCs were cultured for three days and infected with M.bovis. Either total NK 
cells (Fig 5.2.1 and 5.2.3) or NK cell subsets (Fig 5.2.2 and 5.2.4) were purified from peripheral 
blood and cultured with the infected DCs at previously determined optimal ratios (2.10). Each 
culture condition was replicated in triplicate with NK cells cultured alone, with uninfected DCs 
or with M.bovis alone serving as controls. After overnight co-culture supernatants were 
retrieved and cytokine production was assayed by ELISA (2.8). Data represents the average 
levels of IL-12 bu/ml (Fig 5.2.1 and 5.2.2) or IFNγ ng/ml (Fig 5.2.3 and 5.2.4) from 4 animals 
with error bars representing the standard deviation between animals. Significance between co-
culture conditions was assessed using log transformed data and a GLM with Tukey post-hoc 
comparisons (95% CI); p<0.05*, p<0.01**. 
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5.2.2.1 Assessing the IFNγ producing capacity of CD2+ NK cells  
Studies of bovine NK cell subsets have illustrated that upon cytokine stimulation with 
IL-2 and IL-12, the CD2- subset appeared inherently better able to produce IFNγ when 
compared with CD2+ NK cells (Boysen et al., 2006b). Within co-culture assays, the 
predominant CD2+ NK cell subset found in peripheral blood was not able to produce 
detectable levels of IFNγ despite contact with M.bovis infected DCs. To determine 
whether purified CD2+ NK cells lacked the capacity to produce IFNγ, IL-12 and IL-18 
stimulation of NK cell subsets (2.5) was incorporated as an additional condition and 
IFNγ and IL-12 levels within supernatants were measured by ELISA (2.8). 
As previously observed, CD2+ NK cells did not produce IFNγ (Figure 5.3) despite the 
presence of secreted IL-12 from M.bovis infected DCs (data not shown). However, 
supplementation of NK cell activating cytokines IL-12 and IL-18 into the co-culture with 
the M.bovis infected DCs induced a significant increase in secretion of IFNγ (p=<0.001) 
up to levels observed with either IL-12 and IL-18 stimulation alone (CD2+ NK cells) or 
IL-12 and IL-18 stimulation of CD2- NK cells; indicating that the CD2+ NK cells were 
capable of IFNγ secretion.  
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Figure 5.3 Assessing the IFNγ producing capacity of CD2+ NK cells    
Co-culture experiments were repeated with peripheral blood derived CD2+ NK cells co-cultured 
with M.bovis infected DCs, supplemented with or without IL-12 and IL-18 at optimal 
concentrations (2.5). Each culture condition was replicated in triplicate with cytokine 
stimulation of CD2+ and CD2- NK cells serving as controls. Retrieved supernatants were 
assayed for IFNγ and IL-12 (data not shown) by ELISA (2.8).  Data represents the average levels 
of IFNγ ng/ml (Fig 5.3) from 4 animals with error bars representing the standard deviation 
between animals. Significance between co-culture conditions was assessed using log 
transformed data and a GLM with Tukey post-hoc comparisons (95% CI); p<0.01**. 
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5.2.2.2 The role of IL-12 in NK cell and DC interactions 
DC derived cytokines such as IL-12 are considered particularly important to the 
induction of NK cell activation. Results herein have suggested that M.bovis infection 
results in IL-12 production (5.2.2) and that both CD2+ and CD2- NK cell subsets 
supplemented with IL-12 along with IL-18 are able to produce IFNγ (5.2.2.1).   
For this reason, the contribution of IL-12 to the observed IFNγ production by CD2- NK 
cells in contact with M.bovis infected DCs was investigated (5.2.2). Blocking 
experiments were optimised using IL-12 stimulated NK cells supplemented with the IL-
12 specific mAb CC326 (9.2) at a range of concentrations (0.1-100μg/ml) and analysis 
of IFNγ levels within supernatants. After cytokine stimulation, NK cells produced 
elevated levels of IFNγ (Figure 5.4). The subsequent addition of CC326 resulted in 
significantly decreased IFNγ levels at all tested concentrations, with 10μg/ml found to 
be sufficient to reduce IFNγ (>90% reduction) back to the basal levels produced by un-
stimulated NK cells. It has previously been shown that supplementation with isotype 
control antibodies does not influence IL-12 induced IFNγ secretion (Hope et al., 2002a) 
indicating that the blocking effect observed with CC326 was specifically inhibiting IL-
12.   
Introduction of CC326 at optimal concentrations into the co-culture induced effective 
blocking (Figure 5.5.1 and 5.5.3), with significantly reduced detectable IL-12 levels 
within supernatants of CD2- NK cells cultured with M.bovis infected DCs (p=0.046) 
(49.3 ± 14.7 % reduction) and also with CD2- NK cells stimulated with IL-12 and IL-18 
(p=0.031) (61.5 ± 15.5 % reduction). Importantly, analysis of IFNγ levels produced 
under these conditions highlighted that CD2- NK cells stimulated with IL-12 and IL-18 
at optimal concentrations produced high levels of IFNγ and blocking of IL-12 resulted in 
only a marginal reduction (3.9 ± 6.1%) in the observed levels. In contrast, blocking of 
IL-12 produced by M.bovis infected DCs resulted in a substantial (62.5 ± 18.8%) and 
significant (p=0.017) reduction in the IFNγ produced by CD2- NK cells (Figure 5.5.2 and 
5.5.3).  
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Figure 5.4 Blocking of IL-12 induced IFNγ production  
NK cells isolated from peripheral blood were cultured with IL-12 at optimal concentrations (2.5) 
and supplemented with IL-12 blocking antibody - CC326 (9.2) at dilutions ranging from 0.1-
100μg/ml. NK cells without stimulation were used as a control and supernatants retrieved were 
analysed for IFNγ levels by ELISA (2.8). Data represents the average IFNγ levels (ng/ml) from 2 
animals with error bars denoting the standard deviation between animals. The efficacy of 
CC326 was assessed using log transformed data and a 1-Way ANOVA with Tukey post-hoc 
comparisons (95% CI); p<0.01**.  
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5.5.3 
 % reduction in IL-12 % Loss of IFNγ 
IL-12+IL-18 (CC326) 61.9% ± 15.5 3.9% ± 6.1 
DC+M.bo (CC326) 49.3% ± 14.7 62.5% ± 18.8 
 
 
Figure 5.5 Contribution of IL-12 to IFNγ production within co-culture 
Co-culture experiments were repeated with peripheral blood derived CD2- NK cells co-cultured 
with M.bovis infected DCs with or without CC326 (10μg/ml). Each culture condition was 
replicated in triplicate with IL-12 and IL-18 cytokine stimulation of CD2- NK cells serving as a 
control. Supernatants were retrieved and analysed for cytokine levels by ELISA. Data represents 
the average levels of IL-12 bu/ml (Fig 5.5.1) and IFNγ ng/ml (Fig 5.5.2) from 4 animals with 
error bars representing the standard deviation between animals. The percentage reduction in 
IL-12 and IFNγ following supplementation with CC326 is summarised (Table 5.5.3) with efficacy 
of CC326 blocking assessed using log transformed data and pair-wise T-tests (95% CI); p<0.05*, 
P<0.01**.  
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5.2.3 NK cell cytolytic activity  
Fundamental to the role of NK cells within the innate immune system is their capacity 
to function as cytolytic lymphocytes, a response activated by the balance of signals 
received through activatory and inhibitory receptors resulting in the release of 
cytolytic proteins such as perforin and granzymes. For this reason, intracellular 
perforin levels of NK cells were analysed as a measure of their capacity to kill target 
cell populations. In particular, experiments were performed to determine whether 
contact with mycobacterially infected DCs was able to influence the cytolytic potential 
of NK cells.  
Monocyte derived DCs from four animals were infected with M.bovis and cultured 
with peripheral blood derived NK cells overnight prior to analysis of perforin 
expression (2.12.1). NK cells cultured alone, with uninfected DCs or with only M.bovis 
served as control conditions. With no stimulation, small percentages (5-15%) of both 
CD2+ and CD2- NK cells expressed detectable levels of perforin (Figure 5.6.1 and 5.6.3). 
Upon culture with uninfected DCs, a minor increase in the percentage of NK cells 
expressing perforin could be observed and this was found to be significantly so for 
CD2- NK cells (p=<0.001). Furthermore, a significantly higher proportion of both CD2+ 
(p=0.013) and CD2- (p=<0.001) were found to express perforin in response to M.bovis 
alone (Figure 5.6.3) signifying a certain level of activation without DC involvement. 
However, within co-cultures with DCs infected with M.bovis the response was 
significantly augmented over all control conditions with 50-70% of both CD2+ 
(p=<0.001) and CD2- (p=<0.001) expressing cytolytic proteins (Figure 5.6.2 and 5.6.3) 
with no observed differences between NK cell subsets.  
Additionally, detailed analysis of the mean fluorescence intensity levels indicated that 
after contact with infected DCs, the increase in the percentage of perforin positive NK 
cells was coupled with a significant increase in perforin intensity for both CD2+ 
(p=<0.001) and CD2- (p=<0.001) NK cells when compared with all control conditions 
(Figure 5.6.4).  
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5.6.4 
 
 
Figure 5.6 Perforin expression within co-cultures of NK cells and DCs  
Monocyte derived DCs were cultured for three days and infected with M.bovis. NK cells were 
purified from peripheral blood and cultured with the infected DCs at previously determined 
optimal ratios (2.10). Each culture condition was replicated in triplicate with NK cells cultured 
alone, with uninfected DCs or with M.bovis alone serving as controls. After overnight co-culture 
cells were labelled with mAbs for NKp46, CD2 and perforin (2.12.1) and analysed by flow 
cytometry. FACS plots from one representative animal display the percentages of CD2+ or CD2- 
NK cells expressing perforin within the total NK cell population; NK cells alone (Fig 5.6.1) or NK 
cells after co-culture with M.bovis infected DCs (Fig 5.6.2). Pooled data from four animals (Fig 
5.6.3) indicates the percentage of perforin positive cells expressed as a percentage of the total 
CD2+ or CD2- NK cell population and the mean fluorescence intensity of perforin (Fig 5.6.4)  
with error bars representing the standard deviation between animals. Significant changes in 
perforin production between culture conditions were assessed using log transformed data and 
a GLM with Tukey post-hoc comparisons (95%CI); p<0.05*, p<0.01**. 
 
0 
5 
10 
15 
20 
25 
30 
35 
N
K
 
D
C
 
M
.b
o
 
D
C
+M
.b
o
 
N
K
 
D
C
 
M
.b
o
 
D
C
+M
.b
o
 
NKp46+ CD2+ NKp46+ CD2- 
P
er
fo
ri
n
 In
te
n
si
ty
 
  **   ** 
 
162 
5.2.3.1.1 TLR expression by NK cell subsets  
Investigation of perforin production by NK cells revealed that both CD2+ and CD2- NK 
cells expressed elevated levels of cytolytic proteins in response to mycobacterial 
stimulation, independent of DC involvement. It has been suggested that NK cells 
express functional PRRs such as TLRs which enable direct responsiveness to bacterial 
PAMPs to induce NK cell cytolytic activity (Marcenaro et al., 2008).  
To determine if this may also be the case with bovine NK cells, cDNA from peripheral 
blood derived NK cell subsets (3.2.4) was subjected to transcript analysis for TLRs 1-10 
(9.5).Transcripts for all TLRs were detected on NK cells with TLR2 and TLR6 expressed 
at significantly higher levels than all other TLRs by both CD2+ and CD2- NK cells (Figure 
5.7). Similar to the patterns found with chemokine receptors, TLRs were also found to 
be differentially transcribed between subsets of NK cells with elevated levels of TLR1 
(p=0.040) and TLR7 (p=0.010) on CD2- NK cells and TLR3 (p=0.002) and TLR4 (p=0.001) 
on CD2+ NK cells. However, despite differences between subsets, transcript levels for 
these were significantly lower than those observed for TLR2 and TLR6 (Figure 5.7).  
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Figure 5.7 TLR expression by NK cell subsets 
NK cell subsets (NKp46+ CD2+ and NKp46+ CD2-) were isolated from peripheral blood from 
eight animals as described (3.2.4). RNA was reverse transcribed and subjected to quantitative 
PCR analysis for the bovine TLRs. Each sample was tested in triplicate, quantified against a 
plasmid DNA standard curve and normalised to the housekeeping gene BoPo. Data represents 
the Log2 normalised copy number (CN), CD2+ NK cells are shown in red and CD2- in blue with 
each point denoting the transcriptional value obtained from one animal. Significance was 
assessed using the GLM and paired T-test p<0.05 *, p<0.01**. 
 
 
 
 
-20 
-15 
-10 
-5 
0 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
C
D
2
+
 
C
D
2
- 
TLR1 TLR2 TLR3 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9 TLR10 
lo
g2
 C
N
 
** 
 *   **  **    * 
 
164 
5.2.3.2 Killing Assays 
Experimental examination of NK cells after contact with mycobacterially infected DCs 
demonstrated increased expression of cytolytic proteins and therefore, the potential 
induction of NK cell mediated killing activity. To determine whether DCs could directly 
activate a cytolytic response, NK cells from co-culture experiments were incubated 
with murine tumour P815 cells, known targets for perforin mediated killing by bovine 
NK cells (Boysen et al., 2006b).  
Within initial killing assays, NK cells were incubated with P815 target cells at effector 
target (E:T) ratios ranging from 25:1 to 0.39:1 (Figure 5.8). Effective killing was 
determined by identifying percentages of P815 cells which incorporated propidium 
iodide (2.11) as an indicator of cell death. NK cells were able to kill P815 cells at all E:T 
ratios tested with no significant cell death observed when P815 cells were cultured 
without NK cells (data not shown). With increasing numbers of NK cells, the 
percentages of P815 cells killed also increased with 35-45% killing observed at 25:1. 
Effective killing was also observed at the E:T ratio of 12.5:1 and this ratio was selected 
for all subsequent killing assays. 
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Figure 5.8 Optimising NK cell mediated killing assays  
Peripheral blood derived NK cells were isolated by positive selection of NKp46 expressing 
lymphocytes (2.4). Target P815 cells were labelled with CFDA-SE membrane dye prior to 
incubation with activated NK cells in triplicate, at a range of effector to target (E:T) ratios for a 
3 hour duration. Specific killing was analysed by labelling P815 cells with Propidium Iodide (PI - 
25μg/ml) followed by analysis of the proportions of high FSC/SSC, CFDA-SE and PI positive 
target cells by flow cytometry. Data represents the percentage killing of P815 cells by activated 
NK cells from 4 animals at a range of E:T ratios.  
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To establish whether the observed increase in perforin production within NK cells 
cultured with M.bovis infected DCs (Figure 5.6.3) translated into effective induction of 
cytolytic activity, NK cells from co-cultures were incubated with P815 target cells at the 
optimised E:T ratio of 12.5:1. Total NK cells, rather than subsets were used as perforin 
production was found to be equivalent between CD2+ and CD2- NK cells (Figure 5.6.3) 
following co-culture with M.bovis infected DCs.  
No substantial cell death was observed within the control conditions where uninfected 
DCs or DCs infected with M.bovis were added to cytolytic assays, highlighting the 
requirement for NK cells for effective target cell killing (Figure 5.9.5). Without prior 
stimulation, NK cells were found to possess the innate capacity to induce significant 
killing of P815 target cells (Figure 5.9.1 and 5.9.5). Following culture of NK cells with 
uninfected DCs (Figure 5.9.2) or M.bovis alone (Figure 5.9.3), minor variations in killing 
activity were observed, but found to not be significant when compared with NK cells 
alone. In contrast, prior contact with M.bovis infected DCs augmented the killing 
capacity of NK cells with significantly higher percentages of killed/dead P815 cells 
(Figure 5.9.4 and 5.9.5) compared with all control conditions (p=<0.001). 
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Figure 5.9 M.bovis infected DCs augment the killing capacity of NK cells  
Co-culture experiments were repeated with peripheral blood derived NK cells co-cultured with 
M.bovis infected DCs. Each culture condition was replicated in triplicate with NK cells cultured 
alone, with uninfected DCs or with M.bovis alone serving as controls. After overnight co-culture 
NK cells were retrieved and incubated for 3 hours with CFDA-SE labelled P815 target cells at an 
optimum (12.5:1) E:T ratio (Fig 5.8). NK cell specific killing was analysed by labelling P815 cells 
with Propidium Iodide (PI - 25μg/ml) followed by analysis of the proportions of high FSC/SSC, 
CFDA-SE and PI positive populations by flow cytometry. FACS plots from one representative 
animal display the percentages of CFDA-SE/ PI positive P815 cells after incubation with NK cells 
alone (Fig 5.9.1), NK cells with uninfected DCs (Fig 5.9.2), NK cells with M.bovis (Fig 5.9.3) or NK 
cells with M.bovis infected DCs (Fig 5.9.4). Pooled data from four animals (Fig 5.9.5) indicates 
the percentage killing with significance between conditions assessed using log transformed 
data and 1-way ANOVA’s with Tukey post-hoc comparisons (95% CI); p<0.05*, p<0.01**. 
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5.2.4 Contact dependency of NK cell activation 
The in vitro co-culture assays demonstrated that DCs infected with M.bovis were able 
to functionally activate NK cells; with up-regulation of CD25 and perforin expression 
resulting in augmented NK cell specific cytolytic activity and cytokine production. DC 
derived cytokines released following infection were found to be implicit to the 
increased levels of IFNγ produced by CD2- NK cells. Research has indicated that the 
interaction between NK cells and DCs may also be reliant on cell to cell contact to 
enable receptor-ligand interactions and directed cytokine delivery. To determine 
whether this was also the case with the observed activation of bovine NK cell subsets, 
co-culture assays were repeated with a culture well insert to prevent cell contact but 
to retain cytokine induced responses. Subsequent changes in CD25, perforin and IFNγ 
levels were assayed. Stimulation with IL-12 and IL-18 was incorporated as a culture 
condition as a positive indicator of cytokine movement through the transwell.    
Analysis of CD25, perforin and IFNγ levels revealed a significant dependence on cell-
cell contact for NK cell activation by M.bovis infected DCs. As expected, within IL-12 
and IL-18 controls, no effect of transwell separation was observed (data not shown). 
However, separation of NK cells from M.bovis infected DCs (Figure 5.10.1) resulted in a 
significant loss in the percentage of CD25 positive CD2+ (p=0.008) and CD2- NK cells 
(p=0.001). Additionally, blocking cell to cell contact significantly decreased the 
intensity of CD25 on CD2- NK cells (p=0.007) (Figure 5.10.2). Comparison of NK cell 
subsets highlighted that the loss in the percentage of CD25 expressing CD2+ (40.8% ± 
13.3) and CD2- (38.7 % ± 9.5) NK cells was similar (Table 5.10.3), however following 
transwell separation, there were significantly higher residual numbers of CD2- NK cells 
expressing CD25 (p=0.012) compared with CD2+ NK cells (Figure 5.10.1). Therefore, 
loss of cell-cell contact had a more profound effect on the activation of CD2+ NK cells.  
Similar experiments to determine the role of contact dependency on perforin 
production resulted in significantly lower percentages of perforin positive NK cells, 
after separation of DC (p=0.014), M.bovis (p=0.005), M.bovis infected DCs (p=<0.001) 
from CD2+ NK cells and also DC (p=0.024), M.bovis (p=0.030) and M.bovis infected DCs 
(p=0.045) from CD2- NK cells (Figure 5.11.1). Furthermore, there was an observed loss 
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in the intensity of perforin expression following separation of both CD2+ or CD2- NK 
cells from M.bovis infected DCs, however this was found not to be significant due to 
large variations between animals (Figure 5.11.2). Comparison of NK cell subsets 
revealed that in a similar manner to CD25 expression, separation from M.bovis 
infected DCs appeared to affect CD2+ NK cells more profoundly with a larger reduction 
(42.8% ± 4.7) in the percentage of perforin positive NK cells (Table 5.11.3).     
Within further co-culture assays the consequences of transwell separation on NK cell 
derived IFNγ production was investigated. As previously observed, CD2+ NK cells did 
not produce detectable levels of IFNγ after contact with M.bovis infected DCs and 
were only able to do so after IL-12 and IL-18 stimulation. In contrast, IFNγ secretion by 
CD2- NK cells was highly dependent on contact with M.bovis infected DCs with an 
almost complete loss (p=<0.001) of cytokine (Figure 5.12).   
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Figure 5.10 Loss of CD25 expression following separation of NK cells from DCs 
Co-culture experiments with monocyte derived DCs infected with M.bovis and peripheral 
blood derived NK cell subsets were performed as described (2.10).  NK cells were either in 
contact with or separated from each culture condition using a 0.2μm culture well insert. Each 
culture condition was replicated in triplicate and NK cells were labelled with mAbs for NKp46, 
CD2 and CD25 and analysed by flow cytometry. Data is from four animals, representing the  
percentage of CD25 positive NK cells (Fig 5.10.1) expressed as a percentage of the total CD2+ or 
CD2- population and the mean fluorescence intensity (Fig 5.10.2) with error bars representing 
the standard deviation between animals. Transwell separation is indicated by [ ]. Table 5.10.3 
summarises the percentage loss of CD25 expressing NK cells and intensity as an average and 
standard deviation between four animals. Significant effects of transwell separation were 
analysed using log transformed data and the paired T-Test (95%CI); p<0.05*, p<0.01**. 
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5.11.3 
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Figure 5.11 Loss of Perforin expression following separation of NK cells from DCs 
Co-culture experiments with monocyte derived DCs infected with M.bovis and peripheral 
blood derived NK cell subsets were performed as described (2.10).  NK cells were either in 
contact with or separated from each culture condition using a 0.2μm culture well insert. Each 
culture condition was replicated in triplicate and NK cells were labelled with mAbs for NKp46, 
CD2 and perforin and analysed by flow cytometry.  Data is from four animals, representing the  
percentage of perforin positive NK cells (Fig 5.11.1) expressed as a percentage of the total CD2+ 
or CD2- population and the mean fluorescence intensity (Fig 5.11.2) with error bars 
representing the standard deviation between animals. Transwell separation is indicated by [ ]. 
Table 5.11.3 summarises the percentage loss of perforin expressing NK cells and intensity as an 
average and standard deviation between four animals. Significant effects of transwell 
separation were analysed using log transformed data and the paired T-test (95%CI); p<0.05*, 
p<0.01**. 
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Figure 5.12 Loss of IFNγ release following separation of NK cells from DCs  
Co-culture experiments with monocyte derived DCs infected with M.bovis and peripheral 
blood derived NK cell subsets were performed as described (2.10).  CD2- NK cells were either in 
contact with or separated from M.bovis infected DCs using a 0.2μm culture well insert. Culture 
conditions were replicated in triplicate with cytokines (IL-12 and IL-18) alone serving as a 
control (data not shown). Supernatants were retrieved for analysis of IFNγ production by ELISA. 
Data represents the average levels of IFNγ ng/ml from four animals with error bars 
representing the standard deviation between animals. Transwell separation is indicated by [ ]. 
Significance was determined using log transformed data and the paired T-Test (95%CI); 
p<0.05*, p<0.01**. 
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5.2.5 Activatory and inhibitory receptor expression by NK cell subsets 
Mycobacterially infected DCs have been shown to differentially influence effector 
functions of NK cell subsets with a role for both DC derived cytokines as well as cell-cell 
contact. Furthermore, CD2+ and CD2- sub-populations of NK cells were found to differ 
in their individual requirements for contact with infected DCs, resulting in altered 
states of activation. It has been proposed that the capacity of an NK cell to respond in 
this manner is influenced in part by the balance of activatory and inhibitory receptor 
expression (Holmes et al., 2011, Ortaldo and Young, 2003). As disparity was observed 
between CD2+ and CD2- NK cells, further transcriptional analysis was conducted to 
elucidate NK cell receptor expression patterns between subsets. Preliminary analysis of 
KIR (generic) expression by real time PCR indicated higher transcripts expressed by 
CD2+ NK cells (Dobromylskyj, 2009). 
To further establish differences in NK cell receptors, quantitative PCR assays were 
designed to amplify genes for the NK cell receptors; NKp30 and Ly49 (3.2.3). Primers 
and probes were based on published sequences; NKp30 (NM_001040524), Ly49 
(AY075101) and transcript levels expressed by peripheral blood derived NK cells were 
analysed. The natural cytotoxicity receptor, NKp30 was expressed at significantly 
elevated levels (p=<0.001) by CD2+ NK cells (Figure 5.13.1) compared to CD2- NK cells, 
with transcription almost equating to house-keeping gene levels. In comparison, CD2- 
NK cells expressed significantly higher levels of Ly49 (p=0.002) (Figure 5.13.2) but 
transcript levels were considerably lower than those observed for NKp30.  
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Figure 5.13 NKp30 and Ly49 expression by NK cell subsets 
NK cell subsets were isolated from peripheral blood from eight animals as described (3.2.4). 
RNA was reverse transcribed and subjected to quantitative PCR analysis. Each sample was 
tested in triplicate, quantified against a plasmid DNA standard curve and normalised to the 
housekeeping gene BoPo. Plasmid standards were kindly provided by Tim Connelly (NKp30) and 
Melanie Dobromylskyj (Ly49). Data represents the Log2 normalised copy number (CN) of NKp30 
(Fig 5.13.1) and Ly49 (Fig 5.13.2) with each point denoting the transcriptional value obtained 
from one animal. Significance between NK cell subsets was assessed using the paired T-Test 
p<0.05 *, p<0.01**. 
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5.2.6 Reciprocal activation of DCs  
Results herein have established that under conditions of mycobacterial infection, DCs 
are able to induce effector functions of NK cells including cytokine production and 
cytolytic activity involving both DC derived cytokines as well as cell-cell contact. It has 
been well documented that this interaction may be reciprocal with NK cells able to kill 
immature DCs or induce their maturation and in this manner promote the subsequent 
Th1 priming of the immune response.  
To ascertain whether NK cells were able to reciprocally activate DCs, co-cultures were 
repeated with DCs cultured with CD2+ or CD2- NK cell subsets either with or without 
M.bovis infection. DCs alone or DCs infected with M.bovis served as control conditions. 
DCs were identified within the co-cultures by gating a population of high FSC cells 
(Figure 5.14.1) which expressed SIRPα (Figure 5.14.2) and maturation of DCs was 
determined by analysis of cell surface expression levels of MHC class II, and co-
stimulatory molecules CD40, CD80, CD86.  
After contact with NK cells, either with or without the presence of M.bovis, there were 
no alterations in the percentage of DCs expressing MHC class II or any co-stimulatory 
molecules above the levels expressed by DCs alone (data not shown). As previously 
reported (Hope et al., 2004), the intensity of CD40 expression increased marginally 
after M.bovis infection of DCs (data not shown) and this remained unaltered upon 
addition of NK cells. Similarly, infection of DCs with M.bovis induced an elevated 
intensity of MHC class II expression on the cell surface of DCs (Figure 5.14.4 and 5.14.6) 
but this was found not to be significant compared to DCs alone (Figure 5.14.3 and 
5.14.6). In contrast, when M.bovis infected DCs were in contact with CD2- NK cells 
(Figure 5.14.5 and 5.14.6), DCs significantly up regulated MHC class II with increased 
intensity of expression compared with uninfected DCs and CD2- NK cells (p=0.002) or 
DCs infected with M.bovis (p=0.042), or any response that was seen with infected DCs 
cultured with CD2+ NK cells (p=0.044).   
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Figure 5.14 Reciprocal effects on DCs after culture with NK cells  
Co-culture experiments were performed with peripheral blood derived NK cells cultured with 
DCs and M.bovis. Each culture condition was replicated in triplicate with DCs cultured alone, 
with CD2+ or CD2- NK cells or with M.bovis alone serving as controls. After overnight co-culture 
cells were labelled with mAbs for SIRPα, MHC class II, CD40, CD80 and CD86 and analysed by 
flow cytometry. FACS plots from one representative animal are shown with DCs identified by 
high FSC (Fig 5.14.1) and SIRPα expression of gated cells (Fig 5.14.2). The intensity of MHC class 
II expression (red) of DCs alone (5.14.3) M.bovis infected DCs (Fig 5.14.4) or M.bovis infected 
DCs cultured with CD2- NK cells (Fig 5.14.5) is illustrated. Pooled data from four animals 
represents the mean fluorescence intensity of MHC class II (Fig 5.14.6). Significance between 
co-culture conditions were assessed using a GLM with Tukey post-hoc comparisons (95%CI); 
p<0.05*, p<0.01**. 
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5.2.7 M.bovis infected DCs augment MHC class II expression on CD2- NK 
cells  
Recent reports suggest that discrete subsets of NK cells also express MHC class II 
proteins and this population preferentially expanded and was activated in the immune 
response to BCG infection (Evans et al., 2011). To determine whether this was also the 
case following M.bovis infection in vitro, MHC class II expression levels of NK cells after 
contact with infected DCs were analysed. Subsets of CD2+ or CD2- NK cells with 
uninfected DCs served as controls. During analysis of the mixed co-culture, NK cells 
were differentiated from DCs by excluding the high FSC/SIRPα positive population of 
DCs and positively gating the remaining live NK cell population (Figure 5.15.1). MHC 
class II expression within this population was subsequently analysed (Figure 5.15.2).   
It has previously been observed that freshly isolated peripheral blood derived NK cells 
do not express MHC class II molecules (3.2.2). This was also the case when purified 
CD2+ NK cells had been in co-culture with uninfected DCs (Figure 5.15.3). Following 
infection with M.bovis, there was a very minor increase in the percentage of CD2+ NK 
cells expressing MHC class II however, this was not found to be significant. In 
comparison, small percentages of CD2- NK cells (~2%) expressed MHC class II after 
contact with DCs and the proportions of MHC class II positive CD2- NK cells were 
significantly augmented (p=0.003) after contact with M.bovis infected DCs (Figure 
5.15.3)  
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Figure 5.15 MHC class II expression by NK cell subsets following co-culture  
Cells from co-culture experiments (Fig 5.14) were re-analysed to determine the percentages of 
NK cells expressing MHC class II with CD2+ or CD2- subsets cultured with uninfected DCs serving 
as controls. NK cells were identified by negative selection (gated in red) to eliminate the high 
FSC/SIRPα positive dendritic cell population (Fig 5.15.1) and MHC class II expression within the 
remaining NK cell population was analysed (Fig 5.15.2). FACS plots from one representative 
animal are shown. Pooled data from four animals demonstrates the percentage of NK cells 
expressing MHC class II (Fig 5.15.3). Significance between co-culture conditions was assessed 
using a GLM with Tukey post-hoc comparisons (95%CI); p<0.05*, p<0.01**. 
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5.3 Discussion 
In the aftermath of pathogenic insult, reciprocal interactions between cells of the 
innate immune system and their resulting effector responses are implicit to the 
developing immune response. NK cells primarily function as cytolytic cells but are also 
a significant source of immuno-modulatory cytokines, functioning to bridge the innate 
and adaptive immune systems. Research within a number of disease models has 
demonstrated that the effector responses of NK cells may be induced or enhanced by 
co-stimulatory signals from DCs in the form of soluble stimuli or contact dependent 
receptor-ligand interactions. Importantly, within this bi-directional interaction NK cells 
may potentiate DC maturation with implications for the subsequent priming of 
adaptive immunity. Within this thesis, it has previously been demonstrated that 
M.bovis infected DCs selectively recruited CD2- bovine NK cells (4.2.2.2) and were a 
significant source of IL-12 (4.2.4); a known stimulant of NK cell activity. In continuation 
of these studies, in vitro co-culture assays were utilised to further illustrate that bovine 
NK cells and DCs reciprocally interact during M.bovis infection and to define important 
features and mechanisms of this interaction. 
The IL-2 receptor-α-chain (CD25) is widely expressed by lymphocytes and its up-
regulation is associated with an increased capacity to respond to cytokine stimulation. 
As such, analysis of CD25 expression levels is commonly used as an indicator of NK cell 
activation. Within these studies, large percentages (40-60%) of peripheral blood 
derived NK cells up-regulated expression of CD25 and secreted IFNγ after contact with 
M.bovis infected DCs. However, whilst similar percentages of NK cell subsets appeared 
to be activated, an enhanced intensity of CD25 expression was restricted to the CD2- 
sub-population of NK cells (Figure 5.2). Differential responses between populations of 
human NK cells have previously been reported with the CD56bright subset preferentially 
proliferating and producing IFNγ following stimulation by DCs (Ferlazzo et al., 2004a, 
Vitale et al., 2004). In addition, murine CD27high NK cells selectively migrated towards 
lymph nodes and interacted with DCs (Hayakawa and Smyth, 2006). In a similar 
manner, purification of subsets revealed that the IFNγ production by bovine NK cells in 
response to M.bovis infected DCs was restricted to the CD2- NK cell subset, with higher 
levels of IFNγ observed upon isolation of the subset when compared with the total NK 
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cell population. This is likely to be as a consequence of a change in proportions; within 
the total NK cell population the IFNγ producing CD2- subset would only constitute 20-
30% of the total cells whereas when separated, would represent the predominant 
population. (Feng et al., 2006) demonstrated that the early control of mycobacterial 
infection was reliant upon IFNγ derived from NK cells, functioning to promote the 
bactericidal activity of macrophages. Therefore, the proportions of CD2+ and CD2- 
subsets within the tissues of the respiratory tract may have significant implications for 
the levels of IFNγ produced and the subsequent control of bacterial replication early 
following infection. 
Importantly, data herein suggests that the CD2- NK cell subset may be further 
composed of smaller heterogeneous sub-populations with differing responses during 
mycobacterial infection. Within chemotaxis assays, it was previously observed that 30-
40% of CD2- NK cells migrated towards M.bovis infected DCs (Figure 4.4). Of interest 
was the finding that, similar percentages (~30%) of NK cells within the CD2- subset, 
also appeared to express CD25 at higher intensities and may therefore represent a 
discrete population of cells that preferentially migrate towards and interact with DCs 
during mycobacterial infection. Similar responses have been reported in humans with 
small sub-populations of HLA-DR+ NK cells preferentially secreting IFNγ following BCG 
infection (Evans et al., 2011). Interestingly, an increase in expression of MHC class II by 
CD2- NK cells following co-culture with M.bovis infected DCs was also observed. 
However, further investigations would be required to determine if the migrating, MHC 
class II positive and IFNγ producing CD2- NK cells represent corresponding populations. 
The reasons for the observed disparity between the IFNγ producing capacities of 
bovine NK cell subsets are not known. It has previously been suggested that 
heterogeneity in IFNγ production by NK cells directly correlated with levels of DC 
derived IL-12 (Newman et al., 2006). However, analysis of IL-12 and IL-10 protein 
content within supernatants revealed that both CD2+ and CD2- NK cells received 
equivalent levels of these soluble signals from M.bovis infected DCs. In addition, upon 
optimal supplementation with IL-12 and IL-18, CD2+ NK cells produced IFNγ with levels 
equivalent to those produced by CD2- NK cells. Boysen et al., (2006b) previously 
reported that CD2+ bovine NK cells proliferated in the presence of IL-2 however; the 
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response was slower when compared with CD2- NK cells. Therefore, during 
interactions with mycobacterially infected DCs, the activation requirements of bovine 
NK cell subsets appear to be significantly different with CD2+ NK cells potentially 
requiring a larger or more prolonged stimulus to induce IFNγ production.  
NK cells are prolific killers with release of cytolytic proteins functioning to control the 
spread of infection. Bovine NK cells constitutively produce perforin and predominantly 
function as cytolytic cells through perforin mediated mechanisms (Boysen et al., 
2006b, Endsley et al., 2006, Graham et al., 2009). These findings were confirmed with 
small percentages (10-20%) of both CD2+ and CD2- NK cells found to express perforin 
and both populations able to kill P815 tumour target cells. Upon contact with 
uninfected DCs, the percentage of CD2- NK cells expressing perforin was significantly 
augmented. Autologous immature DCs are susceptible to NK cell mediated lysis as a 
consequence of low HLA class I expression (Ferlazzo et al., 2003, Ferlazzo et al., 2001, 
Wilson et al., 1999). Killing in this manner functions as an editing process such that NK 
cells bias the immune response to those DCs which have undergone appropriate 
maturation (Ferlazzo et al., 2002). The observed induction of perforin expression may 
therefore represent a mechanism by which CD2- NK cells are able to kill autologous 
immature DCs.  
Similarly, small percentages of both CD2+ and CD2- NK cells also increased expression 
of perforin after stimulation with M.bovis alone. The induction of migratory responses 
of NK cells exposed to mycobacteria, independent of antigen presenting cell 
involvement was also observed previously (Figure 4.4). NK cells are known to respond 
directly to microbial stimuli, with BCG able to induce proliferative and cytolytic activity 
of human NK cells (Batoni et al., 2005, Esin et al., 2008, Esin et al., 2004, Marcenaro et 
al., 2008). This represents mechanisms by which cytolytic effector cells can be rapidly 
activated to a certain extent following infection, without complete dependency upon 
co-stimulatory signals. Within these human studies BCG was directly recognised via 
NKp44 (Esin et al., 2008) and TLR2 (Marcenaro et al., 2008). The bovine orthologue for 
NKp44 has not been identified within the genome, however by quantitative PCR 
transcripts for all the TLRs were found within bovine NK cells with significantly 
elevated expression of TLR2 and TLR6; receptors with a known capacity to bind 
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mycobacterial PAMPs. NK cell cytolytic activity can be induced via signalling through 
TLRs (Sivori et al., 2004); therefore the observed increase in perforin may be as a result 
of direct activation in this manner. However, cytolytic assays herein illustrated that the 
small induction in perforin expression by mycobacteria alone did not augment the 
capacity of NK cells to kill P815 tumour target cells. In contrast, in the presence of 
M.bovis infected DCs, a much larger increase in the expression and intensity of 
perforin coincided with augmented cytolytic activity. Importantly, the response was 
not restricted to either subset of NK cells. Evidence therefore suggests that fully 
functional effector responses of bovine NK cells require multiple signals received from 
mycobacteria alone as well as antigen presenting cells. It has previously been reported 
that bovine NK cells were able to control M.bovis replication within macrophages 
(Denis et al., 2007). In further investigations, it would therefore be interesting to 
determine whether NK cells activated by DCs may in turn function to kill 
mycobacterially infected DCs or macrophages as a means to directly control bacterial 
expansion.  
Data herein has demonstrated that during M.bovis infection, the induction of NK cell 
derived IFNγ release and cytolytic activity was reliant upon co-stimulatory signals 
received from DCs. Numerous studies have illustrated that DC derived cytokines are 
fundamental to the cross-talk between NK cells and DCs. Mycobacterially infected DCs 
are a significant source of IL-12 (Hickman et al., 2002, Hope et al., 2004) which is 
implicit to the early innate release of IFNγ within the lungs of M.tuberculosis infected 
mice (Feng et al., 2006) and effective Th1 polarisation of the immune response 
(Hickman et al., 2002). Analysis of protein levels within supernatants confirmed that 
NK cells in co-culture with M.bovis infected DCs were exposed to IL-12. Olsen et al., 
(2005) reported that the release of IFNγ by bovine NK cells was partially reliant on IL-
12 derived from antigen presenting cells exposed to mycobacterial antigens. This 
finding was confirmed herein, with blocking of IL-12 resulting in a substantial (62%) 
decline in the level of IFNγ produced by CD2- NK cells responding to M.bovis infected 
DCs. However, the partial decline suggests that other factors also influence the IFNγ 
producing ability of CD2- NK cells. Roles for TNFα (Humann and Lenz, 2010), IFNα 
(Newman et al., 2006), IL-18 (Artavanis-Tsakonas et al., 2003, Artavanis-Tsakonas and 
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Riley, 2002, Bastos et al., 2008, Van Elssen et al., 2010), IL-15 (Lucas et al., 2007) and 
IL-2 (Granucci et al., 2004) have also been described in the induction of DC derived 
effector responses of NK cells however, M.bovis infected bovine DCs did not appear to 
produce detectable levels of TNFα or IL-2. Levels of IL-15 and IL-18 could not be 
confirmed as at present there are no bovine antibodies to detect these cytokines. In 
addition, whilst transcripts for IL-18 were previously detected within bovine DCs, 
expression levels did not change significantly following M.bovis infection (Thom, 2005). 
Furthermore, indirect evidence suggests that there may be a minimal role for IL-18 
within these co-culture conditions. During blocking experiments NK cells exposed to 
both IL-12 and IL-18 were not substantially affected by the loss of IL-12 with only a 
very small decrease (3%) in the levels of IFNγ produced. Titration experiments have 
previously demonstrated that very low levels of IL-12 are able to synergise highly 
effectively with IL-18 to induce optimal IFNγ release of bovine WC1+ γδ T cells (Price et 
al., 2007). As such in the presence of IL-18, a significant loss in IL-12 does not 
substantially influence the levels of IFNγ produced. In contrast, blocking of IL-12 
produced by M.bovis infected DCs substantially reduced the levels of IFNγ produced by 
CD2- NK cells in co-culture with M.bovis infected DCs; suggesting that IL-18 may not 
have been present or may have been present at low levels and could therefore not 
compensate for the loss of IL-12. Van Elssen et al., (2010) reported that DC derived IL-
12 also influenced the cytolytic activity of NK cells and further experimentation would 
be required to determine if this was also the case within these assays. 
Bovine CD2- NK cells in co-culture with M.bovis infected DCs partially retained the 
capacity to produce IFNγ despite the loss of IL-12. Whilst this may be explained by the 
presence of additional cytokine stimuli, studies have reported that optimal induction 
of NK cell effector responses require direct receptor-ligand interactions. Experiments 
utilising transwell separation demonstrated that subsets of NK cells and their effector 
responses had differential contact requirements. In this manner, both CD2+ and CD2- 
NK cells were found to require contact with M.bovis infected DCs to maintain 
expression of CD25 and perforin. However, CD2+ NK cells appeared more reliant upon 
direct interactions with DCs with larger percentages of CD2- NK cells remaining 
activated and expressing perforin despite separation from M.bovis infected DCs. In 
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contrast however, secretion of IFNγ by CD2- NK cells was found to be completely 
reliant upon cell-cell contact with a complete loss upon transwell separation from 
M.bovis infected DCs. Therefore, despite the presence of cytokines, in the absence of 
contact dependent signals, CD2- NK cells were rendered unresponsive. Within TB 
infection, elevated levels of IFNγ may contribute to immuno-pathological states 
observed during chronic infection. It is likely that the requirement of CD2- NK cells for 
multiple signals prior to the release of IFNγ illustrates a control mechanism preventing 
excessive secretion in response to cytokines alone. Similarly, CD2+ NK cells constitute 
the predominant population within peripheral blood and therefore the requirement 
for contact with infected DCs may represent a mechanism by which cytolytic activity is 
controlled.  
It is increasingly apparent that the interactions between NK cells and DCs during 
mycobacterial infection are highly complex and diverse. Bovine NK cell subsets appear 
to differ substantially in their requirements for cytokines and cell-cell contact to 
initiate effector responses. These observations are not restricted to the bovine system 
with divergences in IFNγ production reported within human NK cell population (De 
Maria et al., 2011, Evans et al., 2011, Ferlazzo et al., 2004a, Vitale et al., 2004) and also 
between donors (Artavanis-Tsakonas et al., 2003, Artavanis-Tsakonas and Riley, 2002). 
Emerging evidence has suggested that variations in NK cell responses may in part be 
explained by the existence of a threshold of activation. Bovine CD2- NK cells required 
cytokines and contact dependent stimuli from M.bovis infected DCs to produce IFNγ 
whilst remained activated and maintained perforin expression with cytokines alone. In 
comparison CD2+ NK cells were unable to secrete IFNγ unless additional cytokine 
stimuli were provided and were entirely dependent on cytokines and cell-cell contact 
to remain activated and maintain a cytolytic status. Therefore, subsets of bovine NK 
cells may possess differing thresholds of activation that govern responsiveness during 
mycobacterial infection. It has been proposed that thresholds are determined by the 
balance of expression between activatory and inhibitory receptors (Holmes et al., 
2011, Ortaldo and Young, 2003) and it is likely that deciphering the precise 
components will prove a significant challenge for future studies. The study of bovine 
NK cell receptors is still in its infancy. Multiple KIR genes that may encode activatory 
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and inhibitory receptors have been identified (Dobromylskyj and Ellis, 2007, Storset et 
al., 2003). In addition cattle also possess a polymorphic Ly49 gene that encodes 
inhibitory receptors (Dobromylskyj et al., 2009, McQueen et al., 2002). Importantly, 
within initial studies transcript analysis revealed significant divergences may exist 
between the expression levels of activatory and inhibitory receptors between bovine 
NK cell subsets. Ly49 was found to be preferentially transcribed by CD2- NK cells. In 
comparison the activatory NKp30 receptor with known involvement in the recognition 
of immature DCs (Ferlazzo et al., 2002), was expressed at higher levels by CD2+ NK 
cells. However, substantial research will be required before it is known whether the 
differential levels of expression influence the divergent responses observed during 
interactions with M.bovis infected DCs.  
Perhaps more important however is the reciprocal interaction between NK cells and 
DCs, reported to influence the progression and development of the adaptive immune 
response. Murine studies have elucidated that the effective control of mycobacterial 
infection is reliant upon transport of antigen by migratory DCs to draining lymph nodes 
(Marino et al., 2004) to effectively prime CD4+ T cells and subsequently polarise Th1 
biased immune responses. NK cells play an implicit role in this process, functioning to 
promote the maturation of DCs (Lande et al., 2003, Mailliard et al., 2003, Marcenaro et 
al., 2009, Morandi et al., 2009, Van Elssen et al., 2010) such that DCs that had been in 
contact with NK cells were better able to induce IFNy release by CD4+ T cells (Van 
Elssen et al., 2010). Herein, we observed a significant increase in the intensity of MHC 
class II expression on DCs, however importantly the response was restricted to DCs 
that had been in contact with CD2- NK cells. It is possible therefore that the CD2- NK 
cell subset in particular plays a prominent role in modulating adaptive immune 
responses however, further experiments would need to be conducted to determine 
whether the observed increase in intensity of MHC class II translated into an 
augmented capacity to present antigen and prime T cell responses during 
mycobacterial infection.  
In summary, co-culture assays herein have demonstrated evidence for reciprocal 
activating signals between bovine NK cells and M.bovis infected DCs that are initiated 
by both cell contact and soluble mediators. In addition, the substantial heterogeneity 
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observed between the activation requirements of bovine NK cell subsets is likely to 
influence their capacity to respond and interact with DCs during mycobacterial 
infection with implications for the innate control of mycobacterial expansion as well as 
the developing adaptive immune response.  
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6 Distributions of NK cells in vivo during mycobacterial infection 
6.1 Introduction 
Bovine NK cells are localised in numerous compartments ideally placed to rapidly 
respond in the innate immune response to antigenic insult with heterogeneous 
subsets differentially distributed within these compartments. CD2- NK cells, 
demonstrated herein to preferentially migrate towards and interact with 
mycobacterially infected DCs, constitute the minor blood derived NK cell population 
but are found in significant numbers within the parafollicular and medullary regions of 
lymph nodes (Boysen et al., 2008). Similarly, both human CD56bright (Fehniger et al., 
2003, Ferlazzo et al., 2004b) and murine NK cells form resident populations within 
these regions, however percentages are significantly lower within murine lymph nodes 
(Bajenoff et al., 2006). Despite this, the murine model has delivered significant insight 
into the in vivo migratory behaviour of NK cells. During steady-state conditions, small 
percentages of NK cells within murine lymph nodes exist in a motile state with a large 
proportion in contact with resident networks of DCs (Bajenoff et al., 2006). 
During an inflammatory immune response NK cells accumulate at the site of infection 
and also within draining lymph nodes. Administration of LPS matured DCs to mice, 
enhanced the in vivo migratory responses of NK cells such that significant numbers 
were recruited from the periphery to draining lymph nodes (Martin-Fontecha et al., 
2004) to influence the polarisation of Th1 immune responses. In a similar manner, 
intranasally inoculated BCG is rapidly phagocytosed by infiltrating DCs (Reljic et al., 
2005) and both BCG and M.tuberculosis infection induced increases in the absolute 
numbers of activated, IFNγ producing NK cells within the lungs (Feng et al., 2006, 
Junqueira-Kipnis et al., 2003, Saunders et al., 2002, Saxena et al., 2002). A similar 
response was also seen following administration of mycobacterial antigens resulting in 
increased percentages of activated NK cells within localised lymphoid tissue (Hall et al., 
2010) with redistribution to more central regions of the parafollicular areas (Beuneu et 
al., 2009, Hall et al., 2010). Consequently, activated populations of NK cells can also be 
detected in the periphery; however within mice this depends on the entry of NK cells 
to draining lymph nodes to enable interactions with DCs (Lucas et al., 2007).  
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Mycobacterial infection in cattle influences the proportions and distributions of innate 
effector cells highlighting involvement within the developing immune response. 
Following BCG vaccination percentages of circulating γδ T cells increased (Buza et al., 
2009), prior to the development of antigen specific immunity (Buddle et al., 1995). In 
addition IFNγ producing WC1+ γδ T cells accumulated in the lungs and tonsils upon 
intranasal infection with BCG (Price et al., 2010) and activated γδ T cells have been 
detected in the periphery of M.bovis infected cattle (Kennedy et al., 2002). Despite 
this, the depletion of WC1+ γδ T cells did not significantly influence the pathogenesis 
or progression of M.bovis infection highlighting redundancy within the innate immune 
response (Kennedy et al., 2002). This is largely believed to be derived from NK cells due 
to functional overlap with γδ T cells, however very little is known of the in vivo 
distributions and responses of bovine NK cells under inflammatory conditions. 
Percentages of NK cells within the blood were reported to decrease early following 
parasitic infection with Neospora caninum followed by an increase in numbers of IFNγ 
producing, cytolytic NK cells detected at later time-points (Klevar et al., 2007). 
However, in the only reported study of NK cells and mycobacterial responses in cattle, 
NK cell numbers in the peripheral blood were not altered at 6 weeks post-BCG 
vaccination (Denis et al., 2007).  
Within this thesis it has previously been demonstrated in vitro that bovine NK cells are 
responsive during mycobacterial infection with elevated migration and reciprocal 
interactions with infected DCs. In initial experiments, we sought to comprehensively 
describe the distribution of NK cell subsets within the tissues and lymph nodes of the 
head, respiratory tract and prescapular lymph nodes; regions which would be directly 
involved in the immune response to respiratory pathogens or vaccination. In 
subsequent experiments, this study sought to investigate whether administration of 
mycobacteria influenced the percentages or effector responses of the NK cell 
populations within these compartments and also within the peripheral circulation.  
 
 
 
 
197 
6.2 Results 
6.2.1 Intranasal BCG inoculation  
Experiments were conducted to ascertain percentages of NK cells and proportions of 
subsets within tissues and lymph nodes from the head and respiratory tract (Table 2.1) 
and to determine whether mycobacterial exposure altered these levels. Calves 
received BCG Pasteur delivered intranasally (2.2.2) to mimic the natural route of 
mycobacterial infection and tissues and lymph nodes were retrieved after 7 days at 
post-mortem with naïve age matched calves serving as controls. Percentages of NK 
cells and proportions of CD2+ and CD2- subsets were determined by flow cytometry 
following labelling of lymphocytes for NKp46 and CD2 (2.12.1). 
Tissues derived from the apical to diaphragmatic regions of the lungs were found to 
contain the highest percentages of NKp46+ cells, with 10-20% of lymphocytes 
constituting the NK cell population (Figure 6.1.1). When compared, no significant 
differences were found between the different lobes of the lung and numbers were not 
altered after exposure to BCG. In contrast, tissues and lymph nodes of the head 
contained fewer percentages of NK cells (1-5%), similar to levels seen within lung 
associated and peripheral lymph nodes. Overall the percentages of NK cells varied 
considerably between animals and administration of BCG did not significantly influence 
this level in the majority of tissues or lymph nodes. However, within retropharyngeal 
lymph nodes (Figure 6.1.2) which drain the site of inoculation, calves given BCG were 
found to contain higher percentages of NK cells when compared with naïve animals 
and this was significant on the draining (left) side (p=0.040).  
Detailed analysis of the proportions of NK cell subsets within these tissues highlighted 
considerable variations (Figure 6.1.3). As has been described previously, CD2- NK cells 
constituted the predominant population within all lymph nodes examined. In contrast 
tonsillar and lung tissues were found to contain a more equal distribution of CD2+ and 
CD2- NK cells with a minor predominance (50-55%) of the CD2+ NK cell population. 
Generally, NK cell populations within tissues contained higher proportions of CD2- cells 
when compared with the percentages found within peripheral blood. These 
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proportions were not found to be significantly altered within any of the tissues 
examined after administration of BCG (Figure 6.1.4). 
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Figure 6.1 Percentages of NK cells within head and respiratory tract tissues post-
intranasal BCG inoculation  
Calves were inoculated with BCG Pasteur delivered intranasally and tissues and lymph nodes 
from the head and lungs were obtained (Table 2.1) at post-mortem 7 days post-inoculation. 
Naive animals served as controls. Percentages of NK cells and subsets were determined by 
identifying NKp46+ lymphocytes and CD2 expression levels by flow cytometry. Data represents 
the average percentages of NK cells from 3 naive animals (pink) and 5 BCG inoculated (green) 
animals (Fig 6.1.1) with percentages of NK cells within RPLNs shown in more detail (6.1.2). 
Proportions of CD2+ (red) and CD2- (blue) NK cell subsets within tissues were determined 
(Figure 6.1.3) and ratios of CD2+:CD2- NK cells compared (Fig 6.1.4). Error bars denote the 
standard deviation between animals. Significance was assessed using paired T-Tests and a GLM 
with Tukey post-hoc comparisons (95% CI); p<0.05*. 
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6.2.2 Influence of subcutaneous BCG vaccination on NK cells within 
draining lymph nodes.    
Experiments conducted to determine the effects of intranasal BCG administration 
indicated small yet significant increases in the percentages of NK cells within draining 
lymph nodes (Left RPLN Figure 6.1.2). As the immune response may have been 
substantially dispersed amongst the lymphoid tissues found within the head and 
respiratory tract, further studies were conducted to ascertain how BCG administration 
may influence NK cell numbers and functionality within specific draining lymph nodes. 
Calves were vaccinated with BCG Pasteur (2.2.1), administered subcutaneously to the 
left shoulder and the prescapular draining lymph node was obtained at post-mortem, 
initially at 7 days post-vaccination. Lymph nodes from the right shoulder served as an 
internal control.   
Within the total lymphocyte population found within prescapular lymph nodes, NK 
cells constituted between 1-3% of cells (Figure 6.2.1) with a predominance of CD2- NK 
cells within this population (Figure 6.2.2). Comparison of numbers between the control 
and BCG administered draining lymph nodes resulted in no observed differences in the 
overall percentages of NK cells (Figure 6.2.1). Additionally, BCG administration did not 
alter the proportions of NK cell subsets (Figure 6.2.2).  
Studies have indicated that the DC induced recruitment of NK cells to draining lymph 
nodes may occur at early time points post-challenge and be transient in nature 
(Martin-Fontecha et al., 2004). For this reason, subcutaneous administration of BCG 
Pasteur was repeated within additional calves and prescapular lymph nodes were 
obtained at day 1 and day 3 post-challenge. Similar to day 7, NK cells numbers and 
proportions of NK cell subsets were not influenced by BCG at earlier time points (data 
not shown). 
As vaccination with BCG appeared not to induce the overall recruitment of NK cells to 
draining lymph nodes, further investigations were conducted to ascertain whether any 
phenotypical differences could be observed within the populations of NK cells. Calves 
were vaccinated with BCG Pasteur to the left shoulder and the right and left 
prescapular lymph nodes obtained 7 days post-challenge were analysed for CD25 cell 
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surface expression and intracellular perforin and IFNγ expression (2.12). Large 
percentages of both CD2+ and CD2- NK cells (30-40%) were found to constitutively 
express CD25 as has been reported previously (Boysen et al., 2008). However, BCG 
administration did not appear to influence these expression levels (data not shown). 
Additionally only a small percentage of NK cells from lymph nodes expressed 
detectable levels of perforin with none found to be expressing IFNγ. In a similar 
manner to CD25; perforin or IFNγ production was not significantly altered by BCG 
vaccination. 
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6.2.1 
 
6.2.2 
 
Figure 6.2 Percentages of NK cells within prescapular lymph nodes following BCG 
vaccination   
Calves received 1X106 cfu BCG Pasteur delivered subcutaneously to the left shoulder and 
draining prescapular lymph nodes (PS) were obtained at post-mortem 7 days post-challenge 
with nodes from the right shoulder serving as controls. Percentages of NK cells and subsets 
were determined by identifying NKp46+ lymphocytes and CD2 expression levels by flow 
cytometry. Data represents the percentages of NK cells from six animals within the BCG 
vaccinated left (L) PS and the control right (R) PS (Fig 6.2.1). Proportions of CD2+ (red) and CD2- 
(blue) NK cell subsets were determined (Fig 6.2.2) with error bars denoting the standard 
deviation between animals. Significance was assessed using paired T-Tests and a GLM with 
Tukey post-hoc comparisons (95% CI). 
0 
1 
2 
3 
4 
5 
PS R (Control) PS L (BCG) 
%
 N
K
 c
el
ls
 
0 
20 
40 
60 
80 
100 
120 
PS R (Control) PS L (BCG) 
%
 N
K
 c
el
ls
 
CD2+ 
CD2- 
 
205 
6.2.3 BCG vaccination induced alterations in the percentages of 
circulating NK cells  
Preliminary investigations to ascertain whether NK cells were recruited in vivo post-
BCG inoculation resulted in varying responses. Small increases in the percentages of 
NK cells were observed within retropharyngeal lymph nodes draining the site of 
intranasal inoculation however, a similar increase was not observed within draining 
prescapular lymph nodes following subcutaneous BCG vaccination. For this reason, a 
more global approach was undertaken. Vaccination experiments were repeated with 
calves receiving BCG Pasteur administered subcutaneously to the left shoulder and age 
matched naïve animals serving as controls (2.2.1). Percentages of NK cells within blood 
were monitored every day post-vaccination up until seven days followed by every 
fortnight thereafter for twelve weeks. Whole blood stimulation (week 7 post-
vaccination) with M.bovis derived purified protein (PPDb) confirmed the presence of 
antigen specific IFNγ responses in all vaccinated animals as an indication of successful 
delivery of BCG (data not shown).  
No significant changes in NK cell numbers were observed within the first week post-
vaccination (data not shown) or at any time points within naïve animals (Figure 6.3). 
However, two weeks following vaccination there was an observed increase in the 
percentages of circulating NK cells compared to naïve animals, with a peak in NK cell 
numbers at four weeks. At this time, percentages of NK cells within vaccinated calves 
were significantly higher than those found prior to vaccination (p=0.037) and also 
compared to naïve animals (p=0.008). Further analysis of the proportions of NK cell 
subsets, by determining CD2 expression levels highlighted no significant effect of BCG 
vaccination on the proportions of CD2+ or CD2- NK cells within the total NK cell 
population (data not shown).  
Detailed examination of intracellular molecule expression (2.12.1) indicated only a 
small percentage of NK cells expressing perforin. Over the twelve week sampling 
period, variations in perforin expression levels were observed however, as this was the 
case in both control and vaccinated animals, it is likely to reflect age related changes in 
expression, as previously described (Graham et al., 2009) rather than a response to 
 
206 
vaccination. Additionally, NK cells from both naïve and vaccinated animals did not 
express intracellular IFNγ at any of the time-points assayed (data not shown).   
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Figure 6.3 BCG vaccination induced changes in percentages of circulating NK cells 
Peripheral blood samples were obtained from eight animals; four of which received BCG 
Pasteur delivered subcutaneously to the left shoulder and four naïve animals which were age-
matched controls. Percentages of NK cells were determined by identifying NKp46+ lymphocytes 
pre-vaccination, each day up to seven days post-vaccination (data not shown) and every 
fortnight thereafter for twelve weeks. Data represents the average percentages of NK cells 
within the total lymphocyte population from BCG vaccinated (green) and naïve (pink) animals 
and error bars denote the standard deviation between animals. Significance was assessed 
using T-Tests and GLM with Tukey post-hoc comparisons (95% CI); p,0.05*,p<0.01**. 
 
 
 
 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
%
 N
K
 c
el
ls
 
Naïve BCG 
** 
 
208 
6.2.4 M.bovis induced alterations in the cytokine production and 
percentages of circulating NK cells   
Further in vivo experimentation sought to determine how infection with virulent 
M.bovis may induce early innate immune responses and in particular whether 
alterations in NK cell numbers and activation status could be observed. Peripheral 
blood samples were obtained from five animals intra-tracheally challenged with 
M.bovis (2.2.3) and percentages of NK cells (Figure 6.4.2) and proportions of NK cell 
subsets were analysed between days 2 and week 3 post-infection. Animals were 
slaughtered at week 12 and post-mortem examination of head and respiratory tract 
tissues to assess the size and severity of lesions revealed that all animals had lesions 
typical of bovine TB infection (9.8). 
Following M.bovis infection, alterations were observed in the percentages of NK cells 
(Figure 6.4.3) with significantly fewer circulating cells at both day 5 (p=0.009) and week 
2 (p=0.017) when compared with percentages of NK cells prior to infection. By week 3 
post-infection, cell numbers had recovered and were similar to pre-infection levels. 
Detailed analysis of the proportions of NK cell subsets, by determining CD2 expression 
levels highlighted alterations in the CD2- population (Figure 6.4.4). In particular the 
proportion of CD2- NK cells appeared to be significantly increased at day 2 post-
infection (p=0.014) compared with pre-infection levels, however the response was 
very small and no other alterations were observed at any other time point.   
In vitro data within co-culture experiments proposed significant alterations in NK cell 
activatory responses following mycobacterial infection (5.2). To determine whether 
this was also the case in vivo, expression of intracellular perforin and IFNγ by 
peripheral blood derived NK cells were assayed at early time-points following 
experimental challenge. As has previously been shown, small percentages of 
circulating NK cells were expressing perforin, however the observed levels did not 
change following infection. In contrast, significant changes in the percentages of NK 
cells producing IFNγ were observed. By day 2 (Figure 6.5.1) post-infection small 
percentages of CD2- NK cells were found to be producing detectable levels of IFNγ. 
This was also the case at day 5 (Figure 6.5.2) and was significantly augmented by week 
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2 (Figure 6.5.3) when compared with the percentages at day 2 (p=0.030) and day 5 
(p=0.003) (Figure 6.5.4). By contrast, CD2+ NK cells did not express IFNγ at any of the 
time-points analysed post-mycobacterial challenge.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
210 
6.4.1           6.4.2 
 
6.4.3 
 
6.4.4 
 
0 
2 
4 
6 
8 
10 
%
 N
K
 c
el
ls
 
0 
20 
40 
60 
80 
100 
120 
%
 N
K
 c
el
ls
 
CD2+ 
CD2- 
 * 
**  * 
 
211 
Figure 6.4 M.bovis induced changes in percentages of circulating NK cells 
Peripheral blood samples were obtained from five animals intra-tracheally challenged with 
M.bovis at time points between days 2 and week 3 post- infection (2.2.3). PBMCs were isolated, 
live cells identified by their FSC and SSC properties (Fig 6.4.1) and percentages of NK cells (Fig 
6.4.2 and 6.4.3) and proportions of CD2+ and CD2- NK cell subsets (6.4.4)  were determined by 
labelling lymphocytes with mAbs for NKp46 and CD2 and analysis by flow cytometry with pre-
challenge data serving as a control. Data represents the average values obtained from five 
animals with error bars denoting the standard deviation between animals. Significant changes 
in the numbers of NK cells and the proportions of subsets were assessed using log transformed 
data and a 1-Way ANOVA or GLM with Tukey post-hoc comparisons (95% CI); 
p,0.05*,p<0.01**. 
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Figure 6.5 M.bovis induced changes in cytokine production by NK cells 
Proportions of NK cell subsets producing IFNγ and Perforin from M.bovis infected animals  were 
determined by overnight incubation of PBMCs with TCM supplemented with BFA (10μg/ml) 
followed by intracellular cytokine staining (2.12.1.1). FACS plots from one representative 
animal are shown with proportions of CD2+ and CD2- NK cells producing IFNγ at days 2 (Fig 
6.5.1),  day 5 (Fig 6.5.2) and week 2 (Fig 6.5.3) post- challenge. Pooled data from five animals 
(Fig 6.5.4) represents the percentage of IFNγ positive NK cell subsets expressed as a percentage 
of the total CD2+ or CD2- population. Significant changes in the proportions of IFNγ producing 
NK cells were assessed using log transformed data and a GLM with Tukey post-hoc 
comparisons (95% CI); p,0.05*,p<0.01**. 
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6.3 Discussion  
The virulent airborne pathogen, M.bovis predominantly infects via the respiratory 
route with naturally infected cattle presenting with granulomatous lesions within the 
respiratory tract and head. Innate effector cells such as NK cells and γδ T cells are likely 
to be amongst the first lymphocytic populations to respond to infected antigen 
presenting cells within these localities. It has previously been documented that NK 
cells play prominent role during mycobacterial infection (Feng et al., 2006) and that NK 
cell derived IFNγ in particular is required for effective Th1 polarisation of the immune 
response (Martin-Fontecha et al., 2004). Under steady state conditions, as well as 
forming a constituent of the peripheral blood derived population, NK cells are also 
prevalent within a number of tissues. Bovine NK cells have been identified in the 
spleen, liver, lung and also within mucosal and non-mucosal lymph nodes (Boysen et 
al., 2008, Goff et al., 2006, Storset et al., 2004).  
Within this study, tissues and lymph nodes of the head and respiratory tract were 
comprehensively analysed with the view that these would be the regions directly 
afflicted by M.bovis infection. The highest percentages of NK cells were found within 
the apical to diaphragmatic region of the lung constituting 10-20% of the total 
lymphocyte population. Similarly innate lymphocytes are commonly found in 
significant numbers within tissues underlying mucosal surfaces such as the gut or 
uterine mucosa, to provide rapid innate defence mechanisms within areas that may be 
exposed to a high level of antigenic insult. In comparison, the head and lung associated 
lymph nodes contained smaller percentages (1-5%) of NK cells. Populations of NK cells 
have also been identified within human lymph nodes (Fehniger et al., 2003, Ferlazzo et 
al., 2004b) however, in contrast are largely excluded from lymph nodes in mice 
(Bajenoff et al., 2006, Gregoire et al., 2007). It has been hypothesised that the 
prevalence of NK cells within lymph nodes of cattle may be a reflection of the higher 
environmental microbial burden to which cattle are exposed to, resulting in a primed, 
CD25 expressing and cytolytic resident population (Boysen et al., 2008).  
Studies within this thesis have demonstrated significant heterogeneity in the 
responses of bovine NK cell subsets; with differential migration and cytokine release. 
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In particular, the production of IFNγ in response to M.bovis infected DCs was 
determined by the proportion of CD2- NK cells present within the total NK cell 
population. Therefore, a greater knowledge of the distribution patterns of bovine NK 
cell subsets within the tissues afflicted by mycobacterial infection may provide further 
insight into the pathogenesis and progression of infection. Bovine CD2- NK cells are 
found in predominant numbers within lymph nodes and it was confirmed that this was 
also the case within lymph nodes of the head and respiratory tract. It has previously 
been reported that IL-2 rich environments, as is the case within lymph nodes, may 
favour the expansion and persistence of CD2- NK cells (Boysen et al., 2008). In 
addition, within this thesis transcripts for CCR7 and CXCR3 were found at significantly 
higher levels within CD2- NK cells; expression of which would confer the capacity to 
home towards CXCL10, CCL19 and CCL21 rich lymphoid tissue. In contrast, the 
proportions of CD2+ and CD2- NK cells within the lungs and tonsillar regions were far 
more equal with a slight predominance of CD2+ NK cells. Within co-cultures of M.bovis 
infected DCs CD2+ NK cells appeared to possess a higher threshold for activation 
compared with CD2- NK cells, requiring both cytokines and cell-cell contact prior to 
activation and induction of cytolytic activity (5.2.4). In addition IFNγ release was only 
induced after optimal cytokine stimulation (5.2.2.1). The environment within the lungs 
and airways is regarded as being relatively anergic, with bovine alveolar macrophages 
reported to require multiple sequential signals in the form of LPS and IFNγ to promote 
bactericidal activity against M.bovis infection (Aldwell et al., 1997). Similarly it might be 
hypothesised that a larger proportion of CD2+ NK cells that require multiple stimuli 
prior to activation may represent a control mechanism to prevent the development of 
large inflammatory immune responses within the airways.  
Models that administer antigen by mimicking the natural route of infection provide a 
useful insight into the progression of an immune response within the tissues that 
would be specifically afflicted by mycobacterial infection. Within mice, intranasally 
delivered BCG was rapidly taken up by DCs (Reljic et al., 2005) with an increase in the 
absolute number of NK cells within the lung parenchyma (Saxena et al., 2002). 
Similarly, following infection with M.tuberculosis, NK cells were recruited to the lungs 
contributing to local IFNγ production (Junqueira-Kipnis et al., 2003). Corresponding 
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studies in cattle demonstrated increased numbers of IFNγ producing WC1+ γδ T cells 
within the pharyngeal tonsils and lung tissue 7 days after intranasal delivery of BCG 
(Price et al., 2010). Despite this, within similar studies we observed only a small 
increase in the percentage of both CD2+ and CD2- NK cells within the left 
retropharyngeal lymph node with no change in any other tissues within the head or 
respiratory tract following intranasal BCG inoculation. The retropharyngeal lymph 
nodes drain the tonsillar region and have been reported as the primary site of lesion 
formation, containing the highest bacterial counts following experimental infection 
with M.bovis (Griffin et al., 2006). Within our intranasal challenge studies, BCG was 
administered to the left nostril and the small yet significant changes in the NK cell 
population observed on this side may therefore be a reflection of elevated bacterial 
exposure and the ensuing immune response at this site. In further investigations, 
analysis of prescapular lymph nodes that specifically drain the site of subcutaneous 
BCG vaccination did not reveal any changes in the percentages, proportions of subsets 
or functional activity of NK cells at time-points ranging from 1 day to 2 weeks post-
vaccination.  
However, we observed a significant increase in the percentages of circulating NK cells 
at 2 to 4 weeks post-vaccination; time-points that correspond with early innate 
immune responses that may occur prior to the development of antigen specific 
immunity (Buddle et al., 1995, Hope et al., 2005b). Similarly Buza et al., (2009) also 
detected increased numbers of circulating γδ T cells in cattle as early as 1 week 
following BCG vaccination. It should however be noted that in future studies, the 
absolute numbers of NK cells would need to be considered in order to fully clarify 
whether the observed change in the percentages of circulating NK cells post-
vaccination are a true reflection of changes in NK cell numbers rather than as a 
consequence of changes in other lymphocytic populations.    
Substantial evidence suggests that BCG primes the innate immune response, with NK 
cells implicated as a source of early innate IFNγ (Hope et al., 2002b, Olsen et al., 2005). 
Herein, whilst changes in the circulating numbers of NK cells could be detected, within 
these studies we could not confirm substantial lymph node involvement. This 
however, does not completely discount a role of NK cells within lymph nodes. Murine 
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studies reported changes in the absolute numbers of NK cells (Saxena et al., 2002) 
upon intranasal BCG administration. We analysed the percentage of NK cells in relation 
to the total lymphocytic population and therefore changes in the absolute numbers 
would not have been detected. In addition, NK cells are largely excluded from murine 
lymph nodes and therefore recruitment during an inflammatory immune response is 
readily detectable. In comparison lymph nodes within cattle contain relatively large 
pre-existing resident populations. It has been reported that NK cells within activated 
lymph nodes are significantly more mobile resulting in a more wide-spread distribution 
and multiple transient interactions with DCs (Beuneu et al., 2009, Hall et al., 2010). In 
addition, upon intranasal inoculation with BCG, local re-distributions of resident γδ T 
cells within lymphoid tissue were observed (Price et al., 2010). It might therefore be 
hypothesised that during mycobacterial infection, rather than a large influx or 
expansion of NK cells, local resident populations may be re-distributed to regions 
where interactions with DCs may ensue prior to release into the circulation. Further 
investigations utilising immuno-fluorescent analysis would need to be conducted to 
determine if this was the case.  
In further preliminary studies, changes in NK cell numbers and phenotype were readily 
detectable in the periphery of M.bovis infected cattle. Similar responses have also 
been described within the bovine γδ T cell population (Kennedy et al., 2002). We 
observed an early decrease in the percentage of circulating NK cells, potentially 
signifying re-distribution and accumulation at the site of infection. In order to confirm 
this, tissues from M.bovis infected cattle would need to be analysed in detail by flow 
cytometry or immuno-fluorescent microscopy. Of interest was the finding that at time-
points prior to the decrease in total NK cells, a transient yet significant increase in the 
CD2- NK cell population was detected. Within in vitro studies, this thesis has 
demonstrated that CD2- NK cells are selectively recruited by M.bovis infected DCs and 
preferentially secrete IFNγ whilst reciprocally promoting DC maturation. As such, it 
may be this subset which is selectively released into the circulation or stimulated to 
proliferate in preparation for the immune response to M.bovis infection.  
Furthermore, evidence herein suggests that CD2- NK cells may play a prominent role 
during the early phases of infection, with IFNγ producing CD2- NK cells detected in the 
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periphery 2 days following M.bovis infection with increasing percentages over time. 
This may contribute to early attempts to control infection however, all animals within 
the M.bovis challenge studies were infected as evidenced by the development of 
lesions within the head and respiratory tract at post-mortem. It is therefore not known 
to what extent the observed responses are associated with protective immunity. 
Studies suggest that high circulating numbers of innate effector cells such as NK cells 
and γδ T cells contribute to the enhanced efficacy that is observed when BCG is 
administered to neonates (Buddle et al., 1995, Hope et al., 2011, Hope et al., 2005b). 
Therefore, future studies comparing vaccinated/infected animals versus infected 
animals would need to be conducted to determine whether any differences in the IFNγ 
responses of CD2- NK cells influence the severity of M.bovis infection and potentially 
correlate with protection.   
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7 Final Discussion 
Tuberculosis is a chronic respiratory illness caused by highly virulent mycobacterial 
species belonging to the M.tb complex. Whilst M.tuberculosis infects only humans, 
M.bovis has much broader host range (Thoen et al., 2006) and is the primary cause of 
TB within cattle. The increasing incidence of bovine TB poses a considerable burden to 
the UK economy as well as a potential health-risk through zoonotic transmission to 
humans. Control ‘test and slaughter’ strategies have been in place for over 50 years 
but have failed to curb the rise in infections particularly apparent in the South West 
regions of the UK. This at least in part may be due to the existence of a reservoir of 
infection with M.bovis endemic within the wild badger population. Shedding of 
M.bovis from infected badgers contributes to the persistence of infection resulting in 
repeated herd breakdowns and spread of bovine TB into new areas of the UK (Krebs et 
al., 1998, Smith et al., 2006). As a consequence, a number of strategies have been 
explored that attempt to control M.bovis infection in badgers as an indirect means to 
reduce the incidences within cattle. Badger culling trials conducted over a number of 
years concluded that whilst localised culling may be effective, long-term repeated 
initiatives would be required to continually remove infected badger populations over 
much larger areas. However, this strategy may not be logistically or financially feasible 
(Jenkins et al., 2010) and highlights the need for alternative control measures to be 
established. The vaccination of badgers with BCG has been licensed in the UK, with 
trials currently being conducted within regions of high incidences. However, it has 
been proposed that the most effective means of controlling bovine TB infection will be 
through development of an effective vaccination strategy for cattle (Krebs et al., 1998).   
The attenuated strain of M.bovis BCG is widely administered in humans throughout 
the world and still remains the most effective vaccine to prevent the most severe 
forms of TB. Despite this, the efficacy that is observed following BCG vaccination is 
highly variable and is most effective when administered to infants (Fine, 1995, 
Marchant et al., 1999). This is also true for cattle with a number of studies 
demonstrating enhanced protection against M.bovis challenge following neonatal 
vaccination (Buddle et al., 1995, Hope et al., 2011, Hope et al., 2005b). The reasons for 
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this are not completely understood however it is believed that exposure to 
environmental mycobacteria may inappropriately prime the immune system and 
influence the subsequent immune response to BCG vaccination (Buddle et al., 2002, 
Fine, 1995). Therefore the vaccination of neonates prior to substantial exposure may 
circumvent these issues. In addition, neonatal calves possess high circulating 
percentages of innate effector cells such as NK cells and γδ T cells that may contribute 
to an enhanced innate and subsequent adaptive immune response following BCG 
vaccination. 
However, BCG vaccinated cattle respond non-specifically in the tuberculin skin test 
that is used throughout the UK to identify M.bovis infected cattle and as a 
consequence, under current EU legislation the administration of BCG to cattle is 
prohibited. This has been the driving force for substantial research within the field, in 
attempts to identify novel vaccine candidates or alternative diagnostic strategies. It is 
clear that concurrent research into the fundamental immune responses that occur 
during M.bovis infection are also required in order to underpin the future 
development of preventative strategies against bovine TB infection. 
Research within this thesis has focussed on the potential for innate immune 
interactions to influence immune responses in cattle during M.bovis infection. It is 
widely accepted that the innate immune system not only functions as a front-line 
defence mechanism but also plays an implicit role in the shaping of adaptive immunity. 
In particular, small sub-populations of cytolytic lymphocytes known as NK cells can 
reciprocally interact with DCs to potentiate the priming of T cell responses. The precise 
mechanisms that confer protective immunity to mycobacterial infection have not been 
established however, the early release of IFNγ and Th1 polarisation is of fundamental 
importance (Cooper et al., 1993, Flynn et al., 1993, Orme, 2004, Welsh et al., 2005). 
This thesis therefore explored the hypothesis that bovine NK cells also play a 
significant role in the innate immune response to M.bovis infection. Previous research 
has defined phenotypically and functionally distinct subsets of bovine NK cells however 
their roles during infection have not been investigated. The main findings from this 
study are summarised in Figure 7.1. 
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Figure 7.1 The reciprocal interactions of M.bovis infected DCs and bovine NK cells  
DCs lining the trachea or resident within the lungs are likely to be amongst the primary 
populations responding to mycobacterial infection (1). NK cells form resident populations 
within the lung parenchyma and lymph nodes highlighting the potential for reciprocal NK DC 
interactions to occur both at the site of infection as well as within draining lymph nodes. DCs 
infected with M.bovis undergo a process of maturation resulting in augmented expression of 
inflammatory chemokines and selective recruitment of bovine NKp46+ CD2- NK cells. DC 
derived cytokines (IL-12) (2) alongside direct cell-cell contact (3) contribute to the activation of 
CD2+ and CD2- NK cells, however the precise contact dependent signals are yet to be 
determined. Upon activation, both CD2+ and CD2- NK cells up-regulate expression of perforin 
which corresponds to an increased capacity to kill target cell populations. In contrast, only CD2- 
NK cells secrete IFNγ (4). Evidence suggests that CD2+ NK cells (5) are more reliant on cell 
contact and cytokine stimulation to remain activated. During reciprocal interactions, CD2- NK 
cells enhance the maturation of DCs with increased intensity of MHC class II expression (6). 
Studies are required to determine whether this translates into an increased capacity to prime 
or activate adaptive immune responses during mycobacterial infection (7/8). The prominent 
role of NK cells during the innate immune response is evidenced by an increase in circulating 
numbers of NK cells following BCG vaccination and IFNγ expressing CD2- NK cells detectable 
within the periphery at early time points following M.bovis infection (9).  
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Substantial differences in the patterns of chemokine receptor expression between 
CD2+ and CD2- bovine NK cells derived from peripheral blood were demonstrated 
herein. Bovine CD2- NK cells transcribed higher levels of important inflammatory and 
lymphoid homing chemokine receptors when compared with the levels observed for 
CD2+ NK cells. These differences appeared to influence the migratory capacity with 
M.bovis infected DCs selectively recruiting CD2- NK cells within in vitro chemotaxis 
assays. Further analysis utilising co-culture assays highlighted the ability of M.bovis 
infected DCs to induce the effector responses of bovine NK cells in a cytokine and cell-
cell contact dependent manner. These interactions were reciprocal in nature with an 
enhanced intensity of MHC class II expression by M.bovis infected DCs following 
contact with bovine CD2- NK cells. Importantly, during this interaction only CD2- NK 
cells secreted IFNγ and significant differences in the activation requirements between 
both subsets of NK cells were observed. In addition, IFNγ expressing CD2- NK cells 
could be detected in the peripheral circulation of cattle as early as 2 days following 
infection with M.bovis.    
Whilst, this study has demonstrated significant involvement of bovine NK cells during 
M.bovis infection, the relevance of these responses in vivo in terms of protective 
immunity is not known. Murine studies have described the importance of NK cell 
derived IFNγ release, required for induction of cell mediated immunity (Martin-
Fontecha et al., 2004). The role of IFNγ in mycobacterial infection is a debated issue 
amongst researchers. It is believed that early innate secretion of IFNγ contributes to 
the control of bacterial replication as well enabling effective Th1 polarisation. 
However, during advanced stages of M.bovis infection in cattle, elevated levels of IFNγ 
positively correlate with an increased severity of infection (Vordermeier et al., 2002). It 
might therefore be hypothesised that at early stages following both vaccination and 
infection, the effective recruitment of bovine CD2- NK cells and subsequent 
interactions with DCs may function to potentiate Th1 immune responses in the 
development of protective immunity. Conversely, during advanced stages of infection 
the resident populations of NK cells within the lymph nodes and tissues of the head 
and respiratory tract may continue to interact with M.bovis infected DCs in an un-
regulated manner to contribute to the immuno-pathological state associated with 
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chronic TB infection. It is possible that the balance of CD2+ and CD2- NK cells within 
tissues afflicted by mycobacterial infection may be pivotal in determining the extent of 
damage, with a larger population of CD2- NK cells potentially more detrimental.  
Clearly, substantial research will be required to determine whether the observed 
responses in vitro influence the balance between protection or progressive infection.   
Interestingly, within in vitro assays the responses of BCG infected DCs and NK cells 
were substantially different. Whilst M.bovis infection of DCs augmented the 
transcription of a number of inflammatory and lymphoid homing chemokines, the 
same was not true for BCG. In a similar manner, DCs infected with BCG secreted 
reduced levels of IL-12 and IL-10 when compared with the levels observed with 
M.bovis. In addition, the intranasal or subcutaneous administration of BCG did not 
appear to substantially influence the percentages of NK cells within local tissues or 
draining lymph nodes. Published reports have defined the implicit nature of DC derived 
chemokines in the recruitment of NK cells, with the resulting interaction fundamental 
for the effective development of Th1-dominated immune responses (Martin-Fontecha 
et al., 2004). It might therefore be speculated that the inability of BCG infected DCs to 
promote the recruitment of NK cells may contribute to the varied efficacy that is often 
observed following vaccination. However, a more comprehensive study of the 
responses of bovine NK cell subsets with BCG both in vitro and in vivo would need to 
be conducted before this conclusion can be made.  
Nevertheless, the potential for targeting the NK cell and DC interaction for vaccine 
induced protective immunity is gaining precedence in a number of disease models. 
Adjuvants may be incorporated into vaccines to induce HIV specific NK cell effector 
responses (reviewed by (Altfeld et al., 2011)). In addition murine studies have 
described the capability of DC based vaccines in the induction of NK cell mediated anti-
tumour responses (Shimizu and Fujii, 2009). Perhaps most significantly however, is the 
finding that during reciprocal interactions NK cells function to enhance the maturation 
of DCs and therefore directly influence adaptive immune responses. In particular, it 
has previously been reported that DCs produced elevated levels of IL-12, increased 
expression of CCR7 and induced stronger T cell mediated IFNγ responses after contact 
with NK cells (Mailliard et al., 2003, Morandi et al., 2009, Van Elssen et al., 2010). The 
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findings within these studies have formed the basis for research into DC based 
vaccination strategies that promote NK cell and DC interactions to skew Th1 mediated 
immune responses. Given that protective immunity to mycobacterial infection is also 
reliant upon cell mediated CD4+ and CD8+ T cell responses, the interaction between 
bovine CD2- NK cells and DCs may represent an important target for future vaccination 
strategies against bovine TB. Particularly, since this interaction appeared to enhance 
the expression of levels of MHC Class II on DCs which may facilitate T cell stimulation. 
Importantly, murine studies have demonstrated the potential for targeting DCs for 
protective immunity against TB infection. Immunisation with DCs pulsed with viral 
vectors expressing mycobacterial antigens induced CD4+ and CD8+ T cell responses, 
conferring significant protection upon M.tuberculosis challenge (McShane et al., 2002). 
However, the involvement of NK cells within these responses was not determined and 
highlights the need for studies to investigate this interaction further as a factor that 
may influence protective efficacy. 
An important consideration in the development of a vaccine to target this pathway 
appears to be that the precise maturation stimuli utilised substantially influences the 
capacity of DCs to recruit and interact with NK cells (Gustafsson et al., 2008). Within 
murine studies, Martin-Fontecha et al., (2004) demonstrated that only certain 
adjuvants were able to promote T cell priming and this was dependent upon the ability 
of matured DCs to recruit NK cells to draining lymph nodes. Signalling via TLRs 
expressed by DCs appears to be an important prerequisite with ligands for TLR4 
stimulating the secretion of CCL5, the recruitment of NK cells (Van Elssen et al., 2010) 
and subsequent IFNγ release (Zanoni et al., 2005).   
The targeting of DCs for vaccination is a particularly attractive prospect in cattle and 
has been the focus of substantial research in recent years. The development of a 
bovine cannulation model enables the acquisition of afferent lymph containing ex vivo 
DCs that drain the site of subcutaneous vaccination (Hope et al., 2006). Evidence 
suggests that DCs within the skin of cattle exist as heterogeneous sub-populations  
that differ in their capacity to stimulate T cell responses (Howard et al., 1997). In 
particular, only a small subset of DCs that constitute on average about 20% of the total 
DC population were able to phagocytose BCG and were subsequently poorly able to 
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stimulate antigen specific CD4+ T cell proliferative responses (Hope JC, unpublished). 
As such, there may be potential to incorporate adjuvants alongside BCG to promote 
the recruitment and interaction between this sub-population of DCs and CD2- NK cells 
as a strategy to enhance T cell mediated immunity.  
In summary, this thesis has presented evidence to suggest that through interactions 
with DCs, bovine NK cells participate in the early innate immune responses to M.bovis 
infection. The distinct roles that NK cell subsets play are likely to be of significant 
importance in particular, in the shaping of adaptive immune responses. Further 
research is required to determine precisely how the responses observed herein 
influence the developing immune response. A greater understanding of the 
mechanisms by which NK cell and DC interaction confer protective immunity may 
underpin the future development of targeted prophylactic strategies in which this 
interaction can be exploited to our advantage.  
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9 Appendices 
9.1 Media 
Tissue culture medium (TCM) 
RPMI 1640 with Glutamax + 25mM HEPES 
10% foetal calf serum 
5x10-5M 2-mercaptoethanol 
Gentamicin (50µg/ml) 
 
Dendritic cell culture medium 
RPMI 1640 with Glutamax + 25mM HEPES 
25mM HEPES 
10% foetal calf serum 
5x10-5M 2-mercaptoethanol 
Gentamicin (50µg/ml)* 
IL-4 (rbo IL-4) 200u/ml 
GM-CSF (rbo GM-CSF) 0.2u/ml (Werling et al., 1999) 
*Gentamicin not included in infected cultures 
 
Phosphate-buffered saline (PBS) pH6.8 
Sodium chloride - 170 mM 
Potassium chloride - 3.4 mM 
Sodium phosphate - 9.2 mM 
Potassium phosphate -1.8 mM 
 
PBS/BSA/Azide 
Bovine serum albumin - 10 g/l 
Sodium azide - 0.1 % (w/v)  
PBS 
 
FACS Flow/BSA (0.5%) 
Bovine serum albumin -5 g/l 
FACS Flow - 0.22µm filtered 
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Ammonium chloride lysis buffer (0.1M) 
Ammonium chloride - 8.29 g/l 
Potassium hydrogen carbonate - 11 g/l 
EDTA (disodium salt) - 37 mg/l 
1M Sodium hydroxide - pH 7.2 
 
Middlebrook 7H9 medium  
Middlebrook 7H9 broth base - 4.7g 
Tween 80 - 0.5ml 
Sodium Pyruvate - 4.1g 
OADC Supplements - 100ml 
Super Q Water - 900ml 
Middlebrook 7H9, containing OADC, 0.05% Tween 80 and pyruvate (4.16 g/lt) – 
Microbiological Services, IAH 
 
Middlebrook 7H10 agar 
Middlebrook 7H10 agar base - 19.0g 
Super Q water - 900ml 
Following autoclaving: Oleic acid, bovine albumin, dextrose, beef catalase 
(OADC Supplements) - 100ml  
 
Middlebrook 7H11 agar 
Mycobacteria 7H11 agar - 18.9g 
0.6% Malachite Green solution - 1ml 
Super Q water - 770ml 
Following autoclaving: Amoxicillin (59mg/ml) - 2ml, Polymixin B (100,000U/ml) 
- 2ml, Trimethoprim (5mg/ml)- 2ml, Amphotericin B (2.5mg/ml)-20ml, Lysed 
sheep blood - 5ml, Foetal calf serum - 100ml, OADC Supplements - 100ml 
 
Guanidine Thiocyanate buffer 
Guanidine thiocyanate 4M  
tri-sodium citrate pH7 – 250mM 
Tween 80 0.5% 
Sodium N-lauryl sarcosine 0.5% 
Super Q water - 100ml 
Supplemented with 0.1M 2-mercaptoethanol prior to use  
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9.2 Monoclonal antibodies 
Antigen Antibody Isotype Specificity Supplier 
NKp46 
CD335 
IgG1 
Mouse anti-bovine 
 
AbD Serotec, UK CD335-PE 
CD335-FITC 
CD2 
ILA43 IgG2a 
Mouse anti-bovine 
IAH 
CC42-647 IgG1 IAH; Directly conjugated 
CD3 MM1A IgG1 Mouse anti-bovine VMRD, Washington 
CD25 
ILA111  
CACT108A 
IgG2a Mouse anti-bovine 
IAH 
VMRD, Washington 
IFNγ 
CC330-PE 
IgG1 Mouse anti-bovine 
IAH; Directly conjugated 
CC330 IAH 
CC302 IAH 
TNFα 
CC327 IgG2b 
Mouse anti-bovine IAH 
CC328 IgG2a 
IL-10 
CC318 IgG2b 
Mouse anti-bovine IAH 
CC320 IgG1 
IL-12 
CC301 IgG2a 
Mouse anti-bovine IAH 
CC326 IgG2b 
IL-6 CC310 IgG2b Mouse anti-bovine IAH 
CD4 CC30 IgG1 Mouse anti-bovine IAH 
CD8αα CC63 IgG2a Mouse anti-bovine IAH 
CD8αβ CC58 IgG1 Mouse anti-bovine IAH 
γδ TCR  GB21A IgG2b Mouse anti-bovine VMRD, Washington 
WC1 CC39 IgG1 Mouse anti-bovine IAH 
CD62L CC32 IgG1 Mouse anti-bovine IAH 
MHC II CC158 IgG2a Mouse anti-bovine IAH 
SIRPα 
ILA24 IgG1 
Mouse anti-bovine 
IAH 
CD172a-RPE/647 IgG2b AbD Serotec, UK 
CD40 ILA156 IgG1 Mouse anti-bovine ILRI Kenya, N McHugh 
CD80 N32/52-3 IgG1 Mouse anti-bovine ILRI Kenya, N McHugh 
CD86 ILA190 IgG1 Mouse anti-bovine ILRI Kenya, N McHugh 
Perforin 
Perforin-FITC 
IgG2b Mouse anti-human BD Pharmingen 
Perforin-PE 
CD16 KD1 IgG2a Mouse anti-human Dr D Pende, Italy 
CD27 MT271 IgG1 Mouse anti-human BD Pharmingen 
CD14 CCG33 IgG1 Mouse anti-bovine IAH 
CD11b CC94 IgG1 Mouse anti-bovine IAH 
CD21 CC21 IgG1 Mouse anti-bovine  IAH 
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9.3 Isotype controls 
Specificity Supplier 
Mouse IgG1 AF 488 conjugate Serotec Ltd 
Mouse IgG1 AF 647 conjugate CALTAG Laboratories 
Mouse anti-human IgG2b RPE conjugate 
BD Pharmingen 
Mouse anti-human IgG2b AF 488 conjugate 
Mouse anti-chicken Bu-1 (AV20-IgG1) 
Dr C Butter, IAH 
(Hope et al., 2000) 
Mouse anti-chicken CD4 (AV29-IgG2b) 
Mouse anti-chicken spleen cells (AV37-IgG2a) 
 
 
9.4 Fluorochromes 
Specificity Supplier 
Goat anti mouse IgG-RPE 
Southern Biotech Goat anti mouse IgG1-FITC 
Goat anti mouse IgG2a-FITC 
Goat anti mouse IgG2a-FITC Zenon® labelling kit - Invitrogen 
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9.5 Primer and Probe sequences 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) Probe (5’ FAM - 3’ TAMRA) 
CCR1 ATGGGCTTGTACAGCGAGAT CAGACGACAATGCTGGTGAT AGTCCGAGCCCGCAGAGCAA 
CCR2 CACAATGTGCTTCCCACATC GAGCTGTGCTTCGATTTGTC CCCTGCCGAAAGACCAGCGT 
CCR3 CAAATGCACTTGAAGGCTGA CAACGAAGGCATAGATCACG TCACCAGCATGGCCAGGTCC 
CCR4 GCCTCTGCAAGCTGATTTCT AGTCAAGGTCCTGGCTCTCA TACCTGGCCATCGTGCACGC 
CCR5 TGTCGCAACGAGAAGAAGAA TGCAGTTATTCAAGCCAAAGAA CGTCCTTCTCCTGAGCACCTTCCA 
CCR6 CTGCTCTTCGGCTTCTTCAT AGTTCTGCGCCTGGACTAAG CCGCTGGTGTTCATGATCTTCTGC 
CCR7 AGCCAATGAAGAACGTGTTG AATCGTCCGTGACCTCATCT TTTCCAGGTGTGCCTCTGCCA 
CCR8 TTCTGGGTCCCTTTCAACAC CTCATGACACACCCATCCAG TTCCCTGCATGACATGCACGTC 
CCR9 CACAGAAGCCACAAGCCTAA TCTCACAGAAGTAGTCCGTGAAG TGCCGTCGTACTCCATGGGC 
CCR10 CCGCAGAACAGGTCTCCT GGGAGACACTGGGTTGGA TCCAGGCCTTCAGTCGCGC 
CXCR1 GGGTTTGAGGATGAGTTTGAA CAG TGCTTATCTCACAGGGACT TCTTCTGTGGGTGGCGTGCC 
CXCR2 ACC TGCCCTCTATTCTAACAGA GCA TGCTTATTGATA TCCAGAATTT CTGCCCCATGTCGGCCAG 
CXCR3 TGAGATGAGTGAACGCCAAG GCACAAAGAGGAGGCTGTAGA CCTGCCCACAGGACTTCAGCC 
CXCR4 TTGCTGACATCAAGGAGGTG ACCACGATGTGCTGAAACTG TCCCAGCGACCTGTGGCTAGTG 
CXCR5 ATGAACTACCCTCTCACTCTGGA CTCCCTAATTCCTTGTACAGGTC CATGGACCTCATGAACTACAACCTGGA 
CXCR6 TTCCGGAAGCACAAGTCTCT GATGAGCTTCACGAGGTTGA CAGGAACACCGCCACCACCA 
CX3CR1 CCATCCTGACCACCTCAGTT CATCTCCATCGCTGGTGTAA TCCCGCCTGCTCCTTTGTGA 
XCR1 TCCTGTACTGCCTGGTGTTC GTCTGAGAGGCACAGGTTGA TCAGCCTGGTGGGCAACAGC 
 
 
 
 
  
2
6
0
 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) Probe (5’ FAM - 3’ TAMRA) 
Chemokines    
CCL2 GCTCAGCCAGATGCAATTAAC CACTTGCTGCTGGTGACTCT TCCCAAGTCGCCTGCTGCTATACA 
CCL3 GCCTGCTGCTTCTCCTATGT TTTGAGACCAGCAGCCAGT CCCGGCAGCTTTCTCGCAAA 
CCL4 ATGAAGCTCTGCGTGACTGT  TCACAAAGTTGCGAGGAATC CGCTCTCAGCACCAATGGGC 
CCL5 CCTGCTGCTTTGCCTATATCT  AGCACTTGCTGCTGGTGTAG CCGCACCCACGTCCAGGAG 
CCL8 GCTCAGCCAGATTCAGTTTCT TGTAGCTGTCCAGCTTCTTGA CCCAATCACCTGCTGCTTTAGTGTGA 
CCL20 TCAGAAGCAAGCAACTTCGAC GATGTCACAGGCTTCATTGG CCAGCTGCTGTGTGAAGCCCA 
CXCL8 TGAAGCTGCAGTTCTGTCAA TGGAAAGGTGTGGAATGTGT TGAGTACAGAACTTCGATGCCAATGCA 
CXCL9 CAAGCAAAGCAGTTTGGTGT CCACAGGCTGATGCAAATAC CTGGGCCTTGCCAAGCTGCT 
CXCL10 ACTCTGAGTCAAGGTGTACCTCTCT GGATTGACTTGCAGGAATGA CGCTGTTCCTGCATCGAGATCA 
NK cell receptors    
NKp30 AGCTGCACATCTGGGACAC GAGGTCCTTCCTCCACCAC CGACACCCAGGCCCAGCAC 
Ly49 CAAAGACCTGACAAGACTGAGG TTGCAGTGACTCTTGGGATC AAGAGTCTTCAGTGCCCTGGCATG 
Toll-like receptors    
TLR1 GCACCACAGTGAGTCTGGAA CAACTGGAGGATCGTGAAGA TGTGTGCTTGATGATAATGGGTGTCCT 
TLR2 ACGACGCCTTCGTGTCCTAC GCTCCTGGACCATGAGGTTC CGAGCGGGATTCCTACTGGGTGG 
TLR3 AAAGAGTTCTCTCCTGGGTGTT TGCTCAGGGACAGATTCTCA CAATGCCAAGCTGAGCCCCA 
TLR4 TGGAGGACATGCCAGTGCT CACCGACACACTGATGATCGT AGTTTCAGGAACGCCACTTGTCAGCTG 
TLR5  CTAGACCTGGGTGGAAGTCAG AGGGATGAAGGTAAAGACTCTGAA TTCCTGTGGTCTCTCCGATGCTG 
TLR6 CCTGCCCATCTGTAAGGAAT TAGGTGCAAGTGAGCAATGG TTGGCAACTTGACCCAACTGAATTTC 
TLR7 GCTGAAGACTGTCCCTGAGA TTTGAGCTGAGGTCCAGATG TCCAACTGTTCCCGCAGCCTC 
TLR8 TCCACATTTGAAACGAAGACC ACATCGGTCAGTCTGGGAAC CCTGACGTTCAGATTTCTGTCCATCC 
TLR9 CACCATCTTCAACGACCTGA CTTCTCCAGGGACACCAGAC TCCTTCGCCCACCTGCACCT 
TLR10 TGGTTGGATGGTCAGATTCA CAGGGCAAATCAAAGTGGA CCATTGTGGTTGTCATGCTCGTTCT 
Housekeeping gene    
BoPo GCACAATTGAAATCCTGAGTG GGGTTGTAGATGCTGCCATT AGCGAAGCCACGCTGCTGAA 
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9.6 Gating strategies 
9.6.1 Identification of NK cells in co-culture  
  
Live lymphocytes were identified by their FSC/SSC properties and NK cells within co-cultures 
were differentiated by identifying NKp46 positive lymphocytes  
 
 
9.6.2 Identification of P815 cells in killing assays with NK cells  
 
 
P815 target cells were identified by their FSC/SSC properties and CFDA-SE positive cells   
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9.7 Statistics results (P values) 
Comparison of chemokine receptor transcripts between NK cell subsets in the blood 
and prescapular lymph nodes  
 Blood 
CD2+ vs CD2- 
Prescapular lymph node 
CD2+ vs CD2- 
CCR1 0.0013 0.0011 
CCR2 0.0006 0.1563 
CCR3 0.8901 0.8528 
CCR4 0.6560 0.1191 
CCR5 0.0054 0.6144 
CCR6 0.0334 0.2662 
CCR7 0.0007 0.0030 
CCR8 < 0.0001 0.0094 
CCR9 0.6973 0.0572 
CCR10 Not enough data  Not enough data 
CXCR1 0.3141 0.5805 
CXCR2 0.1202 0.6512 
CXCR3 0.0004 0.2695 
CXCR4 0.0009 0.4896 
CXCR5 < 0.0001 0.9584 
CXCR6 < 0.0001 0.2433 
CX3CR1 < 0.0001 0.0002 
XCR1 0.4887 0.8184 
 
Comparison of chemokine receptor transcripts between the blood and prescapular 
lymph nodes  
 CD2+ 
Blood vs PSLN 
CD2-  
Blood vs PSLN 
CCR1 0.0821 0.4714 
CCR2 0.0088 0.3824 
CCR3 0.0317 0.0271 
CCR4 0.0299 0.1615 
CCR5 0.0015 0.009 
CCR6 0.0011 0.0109 
CCR7 0.0004 0.0529 
CCR8 0.6468 0.5686 
CCR9 0.5881 0.0002 
CCR10 Not enough data 0.1802 
CXCR1 0.0648 0.0171 
CXCR2 0.4841 0.2365 
CXCR3 < 0.0001 0.0143 
CXCR4 < 0.0001 0.0012 
CXCR5 < 0.0001 < 0.0001 
CXCR6 0.0033 < 0.0001 
CX3CR1 0.0014 0.0146 
XCR1 0.6557 0.9877 
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Comparison of toll-like receptor transcripts between NK cell subsets in the blood  
 
 Blood  
CD2+ vs CD2- 
TLR1 0.0457 
TLR2 0.0787 
TLR3 0.0002 
TLR4 0.0010 
TLR5 0.5843 
TLR6 0.0988 
TLR7 0.0196 
TLR8 0.8904 
TLR9 0.5286 
TLR10 0.1211 
 
 
Comparison of chemokines transcribed by infected DCs – each time point compared 
with negative control.  
 
  CCL2 
(MCP-1) 
CCL3 
(MIP1α) 
CCL4 
(MIP1β) 
CCL5 
(RANTES) 
CCL8 
(MCP-2) 
CCL20 
(MIP3α) 
CXCL8 
(IL-8) 
CXCL9 
(MIG) 
CXCL10 
(IP10) 
D
C
 +
 M
.b
o
 
          
3hr 0.808 0.000 0.000 0.001 0.211 0.000 0.808 0.313 0.022 
6hr 0.931 0.016 0.000 0.032 1.000 0.000 0.012 1.000 1.000 
12hr 0.856 0.000 0.000 0.000 0.938 0.000 0.000 1.000 0.998 
24hr 0.827 0.000 0.004 0.000 0.922 0.000 0.000 1.000 0.541 
          
D
C
 +
 B
C
G
 
          
3hr 0.999 1.000 0.811 0.455 1.000 1.000 1.000 1.000 0.987 
6hr 0.990 0.746 0.160 0.999 0.996 0.009 0.599 0.423 1.000 
12hr 1.000 0.932 0.176 0.023 1.000 0.000 0.947 1.000 0.981 
24hr 0.964 0.554 0.993 0.000 1.000 0.000 0.141 0.994 0.879 
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Comparison of chemokines transcribed by infected DCs – time-point comparison for 
each chemokine  
 
 
CCL3 3h 6h 12h 24h 
 
CCL4 3h 6h 12h 24h 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
D
C
 +
 M
.b
o
 
3h   0.985 0.006 0.000 
 
3h   1.000 0.747 1.000 
6h     0.236 0.006 
 
6h     0.221 1.000 
12h       0.984 
 
12h       0.568 
24h         
 
24h         
           CCL5 3h 6h 12h 24h 
 
CCL20 3h 6h 12h 24h 
3h   0.782 1.000 0.923 
 
3h   0.048 0.000 0.000 
6h     0.429 0.032 
 
6h     0.000 0.000 
12h       0.997 
 
12h       1.000 
24h         
 
24h         
           CXCL8 3h 6h 12h 24h 
      3h   0.962 0.022 0.001 
      6h     0.388 0.036 
      12h       0.988 
      24h         
      
           
            
   
   
D
C
 +
 B
C
G
 CCL5 3h 6h 12h 24h 
 
CCL20 3h 6h 12h 24h 
3h   0.446 0.224 0.020 
 
3h   0.013 0.000 0.000 
6h     1.000 0.698 
 
6h     0.094 0.030 
12h       0.917 
 
12h       0.999 
24h         
 
24h         
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9.8 Pathology scores  
Pathology scores at post-mortem - 12 weeks post-M.bovis challenge  
 
(VL) – Visible lesions 
 
 
  
Animal ID No VL LN Total LN 
score 
No VL Lung 
lobes 
Total lung 
score 
Total path 
score 
C09-5134 2 4 2 7 11 
C09-5135 1 3 2 6 9 
C09-5136 2 4 1 4 8 
C09-5137 1 3 1 4 7 
C09-5138 0 0 1 5 5 
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9.9 Suppliers 
Ambion  
 DNA-Free Kit 
Amersham Biosciences  
 Streptavidin horseradish peroxidase 
Applied Biosystems  
 TaqMan FAST Universal PCR Master Mix 
 ABI Prism 7500 Fast Real-Time PCR System 
 7500 Fast System SDS Software 
Becton Dickinson (BD)  
 40µm cell strainers 
 FACSFlow 
 FACSAria™ cell sorting system 
 FACS Permeabilisation solution 
 Difco™; BD, Oxford,  
UK Middlebrook 7H9 culture medium 
 Middlebrook 7H10 agar 
 Middlebrook 7H11 agar 
 FACSCalibur Flow Cytometer 
BMG Labtech  
 FLUOstar Optima Luminometer 
Corning Life Sciences  
 Costar Tissue Culture-Treated Transwells  
De Novo Software  
 FCS Express 3 
Eurogentec  
 Probes (5’ FAM and 3’ TAMRA) 
ICN Biomedicals  
 3,3’-5,5’ tetramethylbenzidine (TMB) 
Invitrogen  
 RPMI 
 SuperScript® III Reverse Transcriptase 
 Alexa Fluor 647 protein labelling kit 
 Vybrant® CFDA-SE Cell Tracer Kit 
 Zenon® labelling kit – IgG2a-FITC 
 Vectors PCR2.1 – TOPO TA vector 
Leo Laboratories  
 Heparin Sulphate  
Microsoft  
 Excel 2003 Software 
Miltenyi Biotech  
 MACS cell separation system 
  
 Rat Anti-Mouse IgG1 MicroBeads 
 Anti-human-CD14-coupled paramagnetic 
 MACS LS columns 
Nalge  
 24-well tissue culture plates 
Nunc  
 8 well tranwsell strips 0.2µm 
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 96 u-well cell culture plates 
 96 flat well cell culture plates 
 6 well cell culture plates 
 0.4mm tissue culture membrane inserts 
 F96 Maxisorp Nunc Immunoplate 
 96F Maxisorp Black Microwell plate 
Perbio  
 SuperSignal Femto Maximum Sensitivity 
Substrate 
Promega  
 GoTaq DNA polymerase 
 pGEM-Teasy TA cloning vector 
Qiagen  
 Qiashredders 
 RNeasy Mini kits 
 RNeasy Micro kits 
 Qiaquick PCR purification kit 
 Qiaprep spin miniprep kit 
R&D Systems  
 Bovine IL-2 ELISA kit 
Roche  
 Expand High FideltyPlus PCR system 
Scientific Laboratory Supplies  
 96-well transparent plates 
Sigma-Aldrich  
 Gentamicin 
 2-mercaptoethanol (2-ME) 
 Non-enzymatic cell dissociation medium 
 Histopaque 1083 
 Brefeldin A (BFA) 
 Paraformaldehyde 
 Propidium Iodide 
 Concanavalin A (Con A) 
 Bovine Serum Albumin (BSA) 
 Carbonate/bicarbonate buffer capsules 
 Casein 
 Tween-20 
 1M Sulphuric Acid 
 Guanidine Thiocynate (GTC) 
 Ammonium Chloride 
 Primers 
Terumo Europe   
 18G needles 
 Syringes  
TCS Cell Works  
 Foetal Calf Serum (FCS) 
Thermoscientific  
 NanoDrop 1000 spectrophotometer 
Veterinary Laboratories Agency  
 Avian Tuberculin (PPDa) 
 Bovine Tuberculin (PPDb) 
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9.9.1 Recombinant chemokines  
 
Immunotools  
 Recombinant human CXCL11 (I-TAC) 
 Recombinant murine CCL5 (RANTES) 
 Recombinant human CCL2 (MCP-1) 
 Recombinant human CXCL10 (IP-10) 
 Recombinant human CCL3 (MIP-1α) 
 Recombinant murine CCL3 (MIP-1α) 
 Recombinant human CCL19 (ELC) 
 Recombinant human CCL2 (MCP-1) 
Imperial college London – Dr J Pease  
 Recombinant human CXCL11 (I-TAC) 
 Recombinant human CXCL9 (MIG) 
 Recombinant human CXCL10 (IP-10) 
 Recombinant human CCL17 (TARC) 
 Recombinant human CCL1 (I-309) 
 Recombinant human CCL22 (MDC) 
Peprotech  
 Recombinant murine CCL19 (ELC) 
 Recombinant murine CCL21 (SLC) 
 Recombinant human CXCL12 (SDF-1a) 
 Recombinant murine CXCL10 (IP-10) 
 Recombinant human CX3CL1 (Fractalkine) 
 Recombinant human CXCL13 (BCA-1) 
 Recombinant murine CXCL13 (BCA-1) 
 Recombinant human CXCL16 
 Recombinant murine CXCL16 
R&D Systems  
 Recombinant human IL-18 
 Recombinant human CXCL8 (IL-8) 
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